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vAbstract
The goal of biology is to understand how complex systems such as cells and en-
tire organisms function. Systems Biology attempts to quantitatively characterize all
components comprising these systems. A considerable task. Microfluidics provides a
powerful tool for undertaking this endeavor. This thesis describes the development
of Microfluidic Large-Scale Integration (MLSI) using devices fabricated by Multi-
layer Soft Lithography (MSL). MLSI and fluidic components, such as multiplexers
and free-standing membranes, serve as the infrastructure for performing large-scale
biophysical measurements of biological systems. Transcription factor binding energy
landscapes were determined using MLSI and MITOMI, a novel method for measuring
molecular interactions. The biophysical characterization of transcription factors de-
scribed herein were the first comprehensive measurements of their kind, and answered
basic questions regarding how transcription factors recognize DNA. Furthermore, it
was possible to predict the in vivo function of transcription factors using only the
measured binding topographies and a genome sequence, indicating that biological pro-
cesses can be predicted with high accuracy. More generally, the methods described in
this thesis are generally applicable to understanding the properties of any biological
system and should find broad usage in the field of Systems Biology.
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1Chapter 1
Overview
Biology has progressively moved away from characterizing isolated systems and moved
towards understanding systems in their entirety, giving rise to the field of Systems
Biology. Just as with Genomics and Proteomics before, Systems Biology is primarily a
technology-limited field. Pertinent questions to ask are relatively easy to identify, but
techniques applicable to these problems generally do not exist and must be specifically
designed.
Microfluidics presents an extremely useful technique for asking large-scale ques-
tions, because it allows assays to be both scaled down, saving precious biological
samples, and highly integrated. Microfluidic Large-Scale Integration (MLSI) was
developed to achieve this scaling and parallelization, taking the standard micro-
mechanical valve fabricated by Multilayer Soft Lithography (MSL) and integrating
it several thousands of times, generating microfluidic devices that can perform large
numbers of complex biological assays.
Besides MLSI, additional components needed to be developed, such as fluid control
elements and novel detection methods. These components are described in detail
in Chapter 2. Section 2.3.1 describes the design and application of a microfluidic
2multiplexer, which allows the addressing of an exponentially large number of fluidic
channels with a small number of control elements. Use of a multiplexer is essential
to reducing the number of interconnects between the microfluidic device and the
lab. The optimal design of a multiplexer was also discovered, which, unlike the
commonly used binary design, is indeed a ternary one. A fluidic input tree is described
in Section 2.3.2, which allows the introduction of a large number of fluids onto a
device without cross-contamination. A third broadly applicable component, or design
feature, described in Section 2.3.3 involves the use of a control line cascade, allowing
multiple levels of control lines to be staggered. Cascading of control lines achieves
even higher-degrees of integration and complexity than would otherwise be possible;
cascading can also be used to change the logic functions of existing components such
as the multiplexer. A final component, described in Section 2.3.4, is a free-standing
membrane, which, unlike a standard valve, does not shunt liquid but rather contacts
the flow channel surface, physically protecting it from the surrounding solution. This
physical surface contact can be used for surface derivatization as well as detection of
molecular interactions. Most of these fluidic components were integrated into devices
designed for the high-throughput screening of enzyme libraries generated by directed
evolution. These devices and methods are described in Chapter 3.
To study problems in Systems Biology it was not enough to only develop novel
microfluidic components; the biology needed to be addressed as well. In vitro anal-
ysis of biological systems always requires the acquisition of the components to be
studied, most commonly proteins and DNA. DNA is relatively easy to obtain as it
3can be readily synthesized. Proteins, on the other hand, are difficult to produce
and may not always be in a correctly folded state. In Systems Biology obtaining
protein is particularly problematic, as not only one or a small number of proteins
are needed, but often entire proteomes with thousands of members. Chapter 4 ad-
dresses this issue and describes the development of a rapid PCR-based approach for
generating linear expression templates for use in in vitro transcription/translation
systems (ITT). ITT together with the PCR-based approach for template generation
can in principle rapidly generate large-scale, functional protein libraries, especially
when used in conjunction with microfluidics. Coupling these large libraries of linear
expression templates to microfluidics required the development of novel methods for
device programming. This issue of interfacing microfluidic devices with the rest of the
laboratory is known in the field as the ’world-to-chip interface problem’ and is non-
trivial. Chapter 6 presents solutions to this problem, including a powerful approach of
using microarrays for device programming. Here, a single microarray can program a
device with thousands of unique solutions. Once a device is programmed using either
microarrrays or standard surface chemistry (Chapter 5), protein can be synthesized
by ITT. Microfluidics has advantages over classical bench-top approaches, not only
because reagent consumption is minimal, but also because protein may be synthesized
in batch, semi-continuous, and continuous mode; the latter two approaches having
the potential of drastically increasing the final yields.
Completing the integration of high-throughput biology with microfluidics required
the adoption of existing detection methods for molecular interactions and the devel-
4opment of entirely novel methods. Chapter 7 describes the adoption of standard
methods such as antibody-based pull-downs and enzyme methods useful for signal
amplification. A novel detection method, based on the mechanically induced trap-
ping of molecular interactions (MITOMI), was developed to address the need to de-
tect transient and low-affinity biological interactions. All high-throughput methods
— including yeast two-hybrid, mass spectrometry, and protein arrays — only detect
relatively high-affinity interactions. But many biologically interesting interactions are
rather transient in nature. Transcription factor – DNA interactions being one exam-
ple, and the list can be extended to signalling cascades such as the MAPK kinases and
g-protein coupled receptors. MITOMI physically traps interactions at equilibrium,
and renders their dissociation rates irrelevant. Due to the simplicity of MITOMI it
should prove to be widely applicable, potentially having a large impact on the life
sciences.
The technological advances described in Chapters 2–7 were applied to the anal-
ysis of transcription factor binding energy landscapes. Transcription factors play an
intricate role in most, if not all, cellular processes, as they regulate which genes are
expressed at any given time. Due to their importance, transcription factors have
been studied for several decades, elucidating not only the structural basis of DNA
recognition for the various families of transcription factors, but also the topology of
transcriptional regulatory networks. One problem that has thus far been intractable
is measuring the thermodynamics of transcription factor – DNA binding. Unlike en-
zymes, which have been described in great detail, transcription factors bind to not
5only a single target but can bind to a large number of possible DNA sequences. To
understand the biophysical properties of a transcription factor, its affinity to hun-
dreds if not thousands of possible sequences needs to be measured. Exacerbating this
already logistically challenging problem is the fact that measuring the affinity of a
single interaction requires several measurements taken over various concentrations of
one of the two components. From these binding isotherms, the equilibrium dissoci-
ation constant can then be established. This could only be accomplished by using
all technological elements described in Chapters 2–7, including device programming
and, particularly, MITOMI. Binding energy landscapes were established for 4 bHLH
transcription factors, a bZIP transcription factor, and a Zn finger transcription factor.
Two of the bHLH transcription factor binding energy landscapes were then used to
predict in vivo function using solely the biophysical characterization and the genome
sequence. The in silico prediction of transcription factor function worked exceedingly
well, despite the limited amount of information used in the algorithm, raising the
question of whether cells may one day be simulated with sufficient information about
the system. Not only was it possible to use the binding energy landscapes to predict
function, but a basic question of whether base contacts are dependent or independent
could also be answered. The binding energy landscapes for all transcription factors
determined here indicate that base contacts are indeed dependent, and can’t be sat-
isfactorily described with weblogos or position weight matrices (PWMs), which are
universally used today.
The final two chapters, 9 and 10, quickly summarize efforts to understand the
6structure and function of the 19s regulatory particle of the proteasome and the use
of yeast cell arrays, respectively. Chapter 10 provides insights into future research
directions, centered on understanding protein dynamics on the single-cell level with
high temporal and spatial resolution. In short, life yeast cell arrays are generated
by microarraying yeast libraries. These spotted arrays are then transformed into life
yeast cell arrays by growing the cells on-chip. Additionally these yeast cell arrays
may also be transformed into yeast protein arrays presenting an alternative method
for generating protein arrays, as described in Chapter 6.
To summarize, this document describes the development of MLSI and novel com-
ponents for the high-throughput characterization of proteins using microfluidic de-
vices. Specifically, transcription factors were characterized in unprecedented detail
by using MITOMI to measure the binding energy landscape topographies. These
topographies could be used to predict the function of the measured transcription
factor, as well as answer questions regarding the mode of DNA recognition. More
generally, the methods described here are broadly applicable and should increase the
knowledge of large biological systems, including transcriptional regulatory networks,
protein-protein networks, signaling networks, and so forth.
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Microfluidics
2.1 Introduction
Microfluidics promises to become a ubiquitous tool in the biological sciences. Reasons
for this are numerous and include unprecedented throughput and economy of scale,
enabling biologists in the era of ’-omics’ and Systems Biology research. Economy of
scale is accomplished by carrying out reactions on devices with length scales ranging
from tens to hundreds of microns, resulting in nano- to picoliter reaction volumes,
which are up to six orders of magnitude smaller than current standards. Because of
these small volumes and length scales, microfluidic assays can be highly parallelized
so that many hundreds to thousands of reactions may be performed simultaneously on
a single device with a footprint of just a few square centimeters. Finally, it is possible
to perform complex fluidic manipulations, such as mixing and metering, making it
possible to scale down most existing bench-top assays, as well as design novel exper-
iments enabled by smaller length scales, volumes, and fluid physics encountered on
microfluidic devices. Therefore, microfluidics with its economy of scale, high degree
of integration, and fluid control is becoming an integral component of life science
8research, especially, Systems Biology.
Common materials for the fabrication of microfluidic devices include poly-dimethyl
siloxane (PDMS) and silicon. Devices are manufactured using common semi-conductor
industry techniques such as photolithography and etching. The Quake laboratory fo-
cuses on PDMS device fabrication using a method called multilayer soft lithography
(MSL)[1]. Shortly, MSL produces microfluidic devices with at least two distinct flu-
idic layers stacked on top of one another. A thin deflectable membrane of PDMS
forms the interface between the two layers, which in turn may function as a valve
if it is either pneumatically or hydraulically actuated. With a functional valve in
hand more complex fluidic structures may be built, such as pumps [1], rotary pumps
[2], sieve valves [3, 4], multiplexers [5, 6], and freestanding membranes [7]. One of
the main strengths of the monolithic PDMS valve is its simplicity, both in its basic
structure as well as in its manufacturing. This simplicity makes it possible to design
and manufacture highly integrated devices containing thousands of valves robustly
and with minimal effort [5].
Assays performed on microfluidic devices to date can roughly be subdivided into
cell- and molecular-based assays. Multi- as well as single-cell assays have been per-
formed on various cell types including E.coli [8], S.cerevisiae, and eukaryotic cells [9].
Multicellular organisms such as drosophila larvae have also been investigated [10]. Mi-
crofluidics excels at cellular assays, primarily because the length scales of the object
under study and the device used for interrogation are matched. For mammalian cell
assays microfluidics is well suited since the channel dimensions roughly match those of
9the cells, which have diameters on the order of 5–25 µm. Length scales are still off by
one to two orders of magnitude for prokaryotic cells, but even here single-cell assays
can be performed with relative ease. A steady-state bacterial culture can reach up
to 1012 cells per liter, which translates into 1 cell per picoliter. Thus using chambers
on the order of hundreds of picoliters and a hundred fold dilution of the initial stock
solution will result in a distribution of single cells. Scales are not completely matched
but they are considerably closer than standard bench-top approaches, allowing for
more refined and sophisticated experiments at the single-cell level.
By now almost all standard molecular assays in modern biology have been ported
to microfluidic devices, including PCR [11], enzyme-linked immunosorbent assays
(ELISA) [12], in vitro transcription/translation (ITT) [13], separations and purifica-
tions of both DNA [14] and protein, as well as protein crystallization [15, 16, 6, 17].
Some of these assays have been performed on the single-molecule level, allowing the
investigation of non-ensemble behavior of individual molecules, kinetics, and biophys-
ical properties. The unrivaled economy of scale of microfluidic devices is particularly
important for molecular assays, where most assay components are exceedingly expen-
sive or difficult to obtain. Furthermore, the small length scales enable fast reaction
times, even without convective mixing.
Microfluidic devices thus serve as a powerful Swiss Army knife for the molecular
and cellular biologist. The design modularity of PDMS devices fabricated by MSL is
only limited by the creativity of the researcher, leaving plenty of room for improve-
ments on basic device characteristics, components, and applications. The next few
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sections describe new fluidic components especially pertinent to studying large-scale
molecular interactions, such as the mutliplexer, fluid input trees, and a freestanding
membrane used for surface derivatization and molecular detection.
2.2 Microfluidic Large-Scale Integration
In 2000 the Quake lab reported a device with a total of 36 micromechanical valves
fabricated by MSL [1]. In 2001 work was in progress on a device designed by Todd
Thorsen, called serpentine enrichment chip (SEC) containing ∼ 1400 valves on a
footprint of 6 cm2 or about 233 valves/cm2. Even though the total number of valves
was quite high, about 75% of them were part of the central grid and essentially
formed a single valve system. A second device in development in the lab during that
time was a device for the screening of protein crystallization conditions [15] which
contained a total of 480 valves on a ∼ 24.75 cm2 footprint yielding a density of
about 19 valves/cm2. Over the next few years much more complex fluidic devices
were designed with thousands of micro-mechanical valves on a footprint the size of a
postage stamp [5]. The first device designed had a valve density of 330 valves/cm2 and
was called the microfluidic comparator or Microfluidic High-Throughput Screening
Chip (µMHTSC). The second device designed by Todd Thorsen was a microfluidic
memory with a valve density of about 600 valves/cm2. Current DTPA devices contain
above 7000 valves and functional elements with densities of around 720 valves/cm2.
Microfluidic Large-Scale Integration [5] was an important milestone in the de-
velopment of microfluidics. MLSI showed that it was possible to robustly fabricate
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devices with thousands of functional elements. Compared to previous devices, which
contained either a few passive fluidic channels or a few active elements, the increase
to thousands of elements was drastic. Just as in the semi-conductor industry, where
the transistor replaced vacuum tubes and paved the way to the integrated circuit, the
microfluidic MSL valve replaced more complicated valve designs, and, because of its
simplicity, could be highly integrated. The number of floating point operations per
second (FLOPS) directly correlate with the number of transistors per CPU, so does
the functional density of microfluidic devices correlate with the number of valves or
other functional elements on a single device. One can thus expect to perform more
complex assays with devices containing a larger number of valves. Finally, increase
in valve density has been outpacing Moore’s law, which describes the exponential
increase of transistor density. MLSI is therefore expected to have a large functional
increase in the future and be able to tackle more and more complex problems in
Systems Biology.
2.3 Components
The principal component of microfluidic devices is a monolithic micromechanical valve
with a standard footprint of roughly 100 µm x 100 µm. The valve itself consists of
a PDMS membrane located between two fluidic channels. This membrane may be
deflected either up or down, depending on which channel is pressurized. Channels
with depths of around 10 µm may be closed if the membrane is deflected downwards
and channels around 50 µm in height may be closed if the membrane is deflected
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upward. These dimensions depend predominantly on the material properties of PDMS
as well as the geometry of the structure created. Therefore, either modification of the
elastic properties of PDMS or the use of a different compound altogether will result
in the ability to create valves with smaller or larger footprints as well as channel
heights. Likewise, changing the membrane thickness will also allow for changes in
these parameters.
From this principal component more complex fluidic structures may be built. Peri-
staltic pumps can easily be generated by placing three or more valves in series. Over
the years the Quake lab has found many applications for the valve and new functional
uses thereof. The following sections describe new components, including a microflu-
idic multiplexer used to address a large number of flow channels but requiring only a
minimal number of control channels (Section 2.3.1). A fluidic input tree is described
in Section 2.3.2 which allows the introduction of multiple solutions onto a microfluidic
device without cross-contamination issues. As a variation of the standard actuation
scheme, where a control line shunts liquid in a flow line, a control line cascade is
described in section 2.3.3. In a cascade a control line is used to control a second set of
control lines which then in turn manipulate flow lines. This cascading of control lines
allows for drastic improvements in multiplexer efficiency and can be used to invert
the logic function of a multiplexer. Finally, a free-standing deflectable membrane not
acting as a valve but rather as a way to protect a surface from the surrounding liquid
is described in Section 2.3.4. The free-standing membrane is particularly useful for
measuring molecular interactions, an application described in more detail in Section
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7.4.
2.3.1 Multiplexer
Controlling dense arrays of fluidic channels or storage modules is a considerable chal-
lenge in the field of microfluidics. The electronics industry solved this problem by
inventing an integrated circuit called the multiplexer. A multiplexer encodes a series
of wires or channels, into a single output. A de-multiplexer functions in the exact
opposite fashion, routing a single input into any one of a number of outputs. Mul-
tiplexors are commonly used in random access memory (RAM), where a row and
column decoder addresses each memory element so that a bit can be written to that
location and read at a later time. In the microfluidics case a multiplexer (or de-
multiplexer, depending on the direction of fluid flow) consists of a large number of
flow channels, specifically addressed by a smaller number of control channels (Figure
2.1).
A multiplexer allows the addressing of a large number of elements with a logarith-
mically small number of control elements required to perform the addressing. This
is accomplished by forming binary trees of wires or fluidic channels. Each binary
tree divides the elements to be addressed by two, allowing each half to be specifically
addressed. Using consecutive stages of binary trees ultimately allows the addressing
of individual elements. The formula governing the multiplexer efficacy is:
b ∗ logb(n) = m (2.1)
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Figure 2.1: Schematics of a binary and ternary fluidic multiplexer. Control channels
are indicated by red (actuated) and green (not actuated) colors. Crosses indicate that
valves are closed. Each stage of the multiplexers is indicated next to each multiplexer
design.
2log2(n) = m (2.2)
2m/2 = n (2.3)
where m is the number of control channels controlling n numbers of flow channels
and b is the multiplexer base, described in more detail below. The multiplexer was
adopted and used in microfluidic devices to address large numbers of fluidic channels
with the smallest number of control channels possible. To do so one can simply copy
the existing electronics multiplexer and transform it into a fluidic multiplexer (Figure
2.1). But since the microfluidic system is not based solely on binary information it
was possible to enhance on the existing multiplexer design by using ternary stages
(Figure 2.1) instead of binary ones. So that formula 2.1 becomes
3log3(n) = m (2.4)
3m/3 = n (2.5)
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This plexer design is the most efficient design possible since the stage integer of 3 is
the closest integer to e (2.7). Mathematical proof that e is the function minimum
follows:.
m = b logb n (2.6)
m =
b log n
log b
(2.7)
m =
b
log b
(2.8)
m′ =
ln b− 1
(ln b)2
(2.9)
0 =
ln b− 1
(ln b)2
(2.10)
0 = ln b− 1 (2.11)
1 = ln b (2.12)
e = b (2.13)
In the physical world only integers are permitted for m and thus either 2 or 3 must
be chosen. Indeed it is possible to use any integer for m such as 2, 3, 4, 5, etc. but
efficiency drops as the number is deviates from 3. It is nonetheless a useful feature,
which can be exploited by mixing stages with different integers for m. For example, if
it is necessary to address 54 fluid channels one may either use a binary plexer requiring
6 stages or 12 control lines, a ternary plexer with 4 stages using 12 control lines, or
a mix of the two where one stage is binary and the remaining three are ternary and
using only 11 control lines instead.
One of the disadvantages of the multiplexer lies in its mode of action: it is designed
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to address any one element at a time, but not any number of elements in any com-
bination simultaneously. It is possible to simultaneously address certain symmetry
elements, but these are restricted to certain patterns and generally not immediately
useful for fluidic applications. It is also not possible to address all but one element at
the same time using a multiplexer. This problem was solved by inverting the multi-
plexer functionality by using a control line cascade described in more detail in Section
2.3.3. A final shortcoming of a standard multiplexer design is its large dead-volumes,
which, depending on the type of function the multiplexer has to fulfil, can become
prohibitive. This last issue is addressed and solved in Section 2.3.2.
2.3.2 Fluid Input Trees
One necessary aspect in the field of microfluidics is interfacing devices with the rest
of the laboratory, also known as ’the world-to-chip interface problem’. There are
two approaches that will be discussed in this document, one based on programming
devices with spotted micro arrays which will be described in detail in Section 6.2.2.
The other method introduces liquids via an input hole that reaches the fluidic layer.
Even though it is an easy approach for the introduction of liquids, the input hole
approach has problems, such as excessive dead volumes leading to contamination
when consecutive liquids are introduced through the same input port. The obvious
solution to this problem is to have a dedicated input for each solution that is to
be introduced. For a small number of liquids this can be accomplished without the
need of a multiplexer to address the inputs. Therefore by smartly arranging the
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Figure 2.2: Example of a fluid input tree controlled by a multiplexer and every third
line sacrificed for buffer input
input tree and valve structure one can avoid any on-chip dead-volumes and thus
cross-contamination from the different inputs.
When the number of inputs becomes relatively large, a dozen or more, then the
use of a multiplexer becomes necessary. But, as mentioned in Section 2.3.1, the stan-
dard multiplexer has large dead volumes associated with it. In order to reduce dead
volumes, the valve structure can be changed such that the lines to be addressed are
arranged in a tree-like fashion, with the control valves being situated directly at each
branch point. In order to completely avoid downstream cross-contamination one can
sacrifice every second or every third line of a binary or ternary multiplexer for flush-
ing with a buffer solution. These multiplexer-based fluid input trees are only limited
by the large footprint required for the fluid interconnects, can ultimately support up
to hundreds of unique solutions, and are particularly well suited for introducing be-
tween 12–40 unique solutions. If hundreds or even thousands of unique solutions are
to be introduced, a different approach based on spotted microarrays is more suitable
(Section 6.2.2).
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2.3.3 Control Line Cascades
It is possible to control fluid lines, which in turn control another level of fluid lines;
this is termed a control line cascade. A control line cascade can be applied to a multi-
level multiplexer. Here the first level of fluid lines consists of a multiplexer, which in
turn controls a second level of lines that also form a multiplexer. This second stage
multiplexer then in turn controls a third and final stage of fluid lines.
Figure 2.3 shows an example of a 3-level control line cascade. The first level
of control lines (black) consists of a 2-stage ternary multiplexer which controls 9
lines (blue) of a 3-stage ternary multiplexer. The black multiplexer can be used to
sequentially address the blue multiplexer. Thus if the blue multiplexer is initially in an
off state, individual lines may be first addressed and then pressurized. The pressure is
stored for a certain amount of time, depending on the permeability of PDMS and the
solution or gas used to pressurize the system. Now that the blue multiplexer has been
addressed it specifically addresses the third stage of green fluid channels. Cascading
achieves a further reduction in the number of control inputs required. In this basic
example, driving the blue multiplexer directly would have required 9 control lines. By
using a control line cascade, the same functionality was achieved with 7 control lines.
Efficiency scales favorably with the number of lines, so that a first-stage multiplexer
consisting of 5 ternary stages controls 243 second-stage control lines, which in turn
control ∼ 4 ∗ 1038 lines. Likewise, a 4 stage ternary multiplexer controls 81 second-
stage lines controlling ∼7 million lines. This would nominally require 243 and 81
inputs, respectively, but with a control line cascade is instead accomplished with 16
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Figure 2.3: An example of a control line cascade in which the black lines control the
blue lines, which in turn then address the green flow lines.
and 13 lines respectively. A second advantage of a control line cascade is that it can
invert a multiplexer. This is accomplished by using the control line cascade described
above, but having each blue line be a single valve controlling a respective green fluid
line directly. Now if the black multiplexer is addressed it in turns selects any one of
the nine blue control lines, which closes one green fluid channel, effectively inverting
the functionality of the the original multiplexer, which can only open a fluid line while
having all others closed. Inversion of the multiplexer was necessary for a microfluidic
memory device descibed in Section 3.2.3.
2.3.4 Free-standing Membranes
In order to generate areas of defined surface chemistry as well as geometry, a new use
of the microfluidic valve structure was employed. Here, instead of using a deflectable
membrane in the channel structure to obstruct fluid flow by complete closure of the
flow channel, the membrane simply makes contact with the channel surface, but is
otherwise freestanding and not contiguous with the channel walls. It should be noted
that the first membrane designed was indeed not free-standing, but rather mimicked
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Figure 2.4: Close-up view of a D2PA unit cell with control lines filled with colored
food dyes and an empty flow layer. The blue control line creates the freestanding
membrane that is in an open (panel A and C) and closed configuration (panel B and
D). Panels C and D show a schematic of a cross section through the correlating image
along the arrow-demarcated black lines.
Table 2.1: Spot size dependence and uniformity
Membrane
diameter
(µm)
Initial
closing
pressure
(psi)
Spot diam-
eter at 15
psi (µm)
Std.
dev.
(µm)
180 6.5 102 5
160 6.5 80 5
140 6.5 54 5
120 7.5 33 4
100 19 - -
80 19 - -
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Figure 2.5: Testing the dependence of the actual spot size on membrane diameter.
Panel A shows an Autocad diagram of a section of the actual device. Here 5 unit
cells with different membrane diameters are shown (red indicates control lines and
blue flow lines). Membrane diameters are 180 µm on the far left, decreasing to 100
µm in 20 µm steps. The actual device has one additional unit cell with a 80 µm
membrane. Panel B shows the fluorescence of Cy5 labeled DNA templates filled in
the flow channel. The membranes have been closed trapping DNA bound by a surface
bound transcription factor. Note the halo of low intensity around the spots, indicative
of low non-specific binding of templates due to the membrane action. Panel C shows
the same area of the device as Panel B after flushing the flow channel with PBS with
the membranes remaining closed to prevent loss of bound material.
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Figure 2.6: Spot size dependence on membrane diameter
a standard valve, surrounded by bus channels, to allow for fluid exchange while the
membrane is actuate (see chip design in Figure C.4). This protects the channel surface
while the membrane is in the closed state. Figure 2.4 illustrates the fluidic layout and
functionality of the freestanding membrane structure. A round membrane is created
by the blue control channel. The membrane is situated above a larger circular flow
channel. Panel A of Figure 2.4 shows the membrane in an open state, which upon
hydraulic actuation makes contact with the surface (Panel B). Membrane closure
occurs centrally and extends radially outward allowing the membrane to close without
trapping any fluid between it and the surface, an important feature for applications
discussed in Section 7.4.
The membrane makes circular contacts of defined diameter, which may be mod-
ulated by varying the membrane diameter, actuation pressure, membrane thickness,
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and flow channel depth. A chip was designed to address the effect of varying the
membrane diameter (Figure 2.5) by systematically varying the membrane diameter
in 20 µm steps ranging from 80–180 µm. For the given flow channel height and mem-
brane thickness the various membranes closed at pressures ranging from 6.5 psi to 19
psi (see Table 2.1). Figure 2.6 shows the spot size dependance on membrane diameter
at a constant closing pressure of 15 psi. The slope is slightly steeper than 1 (1.165)
with an intercept of -107.5 µm. A change in actuation pressure, membrane thickness,
and flow channel height will likely only affect the intercept value, but otherwise leave
the slope unchanged, making it easy to design membranes that will generate a desired
spot diameter. The smallest spot size generated in this experiment was on the order
of 30 µm, or about 1/2 to 1/3 the size of spots achieved with commercially available
quill pen spotting technology.
The free-standing membrane has two principal applications. First, the membrane
may be used to protect a patch of surface from surface treatments allowing specific
molecules to be deposited to generate a circular area with defined chemistry. Chapter
5 describes how these surface chemistries are built and how they are used to detect
molecular interactions. Using the free-standing membrane it is possible to generate
circular features with variable diameters reaching as low as 30 µm and possibly lower.
Circular features are compatible with most software packages written for the analysis
of DNA arrays and thus facilitate data mining. Furthermore, by creating defined
areas with a small footprint, mass transfer issues that occur when precious samples
with low molarities, such as antibodies, are used for the derivatization are alleviated.
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The second, and more important application of the free-standing membrane allows,
trapping of molecular interactions occurring on the surface. This enables the detection
of interactions with low affinity constants, especially those arising due to high off-
rates where flushing or washing to remove unbound molecules is prohibitive due to
rapid loss of bound material. Closing the membrane also allows for the exchange
of the surrounding solution, useful when enzymatic assays are required for detection
(Section 7.3). These assays generally require the introduction of an enzyme and its
substrate, and may now be accomplished without loss of bound material, resulting in
the highest signal achievable.
2.4 Readout Systems
It is a necessity to measure the results of on-chip experiments in situ. Many biologi-
cal analyses are based on optical information such as light microscopy, fluorescence,
bio/chemiluminescence, etc. All these methods are applicable to devices fabricated
from PDMS since the material is optically transparent. It is thus possible to inter-
rogate samples directly through the device, which is important when flow channels
are entirely made up of PDMS. In most devices described herein, the flow channel
walls and ceilings consist of PDMS, but the bottom of the channel consists of glass,
in which case optical interrogation is trivial.
The most commonly used instrument for optical interrogation is the light micro-
scope, which is ubiquitously used in the laboratory and its features and drawbacks
are described in Section 2.4.1. The possibility of using a home-built fluorescent-based
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scanning system for the interrogation of microfluidic devices was also investigated,
leading to the use of commercially available systems described in Section 2.4.2.
2.4.1 Microscope
The light microscope is a standard tool for interrogating biological systems. It has
several advantages over other standard optical instruments in that it has high tempo-
ral as well as spatial resolution and is a flexible system. The high spatial resolution,
limited only by the diffraction limit of light or roughly λ/2, allows for analysis of
cellular fine structures otherwise not accessible. The high temporal resolution allows
for the measurement of molecular kinetics for example. In early experiments and
for kinetic analysis (Section 8.5) an Olympus IX50 inverted fluorescent microscope
equipped with either a ST7-XME (SBIG Astronomical Instruments) cooled CCD
camera or a E717-21 PMT (Hamamatsu) was used.
2.4.2 DNA Array Scanners
The first array scanner used was a home-built version used to prove the applicability
to the interrogation of microfluidic devices. The home-built scanner was based on a
FACS setup built by Todd Thorsen, to which a motorized x,y stage was added with
a z micrometer for focus adjustment. The FACS setup consisted of an Intelite solid-
state diode laser (λ=473 nm) for illumination and two emission filters centered at 580
nm/30 nm and 535 nm/40 nm. Using the stage, a chip could be panned beneath a 40x
or 60x objective through which the laser was focused on the sample and emitted light
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Figure 2.7: Image of a scan taken with a home-built array scanner of a SEC chip
filled with 1 mM fluorescein in PBS (pH7.2). The raw data was analyzed in Labview
and the resulting image generated using Mathcad.
collected and routed through one of the emission filters. Fluorescence was measured
in one of two channels using PMTs for detection and analog voltage output was read
by a PCI1200 card (National Instruments). The stages were driven by a DCX-PC100
motion control card (Precision MicroControl) and the whole setup was controlled
by a Labview program. Figure 2.7 was acquired using the home-built device. The
statistical variation of all 1024 chambers imaged was 5–6.25% standard deviations,
dependent on initial data binning, and the time required to scan the entire device
was under 5 minutes. Even though it was possible to prove the usefulness of DNA
array scanners for reading out microfluidic devices, the home-built version was not
engineered well enough to yield consistent and high-quality data. One of the major
problems with the home-built setup was that the laser line had to be pulled across the
columns or rows of the device, requiring aligning of the chip axes to the axes of the
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Figure 2.8: Experimental results of signal intensities as a function of focal depth.
The results show that the GenePix4000b scanner is confocal and intensities drop off
radically as focus shifts
x,y stages, a non-trivial task. Furthermore the data is at best 1-dimensional giving
point values of intensities of each chamber. A full 2-dimensional scan of a device is
desirable, but again requires more sophisticated engineering.
The first commercial instrument acquired was the GenePix4000b DNA array scan-
ner (Axon Instruments). The scanner has two laser lines for illumination, at 532 nm
and at 635 nm. These lines efficiently excite Cy3, Cy5, and similar dyes. The reso-
lution of the system is 5 µm and has a dynamic range over 3–4 orders of magnitude.
This scanner was used for all high-throughput screening experiments described in
Chapter 3 and for all scans of standard DNA micro-arrays. Even though a good
instrument for scanning standard planar micro-arrays, it was difficult to obtain high-
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Figure 2.9: Scan obtained of a µMHTSC device running single-molecule enzyme
assays. Note the uniformity of the background and signals across the entire area of
the image.
quality device scans because of the shallowness of the depth of focus of the system
(Figure 2.8), making it difficult to obtain a focused image over a large area. Com-
pounding this problem were three factors: first, the stage of the array scanner is a
tripod design consisting of three sapphire posts; second, due to the limited working
distance of the scanner the devices had to be bonded to number 1 or number 0 cov-
erslips; and lastly, the device had to remain connected to pressure lines to control
the device while it was being scanned. These three factors made it difficult to level
a device consistently. Several level images were nonetheless scanned (Figure 2.9) and
it was possible to obtain quality data from these.
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Realizing that the GenePix4000b was not suited for the routine analysis of mi-
crofluidic devices, a second commercially available scanner had to be found. The
instrument selected was the arrayWoRx e (Applied Precision). Several features of
this instrument made it more suitable for microfluidic applications. The instrument
uses a metal-halide lamp for illumination rather than lasers, which allows for dialing
of any excitation from 350–700 nm using bandpass filters, and, more importantly,
removes the confocal nature of the dependence of the focal depth. Four filter sets can
be housed in the system at any given time and may be easily exchanged, extending
its usefulness into the FITC band commonly used in biological assays. Emission is
collected via a CCD camera. Extending the focal depth of the system, combined with
a custom-designed chip holder for both 1 by 3 inch glass slides as well as 2 by 3 inch
slides made this system very useful in the routine analysis of microfluidic devices.
All other specifications are on a par with the GenePix4000b, with a slightly better
resolution at 3.25 µm but a lower overall sensitivity and scan speed.
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Chapter 3
High-Throughput Screening
Applications
3.1 Introduction
Protein engineering is one of the major tasks of today’s field of bioengineering [18].
Proteins provide moldable platforms of thousands of enzymes and structural building
blocks that may be engineered at leisure by restructuring their amino acid sequence.
This restructuring may yield beneficial changes in the secondary, tertiary, and even
quaternary structure of the protein. Beneficial attributes may include increased sta-
bility at various abnormal environmental conditions, increase in enzymatic turnover
rates and numbers, recognition and processing of unnatural substrates, and changing
affinities to binding partners.
To achieve these engineering feats two general approaches may be taken: rational
design and random mutagenesis. Both approaches require the novel protein to be
screened to ascertain that it possesses the correct function to be engineered. The
rational design path generally yields a low number of potential candidates, numbering
at most in the hundreds. The random mutagenesis approach on the other hand
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yields libraries with member counts reaching astronomical numbers. Historically the
approach for screening random mutagenesis libraries, generated by error-prone PCR,
consisted of cloning a library of mutant linear PCR products into a vector, which then
was transformed into an appropriate host, generally E. coli. The transformation step
insures that clonal libraries are generated, which may be screened in later steps for the
appropriate function. Physical separation of clones is achieved by plating the library,
followed by manual or automated picking. Per library, approximately 2,000–20,000
clones may be screened using these methods. To avoid the time-consuming and labor-
intensive step of plating and picking of clones, followed by the expressing and screening
of each, microfluidic chips were devised which directly take the initial library as input
and perform the necessary screening step on single clonal cells. Furthermore the
devices allow for the recovery of the screened content, which is a necessary requirement
in any high-throughput screening application. Three devices were designed with
various features and capabilities and are described in detail in Sections 3.2.1, 3.2.2,
and 3.2.3.
3.2 HTS Devices and Assays
3.2.1 Serpentine Enrichment Chip
The serpentine enrichment chip (SEC) (Figure 3.1) was the first chip designed for
the high-throughput screening of bacterial libraries. The design goal for this device
was to screen heterogeneous libraries directly without the need for long and tedious
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Figure 3.1: Photoshop design drawing of the SEC device. Dark grey lines indicate
control lines and light grey lines are flow lines.
separation and screening steps, and is accomplished by dilution and segregation of
the heterogeneous mixture into many smaller homogeneous aliquots. On-chip this
is done by introducing the mixture into the input port of the device, which then
branches out into 32 columns. The liquid introduced into those 32 columns is then
segregated into 1024 chambers with a volume of roughly 100 pL each. The input cell
density can be chosen to yield on average 1 cell per chamber, according to Poisson
statistics. Now, since each chamber contains a single cell, and thus a single member
of the clone library, it is possible to screen the function of that single mutant. Of
course, due to the statistical nature of the distribution it is possible to obtain 2 or
more cells per chamber as well. Signals derived from chambers with 2 or more cells
may be deconvoluted from single-cell signals in two ways. One method is to simply
detect the signal and assume that two cells will roughly yield twice the signal. This
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assumption may be flawed, since many mutants may show strongly reduced activity
as compared to wild type, such that a chamber with two inefficient mutants may
appear to only contain a single mutant. Using direct counting of cells, as the second
method, circumvents that problem. Once a chamber containing a single mutant of
interest has been identified, the segregating grid is opened, and the column containing
the clone of interest specifically addressed and purged. At the outlet port a T-
sorting junction could specifically sort out all negative mutants from the positive
clone of interest. Unfortunately this sorting strategy failed due to flow properties in
microfluidic devices. Even though the index of each cell was known before the purge
was started, once flow occurred index could shift, since some bacteria would reside on
the wall whereas others would be located more towards the center of the channel. Due
to laminar flow, those bacteria on the sidewalls would move slower since flow velocities
drop off towards zero near channel walls. Hence, a bacterium located in the central
part of the channel would pass several bacteria located near the walls. This prohibited
the recovery of a single mutant directly from the chip in a single pass. Solutions to this
problem included recovering a whole column and plating all recovered mutants thus
achieving a 32-fold enrichment over the initial chip input. Extending on the above
idea it was in principle possible to take that initial column fraction and re-introduce
it into the same or a new device. Thus achieving another 32-fold enrichment. This
could be repeated until the mutant of interest would be contained in a column all by
itself and thus could be recovered from the chip without any contaminating mutants.
A chip was designed that linked the out port back to the in port. Since such a
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circular geometry does not allow for pressure driven or electrostatic flow, a pump
was introduced into the circle to drive the flow. An additional fluid input was also
needed so that the single column output that was to be re-introduced into the chip
could be diluted accordingly to again fill 32 columns. Sound in principle, the chip was
nonetheless never extensively tested. From this initial design it was obvious though
that a device that addressed chambers directly and individually was a much more
straightforward approach to HTS, leading to the design of the microfluidic memory
and µMHTSC devices.
3.2.2 µMHTSC
In order to overcome the limitations encountered when testing the SEC device, a new
generation of HTS devices were designed and tested. The next-generation devices
were still based on the idea of segregating a complex mixture into small compart-
ments where the contents could be tested. Additionally each compartment had to
be individually addressable, allowing the recovery of a chamber’s contents without
contamination. This required a much more complex fluidic infrastructure based on
large multiplexer arrays. Furthermore the use of more advanced assays was to be en-
abled on the platform requiring the mixing of two solutions in situ so that enzymatic
assays could be started on-chip. Thus the basic layout of the µMHTSC consisted of
256 flow channels controlled by an 8-stage binary multiplexer (Figure 3.3). For sam-
ple introduction the flow channels may be closed perpendicularly by barrier valves,
which generates two serpentines. Once the two sample fluids have been introduced
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Figure 3.2: Panel A shows a SEC device with its serpentine filled with a saturated
solution of bromophenol blue. In panel B columns 2 and 4 (from the left) have been
selectively purged and column 6 is in the process of being purged. Panel C shows
most of the columns purged with only 5 remaining.
into the device they may be segregated by closing the sandwich barrier valve creating
512 chambers of 375 pL. These chambers may then be mixed pairwise by opening the
mixer barrier, creating 256 chambers each of 750 pL, allowing reactions to take place
synchronized with a defined null time. Upon readout of the device and identification
of a chamber of interest the multiplexer is used to address the specific flow channels
and the contents are purged towards one of 4 collection ports (Figure 3.4). In order
to allow more than one sample to be recovered, each device contained 4 columns
each with 64 chambers from the original string of 256, accomplished by the 4 barrier
control lines, which may be seen as an additional multiplexer stage. Each column has
a dedicated sample collection port so that no contamination can occur between indi-
vidual samples. The next step after successful testing of the microfluidics was to run
single enzyme assays. As a model system E.coli expressing the enzyme cytochrome
c peroxidase (CCP) was used. In order to accurately determine enzyme activity of
individual clones it is necessary to normalize substrate turnover to the number of
cells present in a chamber. It is possible to count bacteria by eye using an 60x oil
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Figure 3.3: Optical micrograph of the µMHTSC. For visualization, control lines have
been loaded with green, red, and yellow food dyes and flow lines with blue dye.
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Figure 3.4: These captures of a section of the µMHTSC show how the device can
be loaded with two distinct samples. In this case a bromophenol blue and orange G
solution, blue and yellow, respectively (Panel 1). The solutions are introduced into
the two serpentines created by closing all barrier valves. Once the serpentines are
filled the fluids may be segregated by closing the sandwich barrier (Panel 2). Once
the samples have been segregated they may be mixed pairwise (Panel 3) and one
chamber can be specifically addressed and its contents purged towards one of the 4
sample collection ports (Panel 4).
immersion objective manually panning and searching all 256 chambers. As manual
counting is a very time-consuming and strenuous task, a fluorescent reporter dye in
conjunction with the GenePix 4000b scanner was used to count cells more efficiently.
One dye suitable for this purpose was SYTO 62, commonly used in cell viability as-
says. SYTO 62 is membrane permeable and will stain both live and dead cells by
intercalating into DNA and RNA, and thus is potentially harmful to the cell. But
HTS methods don’t require the recovery of live cells. All that needs to be recovered
are the plasmid copies coding for the mutant protein of interest harbored in the cell,
which then may be PCR amplified off chip and sequenced.
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Figure 3.5: GenePix 4000b scan of a solution of SYTO 62-stained bacteria. Individual
bacteria light up a small cluster of pixels, indicated by a red to white color.
Figure 3.6: The left graph shows the distribution of wrong counts between Syto 62 and
the eGFP hand count. At most the difference was -2 per chamber and only 14 out of a
total of 512 chambers were counted wrong. The right graph shows the distribution of
the two counts as compared to theoretical values derived from a poisson distribution.
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Using SYTO 62 as the reporter dye visualized individual cells when scanned with
the GenePix array scanner (Figure 3.5). Unfortunately the spatial resolution of that
instrument is 5 µm. Thus it is possible that two cells could cluster together and
light up a single pixel. As a control experiment, a SYTO 62-stained culture of cells
expressing eGFP was loaded and counted by hand as well as by using the scanner.
Comparing the two counts showed that over 97% of all chambers were counted cor-
rectly using SYTO 62 in reference to the manual GFP count. Both counts were also
compared to a hypothetical poisson distribution and the distribution encountered
on-chip followed the expected distribution (Figure 3.6).
Using the above-described method for determining cells per chamber enabled the
single-cell enzyme analysis. E.coli expressing CCP were induced with isopropylthio-
beta-D-galactosidase (IPTG) for 7 hours. A 1 mL confluent culture was spun down
and re-suspended in PBS to 1/100 of the initial concentration. This suspension was
further diluted 1/10 into Amplex Red reaction mixture containing final concentrations
of 100 µM Amplex Red and 880 µM H2O2. This solution was then loaded into one of
the serpentines of the µMHTSC and compartmentalized, followed by a 1-hour-long
incubation at room temperature. The chip was then scanned (Figure 3.7) and the
resulting image analyzed with Genepix3.0 to determine signal intensities per chamber.
The results indicate that single-cell enzyme assays are possible (Figure 3.8). Cham-
bers containing no cells remained at background signal levels. If a cell is present in
a chamber the distribution broadens and the peak shifts to higher fluorescent values,
indicating that substrate is being turned over. Distribution broadening is likely due
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Figure 3.7: GenePix4000b scan of a µMHTSC device containing a distribution of cells
expressing CCP. Chambers containing no cells remain dark, whereas cells containing
1 or more cells expressing CCP turn over Amplex Red and give rise to a fluorescent
signal, as indicated by yellow to orange colors. The inset shows a detailed view of a
section of the serpentine containing cells.
to intrinsic variation in CCP expression from cell to cell; a cell may contain differ-
ent numbers of functional CCP molecules depending on its cell cycle and viability.
Single-cell variability is an interesting aspect of single-cell measurements. In this
case it complicated the goal of determining enzyme fitness on the single-cell level, so
that mutants of varying fitness cannot be distinguished from one another since they
would likely fall within the standard deviation of the distribution exhibited solely
from single-cell variation.
In order to ascertain that the distributions result from variances in single cells, the
signals in each category of cells per chamber were averaged. The result is as expected,
such that the median of the distribution follows a linear relationship, giving rise to
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Figure 3.8: Analysis of the single-cell enzyme assay. Chamber intensities are plotted
as relative fluorescent units. Categories on the x axis are cells per well, determined by
a manual count and are plotted against the RFU of the chamber. No cells in a chamber
give rise to a very sharp background distribution of intensities. As the number of cells
increases per chamber the distribution broadens due to intrinsic variances in single-
cell expression.
quantal increases in fluorescent intensity solely depending on the number of cells per
chamber (Figure 3.9).
Seeing such a large distribution in signal derived from single cells stemming from
variances in copy numbers of enzyme per cell proved to be a problem for the deter-
mination of fit mutants in a library. Possible ways to detect fit mutants in a sea of
variance would include higher-resolution measurements of cell morphology. By using
cell morphology it should be possible to derive enzyme concentrations more reliably.
A simple measurement of cell size could shrink the distribution to levels that are
amenable to detecting fit mutants. Unfortunately none of the commercially available
DNA scanners have optical resolutions high enough for this task. A second option
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Figure 3.9: Averaging the results from Figure 3.9 should give rise to population
averages and quantal increases in fluorescence per chamber dependent on the number
of cells contained within.
Figure 3.10: Schematic of a comparator
would be to fuse the enzyme of interest with a reporter protein such as GFP so that
actual concentrations of enzyme present can be determined directly. Normalizing to
actual enzyme concentrations removes any single cell variance present and thus allows
one to detect variance in enzyme fitness directly.
To take advantage of the µMHTSC’s mixing capability an experiment was devised
to emulate a basic electronics component, namely the comparator. A comparator is
an integrated circuit which is a derivative of an operational amplifier. The comparator
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Figure 3.11: (A) Schematic diagram of the microfluidic comparator logic using an
enzyme and fluorogenic substrate. When an input signal chamber contains cells ex-
pressing the enzyme CCP, nonfluorescent Amplex Red is converted to the fluorescent
product, resorufin. In the absence of CCP, the output signal remains low. (B)
Scanned fluorescence image of the chip in comparator mode. Left side: Dilute so-
lution of CCP-expressing E. coli in sterile PBS (137 mM NaCl, 2.68 mM KCl, 10.1
mM Na2HPO4, and 1.76 mM KH2PO4 pH 7.4) after mixing reaction with Amplex
Red. Arrows indicate chambers containing single cells. Chambers without cells show
low fluorescence. The converted product (resorufin) is clearly visible as green sig-
nal. Right side: Uncatalyzed Amplex Red substrate. (C) A micro high-throughput
screening comparator: Effect of heterogeneous mixture of eGFP-expressing control
cells and CCP-expressing cells on output signal. The resorufin fluorescence mea-
surement (λex=532 nm, λem=590 nm) was made in individual comparator chambers
containing E. coli cells expressing either eGFP or CCP. There is a strong increase
in signal only when CCP-expressing cells are present, with little effect on the signal
from eGFP-expressing cells. The vertical axis is relative fluorescence units (RFU);
error bars represent one standard deviation from the median RFU.
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has two inputs and a single output. The input voltages are compared to one another
and the output is switched to the comparator’s high gain, either to +Vcc for V2 >V1
or -Vcc for V2 <V1 (Figure 3.10).
To realize this experimentally, the mixing capabilities of the µMHTSC were used
to introduce Amplex Red into chambers containing various numbers of cells ranging
from 0 to 3. The cells were a heterogeneous mixture of two clones, one expressing
eGFP, used as a negative control, and the other expressing CCP. The cells were each
diluted to 1/2000 in the same test tube giving rise to a roughly 1:1 ratio of CCP to
eGFP cells. This solution was introduced into the sample input port of the µMHTSC.
Next an Amplex Red reaction mixture containing 10 µM Amplex Red, 88 µM H2O2
in PBS was introduced into the substrate input and kept separate from the sample
channel containing the cells. After compartmentalization the barrier valve was opened
and mixing allowed to proceed for 10 minutes. The chip was then scanned after 45
minutes and the results are summarized in Figure 3.11.
It was shown that the µMHTSC can be used as 256 parallel biological compara-
tors, each chamber pair constituting one comparator element. The data showed that
the presence of E. coli expressing CCP switches the output signal into the high state,
whereas the absence of a cell or the presence of a cell expressing eGFP caused the
output signal to remain at baseline; the reference side containing the Amplex Red
remained at baseline levels as well, indicating that either the signal originated from
CCP contained in the periplasmic space, or that the mixing time was too fast com-
pared to the diffusion time of CCP from the left into the right chamber.
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Finally, single cells may be recovered from a chamber and grown up as a colony on a
Luria-Bertani (LB) agar plate. This was accomplished by using polyetheretherketone
(PEEK) tubing with an inner diameter (ID) of 125 µm pushed into the collection well
of the µMHTSC. This type of tubing is commonly used in high-performance liquid
chromatography (HPLC) applications due to its bio-inertness and its lack of non-
specific binding. A chamber containing a single cell was addressed and its contents
purged to the output well, where the eGFP fluorescing cell could be seen entering
the PEEK tubing. Purging was continued and a few drops were collected on an agar
plate. The plate was then incubated at 37◦C overnight and a colony grew where the
drop containing the single cell was added to the plate. Negative control drops were
also collected from chambers containing no cells and produced no colonies. Three
layer devices were used to make all these experiments work. The third layer simply
constituted a thin layer of 5:1 PDMS spun onto a RCA cleaned cover slip. This
helped attain higher purge pressures and prevented auto-hydrolysis of Amplex Red
and sticking of E.coli cells to glass. All-PDMS devices, due to these reasons, are
generally preferred unless glass chemistry is required.
3.2.3 Microfluidic Memory
The microfluidic memory device (Figure 3.12) was designed by Todd Thorsen and
intended to accomplish the same as the µMHTSC, but without mixing capability.
Eliminating mixing and arranging the addressable chambers to be addressed in a ma-
trix allowed the device to be very densely integrated. The memory device contains a
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Figure 3.12: AutoCad design drawing of the microfluidic memory.
Figure 3.13: Proof of function showing the microfluidic memory acting as a display
showing the letters CIT.
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total of 1000 individually addressable chambers controlled by 3574 valves. Additional
advances included buslines paralleling the chambers so that individual chambers could
be addressed and expelled without interfering with contents of neighboring chambers.
The buslines in the design allowed the matrix to remain planar, as opposed to having
to address each chamber perpendicularly in the Z direction instead. The microfluidic
memory device is also the first device in which advantage was taken of the control
line cascade (Chapter 2.3.3), inverting the column multiplexer used to address the
array.
For a proof of principle experiment, Todd addressed a subsection of the memory
device and spelled out ’CIT’, showing that chambers could indeed be individually
addressed (Figure 3.13). Furthermore it illustrated a potential application as a low-
power liquid display; useful mainly for static images, since the frame rate of the device
would probably be somewhere around 1 frame per minute at best. The design could
potentially be further optimized to achieve reasonable frame rates.
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Chapter 4
In vitro Protein Synthesis
4.1 Introduction
Cell-free protein synthesis or in vitro transcription/translation (ITT) has been used by
biologists for protein synthesis since the early 1960s [19] leading to advances in liter-
ally all aspects of molecular biology. ITT provides a convenient and rapid method for
the synthesis of proteins, and to-date remains the only scalable and efficient method,
since no chemical synthesis (as is available for DNA) exists for proteins. Only short
peptide segments can be generated by chemical synthesis, and it has been shown that
in some cases individual peptide segments may be linked by chemical ligation to form
full-length functional proteins [20, 21]. Yet this method remains labor intensive, is
limited to mostly small proteins on the order of 30 kDa or less, and is not immedi-
ately applicable to proteomic scale methods. ITT offers many unique features not
available in either cell-based expression or chemical ligation. First, ITT uses DNA
as the template from which a protein is synthesized, thus one can make use of the
many methods developed for the manipulation of DNA, allowing genomic- and thus
proteomic-scale application. Second, since ITT is not based on live organisms, it
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allows for the synthesis of proteins otherwise toxic to cells. Site or residue-specific
incorporation of non-natural amino acids [22, 23] via non-sense suppression [24, 25],
spiking of modified natural tRNAs [26], and addition of engineered tRNA synthetases
using non-natural amino acids as substrates for the aminoacylation of their cognate
tRNA [27] are also easier to achieve in ITT systems than cells. ITT takes advantage
of the features of cell based synthesis, as well as chemical ligation, and provides a
transparent platform that may, with relative ease, be adjusted to the requirements of
the protein being synthesized.
In vitro translation systems can be subclassified into various categories, depending
on whether they are coupled or uncoupled and what cell source was used to produce
the lysate. ITT systems are inherently coupled synthesis systems in which DNA serves
as the template for synthesis and is transcribed into mRNA, followed by translation
in the same reaction vessel. Uncoupled in vitro systems rely on mRNA produced in
a separate step, which then serves as the starting material for translation. Coupled
systems generally use highly processive phage RNA polymerases such as T7, T3, and
SP6 for mRNA synthesis. Common lysate sources include Escherichia coli, wheat
germ, and rabbit reticulocytes. The latter two are eukaryotic systems and generally
provide better post-translational modifications, where rabbit reticulocyte lysates have
a tendency to be more aggressive than wheat germ lysates. Yields generally are high-
est for E. coli -based systems, reaching milligram quantities per milliliter of reaction,
followed by wheat germ and rabbit reticulocytes. The latter two generally yield sub-
micrograms to micrograms per milliliter of reaction, with wheat germ roughly being
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one to two orders of magnitude higher. A notable exception to the standard method of
preparing cell-free translation systems was developed by Shimizu et. al [28]. Here the
authors reconstituted a working extract system from over 100 individual components,
allowing complete control over the reaction conditions. Furthermore all components
are labeled with a hexa-histidine tag allowing any product to be ’reverse’ purified
by simply removing all translational components from the mixture rather then the
product itself.
In recent years all three systems have been applied to proteome research, as well
as other novel applications such as running genetic circuits in a cell-free system
[29], and converting plasmid DNA arrays into protein arrays by in situ transcrip-
tion/translation and diffusion-limited capture of product [30]. A commercially avail-
able E. coli lysate has successfully produced protein in 100 nL small nanowells [31].
Wheat-germ-based systems have been extensively engineered and optimized to yield
milligram quantities of protein, and have been made amenable to high-throughput
applications [32, 32, 33, 34]. Only rabbit-reticulocyte-based lysates have not seen
rapid development, but remain commonly used in many in vitro based functional
studies of proteins.
The following chapters describe initial experiments using cell-free systems bench-
top, as well as the design and application of a novel PCR-based method for the rapid
production of linear expression templates for both wheat germ and rabbit reticulocyte
systems using any open reading frame as starting material. Commonly used methods
such as epitope tag-based detection, purification, and post-translational biotinylation
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of product, as well as enzyme-based assays, are also described.
4.2 ITT Systems
This section describes the various in vitro transcription/translation systems used.
All are commercially available and are either based on E. coli, wheat germ, or rabbit
reticulocytes. Each systems has its own characteristics, advantages, and disadvan-
tages, which where alluded to in the previous section and will be discussed in more
detail here.
4.2.1 Prokaryotic-Based Systems
The only prokaryotic ITT systems commercially available are based on E. coli. The
first kit used was the RTS 100 HY kit (Roche Applied Science) with a reported
protein yield of 400 µg ml−1 and a 4–6 hour incubation period at around 30◦C. RTS
100 HY is a coupled system with a T7 driven transcription step, which accepts both
PCR as well as plasmid templates as input. Required 5’UTRs elements include a
T7 promoter, a ribosome binding site (RBS), and a start codon. The only required
element in the 3’UTR is a stop codon, though the presence of a poly(A)30 tail and
a T7 terminator enhances mRNA stability and transcription. Likewise, addition of
a g10 sequence or other phage-derived leader sequences are known to also enhance
protein yield. Aforementioned 5’ and 3’UTR requirements hold true for most if not
all coupled E. coli ITT systems. Initial results with the RTS 100 HY system were
quite promising and led to the continued use of the kit for most studies using E.
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Figure 4.1: Comparison of various commercially available E. coli lysates. Three
lysates were tested with various input concentrations of a PCR-derived linear template
encoding a N-6xHis tagged version of eGFP. The most efficient lysate was EcoPro
T7 (Novagen), followed by RTS 100 HY. Protein concentration was determined by
measuring eGFP fluorescence.
coli -based systems.
A limited comparison of three kits from various vendors was performed in order
to determine whether large quantitative differences exist. The test group consisted
of EcoPro T7 (Novagen), RTS 100 HY (Roche Applied Science), and ProteinScript
Pro (Ambion). All three reactions were spiked with varying amounts of a linear
PCR template amplified from a pT7Blue vector housing a linear expression template
encoding eGFP n-terminally tagged with a 6xHistidine epitope tag. The original
template was generated using pEGFP (Clontech) and Roche’s RTS E coli His6 linear
template kit. The resulting template was screened for expression and cloned into
pT7Blue via blunt end ligation. In this case the vector serves as a host for the linear
template from which future PCR amplifications may be performed. The results are
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shown in Figure 4.1. eGFP concentration was measured on a fluorimeter after 90
minutes of incubation at 30◦C. The results indicate that EcoPro T7 is the most
efficient of the three lysates. It should be noted though that the RTS 100 HY kit
continues synthesis for 4–6 hours. In all cases the final yield is one to two orders of
magnitude lower than the expected yield, which is probably due to mRNA secondary
structure formation in the template, discussed in more detail in Section 4.2.1.1. RTS
100 HY was selected as the standard kit used in most if not all bench-top as well
as on-chip prokaryotic-based ITT reactions, mainly due to higher final yields with
optimal templates. EcoPro T7 should be seen as a potential backup ITT mix in
scenarios where the RTS 100 HY kit fails to perform, since EcoPro T7 seems to be
less sensitive to mRNA secondary structure and produces protein more rapidly than
the RTS 100 HY kit.
5'UTR start
ACTTTAAGAAGGAGATATACC ATG ACC ATG TCT GGT TCT GTG AGC AAG GGC GAG
Met Thr Met Ser Gly Ser Val Ser Lys Gly Glu
ACTTTAAGAAGGAGATATACC ATG ACC ATG ACA ACA ACA GTG AGC AAG GGC GAG
Met Thr Met Thr Thr Thr Val Ser Lys Gly Glu
ACTTTAAGAAGGAGATATACC ATG ACC ATG TCT GGT TCT CAT CAT CAT CAT CAT CAT GTG AGC AAG GGC GAG
Met Thr Met Ser Gly Ser His His His His His His Val Ser Lys Gly Glu
ACTTTAAGAAGGAGATATACC ATG ACC ATG ACA ACA ACA CAT CAT CAT CAT CAT CAT GTG AGC AAG GGC GAG
Met Thr Met Thr Thr Thr His His His His His His Val Ser Lys Gly Glu
ACTTTAAGAAGGAGATATACC ATG ACC ATG TCT GGT TCT CAT CAT CAT CAT CAT CAT AGC AGC GGC GTG AGC AAG GGC GAG
Met Thr Met Ser Gly Ser His His His His His His Ser Ser Gly Val Ser Lys Gly Glu
eGFP N 
+12
eGFP N+3
eGFP N+3 
modified
eGFP N+9
eGFP N+9 
modified
extension 6x Histidine linker start eGFP
Table 4.1: N-terminal sequence variants of eGFP. The above sequences were generated
to assess which lead to efficient expression by E. coli -based lysates. Shown is the
immediate 5’UTR including the RBS, followed by a start codon and the actual coding
sequence. Sequences vary by sequence inserts as well as in the 5’ extension, where
differences are marked by a bold typeface.
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Figure 4.2: mRNA secondary structures for expression of eGFP. The structures were
determined using the mFOLD server version 3.2 and 3.1 for 37◦C and 30◦C, respec-
tively. Panels A and B show eGFP N+3 and eGFP N+3 modified, respectively, folded
at 37◦C. Panels C and D are the same as A and B but folded at 30◦C. Panels F and
G are the sequences of eGFP N+9 and N+9 modified, respectively, folded at 37◦C
and Panels H and I are the same as F and G but folded at 30◦C. Panel E and J are
the sequence of eGFP N+12 folded at 37◦C and 30◦C, respectively. The ribosome
binding sites are shaded grey and the two possible start codons are green.
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Figure 4.3: Various linear expression templates coding for eGFP with various N-
termini were expressed in a RTS 100 HY ITT reaction at 30◦C for 3.5 hours, and
eGFP concentration was determined on a fluorimeter. The experiment was run in
duplicate and the expression levels of both experiments were adjusted to the expres-
sion maximum of eGFP N+12, which were 172 ngµL−1 and 351 ngµL−1 in the first
and second experiment, respectively. Error bars indicate one standard deviation,
where applicable. Black bars are the standard sequences and the grey bars represent
values obtained from the modified sequences.
4.2.1.1 5’ UTR mRNA Secondary Structure Optimization
The first protein expressed in this work using an E. coli -based ITT reaction was a N-
terminally 6xHistidine tagged version of eGFP, which expressed well, yielding close
to the expected yield of roughly 400 ng µL−1. Upon removal of the tag sequence,
expression dropped to around 10 - 20 ng µL−1. The reason for this unexpected
drop in expression efficiency was not immediately apparent, but ultimately traced to
mRNA secondary structure differences upon testing of various N-terminal sequence
additions.
To further define why and how the secondary structure of the mRNA template
affects expression, a series of N-terminal deletion mutants were generated. The
generic N-terminal 6x Histidine fusion is shown in Table 4.1 as sequence eGFP N+12.
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Here the N-terminal sequence consists of 6x Histidine extended by 5 amino acids N-
terminally and linked to the generic eGFP sequence by a 3 amino acid linker. To
generate modified versions and to assess which parts of this sequence are required to
bestow high expressibility on the template, the linker and the linker plus the histidine
tag were removed, yielding sequences eGFP N+9 and eGFP N+12 respectively (Ta-
ble 4.1). Using the mFOLD web-server [35] these three sequences were folded with
version 3.2 at 37◦C and version 3.1 using 30◦C. The resulting sequences are shown in
Figure 4.2, Panels A, C, F, H, E, and J. Furthermore in order to study the effect of
specific sequence interactions rather than sequence deletions, the last 9 bases of the
extension segment were mutated from TCT GGT TCT to (ACA)3, and the resulting
secondary RNA structures are shown in Figure 4.2, Panels, B,D,G, and I. The struc-
tures that most likely affect the expression efficiency are the ribosome binding site
and the start codon, as these are the sites that need to be recognized by the ribosome
in order for translation to proceed. In Figure 4.2 these structures are shaded grey
and green, respectively.
Linear templates of all 5 sequence variants were generated and expressed in a RTS
100 HY ITT reaction in two separate experiments. Sequence eGFP N+12 yielded
the highest quantities of eGFP of 172 ngµL−1 and 351 ngµL−1 in the first and
second experiment respectively. These values were normalized to an expression level
of 100% and all other expression levels for the remaining 4 sequences were adjusted
accordingly in order to allow comparison of both experiments (see Figure 4.3). eGFP
N+9 performed almost as well as the original full-length version, indicating that the 3
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amino acid linker is not responsible for the drastic drop in expression. Upon removal
of the 6xHisitdine in sequence eGFP N+3 the expression drops to a level of roughly
30%, and upon complete deletion of the entire N-terminal addition expression drops to
5%. Notably sequences for eGFP N+12 and N+9 all show the exact same secondary
structure, regardless whether folded at 37◦C or 30◦C in the region starting with the
ribosome binding site, forming a stable hairpin with an interior loop at the ribosome
binding site and a one-base pair bulge centering on the start codon (Figure 4.2 Panels
E, F, H, and J). Existence of this structure apparently confers high expressibility on
the mRNA transcript. When the extension region is modified to eGFP N+9 modified,
the ribosome binding site forms its own hairpin and the start codon is in a base paired
region. This change in structure causes a decrease in expression from 97% to 44%.
Interestingly a similar ribosome binding site structure is found in eGFP N+3, which
also expresses poorly. In the eGFP N+3 structure the central thymine is bulged
similar to the high-expressing sequences. It is thus likely that the structure of the
ribosome binding site rather than the start codon is of primary importance. Upon
modifying the eGFP N+3 sequence to eGFP N+3 modified in the extension segment
expression actually increases from 30% to 77%. Looking at the structure of eGFP
N+3 modified it is apparent that the ribosome binding site is no longer in a hairpin
conformation but rather again contains an interior loop segment similar to the one
found in the other high-expressing sequences of eGFP N+12 and eGFP N+9.
This study indicates that certain RBS secondary structures prohibit binding of
the ribosome holoenzyme and thus lead to extremely low protein yields. An internal
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loop of the RBS leads to efficient translation of the target sequence, whereas when
the RBS is contained in a stable hairpin, protein synthesis is low. The secondary
structure environment of the start codon does not seem to play as crucial a role
as the RBS itself but may contribute to expression level differences. It is likely that
once the ribosome holoenzyme successfully binds to the mRNA strand it progresses to
perform a 2-dimensional diffusional scan along the RNA strand, effectively disrupting
any secondary structures present. The only structures not consistent with this picture
are Panels C and D of Figure 4.2, where the RBS secondary structures are actually
reversed. It is possible that these structures have not been correctly predicted by the
mFOLD server or that structures with similar energy exist that exhibit the above-
described secondary structure characteristics, allowing the ribosome to bind.
Since the mRNA sequence does play a significant role in expression efficiency,
every template to be expressed by E. coli -based ITT reactions should be checked
for adverse structures using a tool such as the mFOLD server, which is easy to use
and returns results instantaneously. Despite the fact the the actual coding structure
was modified here in order to address expression efficiencies, it should be possible to
modify the 5’UTR region instead. This would be preferred over the approach taken
here, since it won’t cause a change in the product to be synthesized. Likewise, silent
mutations can be introduced that will disrupt mRNA secondary structure elements
but won’t lead to a phenotypic change.
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4.2.2 Eukaryotic-Based Systems
Eukaryotic expression systems come in two flavors: wheat germ and rabbit reticulo-
cyte lysates. These two systems have many common features, such as an expected
yield of roughly 1-10 ngµL−1 seen in commercially available kits (Promega). Re-
cently wheat-germ-based systems have been optimized for increased reaction times
and yields of as much as 0.1 to 2.3mg mL−1 in a 36-hour reaction [32]. In order
to extend the reaction time to 36 hours the authors had to use dialysis in order
to continuously remove toxic by-products and supplement the reaction with an ATP
regenerating mix. Even though dialysis is extremely useful for bench-top in vitro syn-
thesis of protein, it is hard to implement on microfluidic devices, mainly due to the
need of a dialysis membrane. It would be possible to implement dialysis on microflu-
idic devices with a planar membrane situated between two PDMS slabs similar to the
devices fabricated by Ismagilov et al. [36], potentially extending protein synthesis by
several hours. Extending synthesis to a day or more is harder to implement since it
also requires re-introduction of new template DNA due to the degradation of DNA
by DNAses present in the system. Microfluidic approaches to extending synthesis
times based on discontinuous and continuous synthesis are described in Sections 6.4
and 6.5, respectively.
Eukaryotic expression systems appear to have a higher propensity for successful
initiation of translation, unlike E. coli -based systems, which were shown to be sen-
sitive to 5’UTR mRNA secondary structure (Section 4.2.1.1). Therefore eukaryotic
systems are the prime choice for large-scale applications expressing hundreds to thou-
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sands of proteins, where individual optimization of the 5’ structure is prohibitive.
Expression of eukaryotic sources such as human-derived cDNA clones is also to be
expected to work more efficiently in homologous expression systems rather than het-
erologous ones.
A final characteristic of eukaryotic expression systems is that post-translational
modifications are possible to certain extents. Here, rabbit reticulocyte lysates seem to
be more aggressive than wheat germ lysates. Those observations are purely empirical
and based on differences between apparent binding affinities of the herein-studied
family of bHLH transcription factors (Chapter 8).
4.3 Template Generation
Generating expression-ready templates is a necessary first step in any application syn-
thesizing protein. Cell-free systems may use either common plasmid-based templates
or linear expression templates derived directly with PCR-based methods. Plasmids
have the advantage of providing a more robust template, which will not be degraded
in the reaction mixture as rapidly as linear templates. The pitfall of plasmids is
the requirement for upstream cloning to generate the plasmid itself, which generally
requires a PCR step, followed by the digestion with restriction exonucleases of both
the plasmid as well as the PCR product to be cloned, and consequent ligation and
transformation. This process, if optimized, requires at least two days, not including
necessary sequencing controls to ascertain the correctness of the insert. These pitfalls
make plasmid-based templates unfeasible for any proteomic-scale application where
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Figure 4.4: Shown here is an outline of the different paths, and their interconnect-
edness, which may be taken in order to arrive at a DNA template viable for ITT.
All approaches require an open reading frame as starting material. The two most
commonly taken approaches are shaded green and yellow. The green path is the
standard cloning approach which leads through an expression plasmid and requires
about 2–3 days from ORF to protein. The second, yellow path runs through the lin-
ear expression template and requires the least number of steps and amount of time,
on the order of 1 day or less, to arrive at protein. One crossover between the paths
occurs, where the linear expression template may be cloned into a vector and from
there follow the green plasmid-based path.
hundreds to thousands of targets have to be prepared for rapid synthesis. Plasmids do
lend themselves for the routine or large-scale production of a handful to a few dozen
targets (see Section 4.3.1). Linear expression templates are the perfect approach for
any large-scale application and will be described in detail in Section 4.3.2. Figure 4.4
summarizes in a flowchart the various paths that may be taken in order to generate
viable templates for ITT reactions.
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4.3.1 Cloning
Molecular cloning is the conventional approach for generating expression-ready tem-
plates for ITT. Most companies offer their own plasmid for optimal expression with
their system. Many cloning strategies in principal start with an initial primer ex-
tension PCR on the open reading frame of choice, adding the required endonuclease
restriction sites, as well as moving the ORF into the correct expression frame. A
second cloning approach is based on blunt-end cloning of PCR templates. This sec-
ond approach is simpler and has resulted in better yields than approaches based on
sticky-end ligation. Except in the case of blunt-end cloning, restriction digests are re-
quired to linearize the plasmid as well as generate sticky ends on the linear template.
Optimally the linearized plasmid should be de-phosphorylated in order to prevent
re-ligation without insert. Once the linear template and the plasmid have been pre-
pared, they are ligated and transformed into a suitable host, generally E. coli. The
resulting plasmids should always be sequence verified, ascertaining the correctness of
the insert, as well as verified for expression. As can be gleaned, the cloning approach
is quite tedious and requires some expertise in the method. The resulting plasmid
is quite useful for high-yield expression of templates and lends itself as a source for
the facile generation of linear expression template using a simple 30-cycle TAQ-based
PCR (refer to Figure 4.4). Enhanced GFP (Clontech) was cloned into the vectors
pIVEX 2.3d (Roche) and pETBLue-2 (Novagen) by using standard cloning method-
ology. GFP was PCR amplified using primer extension PCR, adding a NcoI and
SmaI restriction site on the 5’ and 3’ end of the GFP ORF. The resulting products
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were purified using a PCR purification kit (Qiagen), followed by a double digest using
NcoI and XmaCI. Note that XmaCI is an isoschizomer of SmaI, creating a sticky end
rather than a blunt end. The pIVEX 2.3d vector needed to be linearized with the
same two restriction enzymes, whereas pETBlue-2 is already in a linear form accept-
ing blunt-end PCR templates. Upon complete digestion of the vector and insert, the
linearized and cut products were separated on an agarose gel and selected bands were
gel purified (Gel Purification kit, Qiagen). Next the inserts were ligated into their
respective vectors using Novagen’s Blunt End Ligatin kit and the resulting vectors
were transformed into chemically competent cells, strain NovaBlue (Novagen), and
spread plated. Resulting colonies were confirmed for the correct size by PCR screen-
ing. Colonies containing vectors of correct size were picked and grown overnight in
LB and the vectors were prepared for a control digest. The above-described liga-
tion procedure performed well compared to diffculties with using the recommended
endonuclease SmaI. Use of Novagen’s blunt-end cloning kit to perform the ligation
further enhanced the yield and streamlined the process.
In general blunt-end cloning is to be preferred over sticky-end cloning since it does
not require processing of the PCR product nor the vector. A variety of expression-
ready clones were generated using pT7Blue as a backbone. Constructs include eGFP
variants carrying different N- and C-terminal epitope tags, the histones H2A, H2B,
H3, and H4, and the caspases 4, 6, and 9.
For eukaryotic-based expression using a vector, pTNT (Promega) was modified to
contain a blunt-end cloning site for Pmi I, an N-terminal extension, and a C-terminal
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AviTag, creating vector pTNT+.
Blunt-end cloning is not universally applicable, in which case it is necessary to use
a sticky-end cloning strategy similar to the one described above. It is quite useful to
combine blunt-end cloning with the PCR-based method described in Section 4.3.2,
providing a convenient method for generating a stable template source with minimal
amount of effort, in addition to being completely modular, as entailed by the PCR
approach.
4.3.2 PCR-Based Approach
PCR provides the quickest route to viable expression templates. Roche commer-
cialized a system based on a multi-step PCR generating linear templates for most
of its ITT kits that it sells. Sawasaki et al. developed a PCR-based approach for
wheat-germ-based expression [32]. PCR-based approaches are not only extremely
fast, yielding product within a day, but are also highly modular and can accept a
variety of input templates ranging from cDNA clones and other plasmid-based ORFs
to genomic DNA. One of the main drawbacks to PCR-based approaches is the for-
mation of primer dimers, which is a considerable problem in the Roche based system.
If the PCR is not optimized, additional purification steps, such as tedious and time
consuming gel purification steps, are required.
A novel PCR-based approach was designed in order to address the following points:
1) only commercially available single-stranded oligomers should be required, limiting
individual oligo lengths to 100–135 bp, 2) the PCR should be highly modular, 3) a
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Figure 4.5: 2 step PCR method for generating linear expression templates
gatcttaaggctagagtac TAATACGACTCACTATAGG GAATACAAGCTACTTGTTCTTTTTGCA ctcgagaattc GCCACC ATG
overhang T7 Promoter linkerβ-globin Kozak
Start
Codon
TAATAA cgactcaggctgctac (A)30 CTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG
Stop
codon (2x) Poly A T7 Terminatorlinker
5’UTR
3’UTR
Figure 4.6: 5’ and 3’ UTR sequences added by the 2-step PCR method. All regions
are annotated and all priming sequences are in red. The start and stop codons are
colored green. The entire 5’ and 3’ UTRs are added by the 5’extension and 3’extension
primers, respectively, except for the start and stop codons.
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minimal number of spin column based purifications should be required, 4) it should
be possible to tag the resulting linear template with moieties such as fluorophores
and biotin, and 5) if possible be a single-tube, single-step reaction. The resulting
design is illustrated in Figure 4.5 and was intended to be used in either wheat-germ-
or rabbit-reticulocyte-based coupled ITT systems. It was originally designed as a
one-tube, one-step reaction, with the primer melting temperatures staggered so that
the melting temperature could be ramped down as the PCR progressed, in order to
induce priming of sequences at various times in the reaction and thus sequentially
stepping through the reaction scheme. In praxis the one-tube reaction did return
an unacceptable amount of incorrectly primed by-products and would have required
considerable optimization of melting temperatures and primer concentrations. The
final and currently used approach is a two-step approach. In the first step two ORF-
specific primers are used, which contain overhang sequences allowing downstream
priming with the primers 5’extension 1 and 3’extension 2. It is also possible to
conveniently add N- and C-terminal epitope tags to the ORF using the gene-specific
primers. One simply adds the desired sequence directly downstream or upstream of
the start and stop codon, respectively. Any ORF may be used as template in this first
PCR step, including yeast or bacterial genomic DNA, bacterial colonies, or purified
plasmids. The first PCR step may be run for 10 to 30 cycles and the resulting product
is generally purified using a spin column (PCR purification kit, Qiagen); the product
may then be stored at -20◦C. Several dozen second-step PCRs may be run on the
quantity obtained in the first step, making it a very efficient and convenient method.
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The second PCR step consists of two sub-steps, which take place in the same reaction
vessel. Here, in the first reaction 10 cycles are run in the presence of the 5’ extension
1 and 3’extension 2 primers, which prime the overhang regions added to the ORF
in the first reaction. These primers add the entire 5’ and 3’ UTRs (see Figure 4.6
for sequence details). The products of this sub-step in principal are functional linear
expression templates. In order to reduce the chance of primer dimer formation and
to add the ability to easily label the linear expression templates with moieties on the
5’ and 3’ ends, a second set of short primers is used. These function as amplification
primers, priming the very ends of the linear expression templates. These primers are
also much cheaper to label with fluorophores and other moieties, and may be used at
will, depending on which moieties are needed.
The two-step PCR method was also modified, by redesigning the 5’ extension
primer, to be used in E.coli -based ITT systems. Two new extension primers of
slightly varying sequence were designed and tested with Gateway Entry clones (Invit-
rogen) harboring ORFs from S. pneumoniae (TIGR Pathogen Functional Genomics
Resource Center). The extension primers were based on sequences obtained from Kim
(Schwartz Lab Stanford U., private communication) and sequences used in pIVEX
vectors (Roche) (refer to Appendix B for sequence details). Preliminary results indi-
cated that the sequences were equally efficient in producing protein.
One concern with using PCR-based approaches for template generation is the
accumulation of point mutations due to the DNA polymerase error rate. This is a
concern as the cycle number for the PCR may be as high as 65 cycles. In order
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to assess the impact of high cycle numbers on the viability of the protein product,
a 45-cycle- and a 65-cycle-derived linear template were transcribed and translated.
The synthesized transcription factor showed the same affinity to its target sequence
regardless of the number of cycles used to generate the template. Point mutations
undoubtedly accumulate in the resulting pool of linear templates, but only a subset
will lead to phenotypic mutations, and only a subset of those will have detrimental
effects on protein function.
To further asses the fidelity of the PCR approach, 7 linear templates generated by
a 70-cycle, two-step PCR were bulk sequenced. The resulting sequences (Appendix
D) indicate that a 70 cycle PCR using High-Fidelity Polymerase (Expand High Fi-
delity PCR, Roche) does not have adverse affects on the fidelity of the resulting
bulk sequence. This was established by performing a BLAST search (discontiguous
megablast) with the obtained sequences. The alignments show that 6 out of the 7
sequenced ORFs align perfectly with their match in the first 300–400 bases of the
sequence. Below 400 bps mismatches and gaps are visible, but are due to degradation
of the quality of the sequencing run. The only case that showed discrepancies between
the sequenced results and the BLAST subject was for C-Myc, which returned v-Myc
as the resulting subject, and is the reason for the observed differences. In the case
of C-Myc ∆N249, the sequence again perfectly aligned. This strongly suggests that
there are no contaminating carryovers of misread sequences in the bulk PCR product.
Therefore, since the bulk product seems to be identical to the original sequence, the
resulting bulk protein should also resemble the intended product. This method of
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bulk sequencing of course does not rule out the possibility that many random point
mutations accumulate, but it shows that none of these mutations dominate the PCR
after 70 cycles. Again, in order to establish the exact distribution and occurrence of
these point mutations it is necessary to sequence individual clones.
70
Chapter 5
Surface Chemistries
5.1 Introduction
Surface chemistry is a central component of all on-chip biochemistry, not only due
to the high surface-to-volume ratio intrinsic to microfluidic devices, but also because
it is necessary for performing pull-down-based molecular assay. In order to perform
on-chip protein synthesis from linear expression templates, described in more detail
in Chapter 6, and to perform interaction assays, it is necessary to generate specific
surface chemistries by derivatizing the surface with molecules that specifically bind
other molecules such as streptavidin or antibodies. In order to prevent non-specific
binding, surfaces may be treated with molecules such as BSA and PEG.
The two available surfaces to work with are glass and PDMS. Glass was chosen
as the preferred surface simply because it has been used for many years as a starting
point of various chemistries. Glass surfaces derivatized with functional groups such as
amine, aldehyde, and epoxy are also commercially available. Additionally, glass has
been widely used as a substrate for DNA arrays, which are being used here as a way
of introducing molecular information onto microfluidic devices (Chapter 6). Glass
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may also be coated with metals by sputtering or vapor deposition. PDMS may serve
as a starting point for most if not all above-mentioned methods as well, but generally
has not been optimized and perfected to the point that glass chemistries have.
Glass chemistries have been widely applied to biological molecules, making it a
necessity that they be performed at near-neutral pH, close to room temperature, and
in aqueous phase in order to prevent macromolecules from irreversibly denaturing
and thus loosing their function; yet another beneficial aspect to choosing glass over
PDMS chemistry.
The following chapter describes various methods used to arrive at functional sur-
faces, either on- or off-chip, as well as more detailed information on how the surfaces
are generated. The pros and cons of each method and their integration with the rest
of the microfluidic device are also discussed.
5.2 Building Surfaces
In this study, in order to build specific surface chemistries, only a handful of moieties
and reactive groups were used, which nonetheless could be combined in a number
of ways. Amine reactive chemistry is the predominant method used to generate
covalent linkages. Primary amine groups react by nucleophilic attack with a variety
of groups such as epoxy and succinimidyl esters. These reactions occur at slightly
basic pH, required to protonate the primary amine, and at room temperature. Most
primary derivatization steps are based on an amine reactive group. The second most
commonly used chemistry is binding of biotin by the avidin family of proteins such as
72
Epoxy coated glass
BSA
NHS-ester biotin
Streptavidin
Epoxy coated glass
Biotinylated BSA
Streptavidin
Amine coated glass
NHS-ester biotin
Streptavidin
Epoxy coated glass
Streptavidin
Linear expression template 3’biotin
Biotinylated Antibody
Biotinylated BSA
A B C D
Off-chip
On-chip
Figure 5.1: Shown here are four commonly used surface chemistries ultimately con-
verging on a streptavidin monolayer which can bind a variety of other functional
biotinylated molecules. Panel A, C, and D are chemistries based on epoxy- and Panel
B is based on amine-coated slides. In Panel A the first derivatization step is taking
place off-chip. All other steps are performed on-chip using continuous flow of reagents
over the surface.
avidin, streptavidin, and neutravidin. Biotin binding to these molecules is incredibly
persistent with an affinity constant on the order of 1015 M−1 and a half-life of almost
a day. Not only do streptavidin and neutravidin have high affinity for biotin, but
they also contain four binding sites, allowing streptavidin to bind up to four ligands.
This is commonly taken advantage of by using streptavidin as a linker between two
or more different ligands, effectively linking streptavidin to a surface-bound ligand
followed by binding a second ligand to streptavidin.
The general strategy for generating surface chemistries useful for protein pull-
down and interaction studies relies on activating a glass surface with a biotin moiety
via amine reactive chemistry. Figure 5.1 summarizes approaches taken here to arrive
at a streptavidin monolayer to which any biotinylated molecule may be attached.
Panels A, C, and D show epoxy-based approaches. Here the first step in all cases
consists of attaching proteins via their primary amine groups to the surface epoxy
groups, creating a protein monolayer. This can either be done off-chip (Panel A)
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in a PBS buffered solution (Appendix E.4.1), or on-chip (Panels C and D). In the
case of off-chip derivatization it is necessary to bond the PDMS device to the protein
monolayer. This, even when done at 80◦C overnight, is not a strong bond and thus
does not permit flow pressures much higher than 5 psi. Additionally it is unlikely
that the protein remains in a native state, due to the high temperature and lack of
bulk water, and thus it should not be considered folded for further downstream steps.
Therefore, use of streptavidin or other functional molecules is not applicable, unless
it is possible to refold the proteins on-chip. In the case of BSA it is not necessary
for the protein to be in its native conformation, since it only serves as a passivization
agent and the second derivatization step is based on a succinimidyl ester reaction
with primary amines on BSA. Coating the entire epoxy glass slide in a BSA bath has
the advantage that the entire surface is being passivated, which is useful to prevent
other molecules such as DNA and protein from binding to the glass surface. Once
the device has been bonded to the BSA-coated glass surface it may be activated
on-chip using a biotin-succinimidyl ester functional group, covalently linking biotin
to all available amine groups on the surface-bound BSA. Biotin in turn may bind
streptavidin, allowing further molecules to be added at will. Instead of passivating
the entire epoxy surface with BSA, it is possible to bond a PDMS device directly to
the surface. This bonding takes place at room temperature, but works better at 40◦C.
This bond is acceptably strong, consistently holding 5–6 psi on the flow layer. More
importantly, it is the only bond that forms at room temperature and thus is extremely
useful when DNA, protein, or cell arrays are to be bonded to a PDMS device. No other
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bonding method works at room temperature, except for plasma bonding, which is not
applicable to arrays for two reasons: it destroys any molecules on the array if the array
itself needs to be treated (which is likely the case), and it is prohibitive to obtain exact
alignment since bonding is instantaneous (preventing realignment and thus making
the process a one-shot deal). Once the chip has been bonded to the epoxy slide,
which can be accomplished in 1–2 hours at 40◦C, further chemistry can be performed
by attaching molecules containing primary amines to the epoxy groups. The first
approach (Panel C) parallels the approach taken before by attaching a BSA protein
to the surface. In this instance it is possible to attach a biotinylated BSA protein
directly to the surface, streamlining the approach by circumventing the biotinylation
step. It was not possible to directly derivatize the entire epoxy slide directly with
biotinylated BSA in the previous approach since the required 80◦C bonding step has
detrimental effects on the biotin moiety either destroying it or destroying the linkage
to the carrier molecule. The third epoxy-based approach simply attaches streptavidin,
or any other protein, directly to the epoxy surface. This approach, even though quick
and straightforward, is not optimal, since background binding is higher due to the lack
of passivation agents such as BSA. Secondly the streptavidin or antibody molecules
will attach in random orientations to the surface, rendering a fraction of the active
sites inaccessible and reducing functional surface density.
A fourth approach is based on amine-coated slides rather than epoxy substrates.
Here the chip is bonded to the glass slide prior to any surface chemistry treatment.
The first on-chip derivatization step consists of covalently linking a biotin moiety to
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the amine groups via a succinimidyl ester. The biotin monolayer is then coated with
streptavidin. This approach works consistently, but has the same drawbacks as the
method described in Panel B, in that there is no passivation layer protecting the
surface, causing increased non-specific binding. Furthermore any un-reacted amine
groups will exhibit a positive charge, increasing non-specific binding of net negatively
charged molecules such as DNA.
Once a streptavidin monolayer has been established, it is quite easy to attach any
molecule of interest to this surface. Here, either biotinylated antibodies or biotiny-
lated dsDNA molecules are generally used. Biotinylated antibodies are commercially
available (Qiagen, AbCam) and biotinylated dsDNA molecules can easily be syn-
thesized in-house using commercially available biotinylated oligos and PCR (Section
4.3.2). Additionally, by using the freestanding membrane described in Section 2.3.4,
it is possible to generate defined spots consisting of one type of molecule surrounded
by a second type of molecule achieved by stepwise derivatization.
Figure 5.2 describes one approach to generating a surface that contains linear ex-
pression templates from which protein is synthesized in situ and a defined circular
region of an anti-penta-histidine antibody used to pull down the synthesized protein.
Panel A shows a schematic of the final surface chemistry used in the experiment. The
initial layers are exactly the same as described in Panel A of Figure 5.1. The functional
molecules linked to the streptavidin monolayer in this case are biotinylated linear ex-
pression templates coding for a bHLH transcription factor N-terminally tagged with
a 6x histidine epitope tag. A biotinylated antibody is also deposited on the device.
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The linear expression templates and antibodies are deposited in two consecutive steps.
First the linear template is deposited while the freestanding membrane is closed (the
membrane-protected area indicates which section of the device is protected. Refer
to Section 2.3.4 for more detail on the freestanding membrane and Section 7.4 for
MITOMI). Once the non-protected area is covered with linear expression template, a
second solution of biotinylated BSA is flown over the same area with the freestanding
membrane remaining closed. This step ensures that all still-available streptavidin
binding sites are passivated. The biotinylated BSA is then cleared out during a PBS
wash step and the membrane is opened, de-protecting the as of yet underivatized
areas. Now a solution of biotinylated antibody is flown over the surface causing
the antibody to deposit at the previously protected sites. Once the surface chem-
istry is set, protein is synthesized in situ and pulled down via an epitope tag by the
surface-linked antibody. Any secondary molecule, in this case short dsDNA carrying
a transcription factor recognition site, is co-pulled down (Panel B). Now MITOMI
2.3.4 may be performed by once again bringing the freestanding membrane into con-
tact with the surface, effectively trapping any surface-bound molecules (Panel C).
Unbound material can now be washed away without loss of bound material (Panel
D) allowing for the sensitive detection of the bound material.
77
BSA
Biotin
Streptavidin
Linear expression template Penta-histidine Antibody
Off-chip
On-chip
Epoxy Glass
Surrounding area Membrane protected area
Linear expression template Penta-histidine Antibody
Surrounding area Membrane protected area
MAX iso A
Ebox DNAprotein
synthesis
MAX iso A
MAX iso A
Ebox DNA
Ebox DNA
MAX iso A
MAX iso A
Ebox DNAEbox DNA
MAX iso A
MAX iso A
Ebox DNA
Ebox DNA
Linear expression template Penta-histidine Antibody
Surrounding area Membrane protected area
MAX iso A
Ebox DNA
MAX iso A
MAX iso A
Ebox DNA
Ebox DNA
MAX iso A
Ebox DNA
Ebox DNA Closed membrane
MAX iso A
Ebox DNA
Linear expression template Penta-histidine Antibody
Surrounding area Membrane protected area
MAX iso A
Ebox DNA
Closed membrane
A) Final surface chemistry B) Protein synthesis and capture of protein/DNA complex
C) MITOMI D) Removal of surrounding background
Figure 5.2: This figure shows a schematic of the surface chemistry that was generated on
the device as well as the process of protein synthesis, capture and MITOMI. Colored boxes
indicate fluorescently labeled molecules: green = fluorescein, yellow=Cy3, and red=Cy5.
Panel A shows the final surface chemistry just prior to introduction of the in vitro tran-
scription/translation reagents. Each grey block represents a monolayer consisting of the
indicated molecule. Panel B describes the process of protein synthesis using the deposited
linear expression templates. The synthesized MAX iso A protein diffuses to the antibody-
coated surface and is pulled down via its N-terminal 6xHistidine tag. The free Ebox DNA
molecules, introduced with the ITT mix, are recognized by MAX iso A and likewise pulled
down to the surface. In Panel C MITOMI is performed by closure of the free-standing mem-
brane, trapping any bound material and expunging any unbound material (corresponding
image: Figure 2.5 Panel B). Panel D shows the final state of the device after the last PBS
wash removes any unbound material from the adjacent material (corresponding image: Fig-
ure 2.5 Panel C).
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Chapter 6
On-chip Protein Synthesis
6.1 Introduction
The previous chapter described in detail the use and applicability of ITT to large-scale
protein biochemistry in providing a fast and facile path towards protein. ITT has the
potential of outperforming classical approaches to generating protein by homologous
or heterologous expression in various cell lines by circumventing all necessary cloning
and culturing steps. But in order for ITT to be applicable to proteomics, two neces-
sary requirements have to be met: first many thousands of proteins will have to be
synthesized in parallel and tested in binary fashion against one another; and second,
the first requirement has to be met on scales small enough to be economically viable,
as commercially available ITT reactions remain rather expensive (0.2 $/µL versus
0.05 $/µL for a PCR reaction). Microfluidics presents a solution to both of the above
requirements in that it allows for massive parallelization of extremely small reactions
with volumes on the order of nano- to picoliters.
Nonetheless, novel methods needed to be developed to address the world-to-chip
interface problem, as a single device must be programmed with thousands of expres-
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sion templates coding for the proteins to be synthesized. Programming of a microflu-
idic device with thousands of unique solutions is a non-trivial task. Current methods
allow for the introduction of tens to hundreds of solutions onto a single device, which
is still one to two orders of magnitude below the projected goal of thousands of unique
proteins (required for most prokaryotic proteomes). Figure 6.2 presents two solutions
to the programming dilemma. The first approach is more classical and based on
the flow deposition of linear expression templates. The second, more powerful and
modular, approach is based on using spotted microarrays for device programming.
The final sections of the chapter describe how protein can be synthesized in situ on
devices using either batch (Section 6.3), discontinuous (Section 6.4), or continuous
synthesis (Section 6.5).
6.2 Programming Devices with DNA
6.2.1 Flow Deposition
Flow deposition generally entails derivatizing at least one surface of a microfluidic
channel with a linear expression template. This is most easily accomplished using
a glass/streptavidin-based surface chemistry (Figure 5.2) in combination with a 3’
biotinylated linear expression template generated via PCR (Figures 4.5 and 4.6). The
linear expression templates are flown over the streptavidin surface, where they are
captured and accumulate until the surface is saturated. Due to the slow dissociation
of biotin from streptavidin, these surfaces stay viable for an extended period of time,
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Figure 6.1: Shown are three approaches for programming devices by surface depo-
sition. (A) The simplest of the three approaches involves programming of a flow
with a unique template. (B) Hybrid approaches are also possible that combine flow
deposition with programming using microarrays. (C) A true combinatoric array can
be established by intersecting the vertical flow channels, as in (A), with horizontal
channels programmed with a second set of templates.
which is an important aspect for discontinuous as well as continuous ITT. Figure 6.1
describes three possible flow deposition schemes.
The first scheme, depicted in Panel A, is the most straightforward method, in
which parallel microfluidic channels are each derivatized with a linear expression
template coding for different proteins. The second approach, shown in Panel B, is
actually a hybrid between flow deposition and spot deposition described in 6.2.2.
The third and final scheme, shown in Panel C consists of two sets of parallel channels
running perpendicular to one another. Each set of parallel channels is derivatized with
its own unique set of linear expression templates (n[A,B,C] and m[1,2,3]). Crossing the
channels allows one to test a complete interaction matrix of all possible combinations
of n x m. A chip design successfully fabricated and tested is shown in C.3. This
device can test 12 x 12, or 144 different protein combinations. This combinatoric
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approach is especially useful when a limited set of proteins are to be tested in all
possible combinations. A possible application includes testing molecular complexes,
which generally consist of tens of proteins. The reason that the approach is limited
to rather small numbers for n and m is that each linear expression template requires
a dedicated fluidic input port, each of which has a rather large footprint and is
tedious to interconnect. A strength of the approach lies in the fact that the linear
expression templates are surface immobilized, allowing for complete buffer exchange
with minimal template loss. The immediate benefit of this lies in the ability to run
consecutive protein synthesis reactions. This is useful as ITT reactions are generally
short lived, on the order of 1–2 hours, and therefore produce only limited amounts
of protein. By being able to repeat the synthesis x number of times (where x is
only limited by the retention of functional linear expression templates on the surface)
one can accumulate large quantities of protein (described in detail in Section 6.4
and Section 6.5). Another technical limitation to flow deposition is based on mass
transfer from solution to the surface. Mass transfer can be in a limiting regime
so that in long channels with high resistance and low flow velocities the time for
complete derivatization can become rather long. Or, in a limited amount of time it
might only be possible to saturate the beginning of the channel while the exit remains
underivatized. The problem of mass transfer is of course also primarily dependent on
the concentration of the material to be deposited; this affects mainly linear expression
templates as other molecules used in derivatization such as streptavidin and BSA-
biotin, can be obtained in large quantities and at high concentrations.
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A solution to the mass transfer problem is shown in the layout of device DTPAx8
(Figure C.17) where rows are addressed in parallel rather than serially. Additionally,
a resistance equalizer up and downstream of the parallel flow channels assures that the
flow velocities through each row of channels is of the same magnitude. Taken together
such a design allows for the rapid and even derivatization of the entire surface of the
device, even with material that is present in limited concentrations.
6.2.2 Microarrays
Spotted microarrays were first described in 1995 by Brown et al. [37]. Microarrays
are fabricated using small dimension quill pens, which pick up liquid from a reservoir,
generally a multiwell plate, and deposit drops with diameters ranging from tens to
hundreds of microns. The resulting microarrays, with up to tens of thousands of
individual spots, are uniquely suited for integration with microfluidic devices as the
length scales of the spot diameters and microfluidic channels are well matched.
To integrate a spotted microarray with a microfluidic device, the spots on the array
need to be aligned to features on the microfluidic device. This is easily accomplished
and requires about the same degree of dexterity as fabricating the microfluidic devices
themselves. One important aspect is that the spots need to be visible, which generally
is the case since most solutions that are spotted will evaporate leaving a crystalline
residue on the surface. If this is not the case, as for some low-concentration DNA
solutions in water or TE buffer, salts or BSA may be added to the solution (the choice
depending on downstream compatibility).
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Figure 6.2: Schematic representations of 3 possible approaches to generating spotted
microarrays. Panel A shows the standard approach where each spot contains a unique
solution (here A–H). Elaborating on this scheme it is possible to co-spot (Panel B)
or neighbor spot (Panel C) additional solutions (here A–B, 1–2, and α − β) either
directly on top of (co-spotting) or in proximity (neighbor spotting) of an existing
spot.
In all current chip designs using microarrays for device programming, each in-
dividual microarray spot is aligned to a chamber on the microfluidic device. These
chambers make alignment easy and protect the spot from solvating and suffering dif-
fusional loss during on-chip processing. Since spots are aligned to a chamber, which
confines the spot, it becomes possible to co-spot multiple solutions onto the same
microarray spot and have them mix on-chip, allowing for complex combinatoric ex-
periments. Figure 6.2 summarizes the three most common and useful approaches to
generating spotted microarrays for use with microfluidic devices. The first approach
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(Panel A) is a standard spotted microarray where each spot is unique and homo-
geneous. More useful approaches include co-multispotting (Panel B) and neighbor-
multispotting (Panel C). Both of the latter approaches generate spots or clusters of
spots containing more than one solution. The co-multispotting approach is the more
space efficient of the two, as all the solutions are spotted on top of one another. Co-
multispotting also allows for concentration of samples, as repeated deposition of the
same solution will result in accumulation of material on the surface. One problem
with co-multispotting is the possibility of contamination, and care must be taken
to clean the quill pen between spots, which drastically adds to the time required
for generating an array. The neighbor-multispotting approach solves the problem of
contamination since no spot comes into contact with any other spot. But neighbor
spotting does require a considerably larger footprint, limiting the number of reactions
that may be run per device.
The use of spotted microarrays is extremely modular, as any soluble substance
may be spotted and thus used to program the device. The only requirement is that the
spotted solution is compatible with the PDMS device itself. Furthermore, colloidal
suspensions, as well as pelleted cellular material, may also be spotted, as demon-
strated in Chapter 10, where a library of yeast strains is arrayed.
6.3 Batch Synthesis
The simplest approach to protein synthesis is based on porting the standard bench-
top ITT reaction onto the microfluidic device. Generally, the expression template is
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present on the device from which protein is being synthesized. The linear expression
template may also be added directly to the ITT mixture before introduction onto the
device. This approach is used in later chapters for transcription factor–DNA binding
energy landscape determination, where the device is programmed with target DNA
rather than expression templates. Premixing the expression templates into the ITT
reaction assures a homogeneous distribution of template, and thus protein expression.
The next two sections describe how protein can be synthesized in batch format
either from flow-deposited or spotted DNA. Batch synthesis implies that only one
synthesis reaction is run from start to finish. The protein yield is therefore limited
by the efficiency of the ITT systems, which in batch mode generally can synthesize
protein for up to 1–2 hours.
6.3.1 Deposited DNA
Flow-deposited DNA is well suited for high-yield on-chip protein synthesis. One
reason for this is that flow-deposited DNA is considerably more concentrated than
can be achieved for solution phase expression templates. This considerable increase in
DNA concentration is due to the high surface-to-volume ratio in microfluidic devices.
In most cases the ratio is generally 1000 µm2 for every 100 pL. With such a ratio,
expression template concentrations of 1 µM can easily be achieved. This compares
favorably to normal solution phase concentrations, which are in the nanomolar range
at best.
A second advantage of flow-deposited expression templates lies in the fact that
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discontinuous batch synthesis as well as continuous synthesis are possible, since the
expression templates are solid phase, making buffer exchanges possible. The capa-
bility to run several batches or continuous synthesis with constant ITT exchange
results in drastic increases in protein yield and, coupled to an appropriate protein
sink, should find broad application in the large-scale protein synthesis using on-chip
ITT.
6.3.2 Spotted DNA
Batch synthesis of spotted expression templates is the method of choice for generating
small quantities of a large number of different proteins. Current devices can synthesize
thousands of different proteins from an appropriate ORF library. As an early proof-
of-principle experiment, eGFP was expressed from spotted expression templates using
E.coli ITT. A 400-chamber device (Figure 6.3) was programmed with 100 spots of
expression templates coding for eGFP. Only 1/4 of the device was programmed to
ascertain that there is no cross-contamination of adjacent chambers. The device was
then loaded with E.coli ITT mix and incubated for 7 hours with fluorescence scans
being taken every few hours. The results show that eGFP synthesized well in most
if not all chambers that were programmed, while all negative chambers remained
dark. The eGFP concentration was so high that its fluorescence could be observed
on a microscope with simultaneous bright field and fluorescence illumination (Figure
6.3B). The time trace indicates that synthesis seizes after roughly two hours and
that the synthesized protein is stable over several hours. Furthermore, synthesis is
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Figure 6.3: eGFP was synthesized from spotted expression templates. (A) Each
template was spotted in every 4th chamber and incubated for several hours with E.coli
ITT. Fluorescence was measured on a microarray scanner. (B) The resulting protein
concentration was so high that fluorescence could be observed while in brightfield
mode on an epifluorescent microscope. (C) Time trace of eGFP fluorescence
quite uniform across the device, with slight variation possibly arising from different
quantities of expression template being deposited in each well.
6.4 Discontinuous Synthesis
Discontinuous batch synthesis can be accomplished from a flow-deposited expression
template. Running several consecutive batches of synthesis allows for a steady accu-
mulation of protein. Discontinuous synthesis should be coupled with a protein sink,
such as an off-chip affinity column that selectively filters out the synthesized protein
and thus concentrates it. eGFP was synthesized by discontinuous batch synthesis
from flow-deposited linear expression templates and the resulting fluorescence was
measured over time (Figure 6.4). Three consecutive batches were run, with the first
run yielding the highest amount of protein and the following two batches yielding
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Figure 6.4: eGFP was synthesized in three consecutive batches from flow-deposited
linear expression templates, and fluorescence intensity was observed over time on
a microarray scanner. The remaining surface-bound linear template was quantified
after each cycle and normalized to the starting amount.
comparable amounts. In all three cases, synthesis stopped after about 2 hours. To
optimize the system one can optimize the run time of individual batches to under
two hours, increasing cycle frequency and protein yield. The only limitation to the
number of cycles that can be run depends on loss of template from the surface, either
due to dissociation or nuclease activity. The rate of loss of functional template from
the surface was determined by labeling the 3’ end of the linear template with Cy3. In
this experiment, after the first and second cycle roughly 90% and 75% of fluorescence
remained. Interestingly, even though only 75% of the initial signal remained after the
third cycle, protein synthesis seemed to be unaffected. It thus seems possible that the
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signal loss may be due to non-specifically adsorbed molecules or bleaching, neither of
which accurately reflects the number of functional linear expression templates present
on the surface. As the protein synthesis yield seems unaffected after three cycles, it
should be possible to run many more additional cycles with acceptable protein yield.
6.5 Continuous Synthesis
In the previous section, discontinuous synthesis has been shown to be easily realized,
yielding good repetitive yields over several consecutive batches. Running continuous
synthesis has not been put into praxis as of yet, but should be easily accomplished.
The simplest instantiation of the method would involve continuously flowing ITT mix
through a channel or a set of channels, with a reservoir at the outlets for collection of
product. It might prove necessary to chill the ITT mix while it is being introduced
onto the device in order to extend its lifetime. Likewise, setting up several ITT
batches is possible, but also more labor intensive. The length of each ITT continuous
batch run will depend not only on the retention of the expression template on the
surface but also on the lifetime of the ITT mix itself. But, judging from previous
experience, the overall lifetime should be long enough to result in increased synthesis
efficiency and product yield.
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Chapter 7
Detection of Molecular Interactions
7.1 Introduction
To understand molecular interactions one must not only be able to synthesize the
required components, described in Chapter 6, but also be able to detect whether two
molecules interact. Commonly used methods include: ELISA, yeast two hybrid, mass
spectrometry, and surface plasmon resonance. The ELISA principle was adopted for
use in microfluidics and two methods are described in Sections 7.2 and 7.3. An entirely
novel method, based on the mechanically induced trapping of molecular interactions
(MITOMI), is described in Section 7.4. MITOMI takes advantage of the ability to
generate free-standing membranes in MSL devices (Section 2.3.4), which are used to
mechanically trap molecular interactions taking place on a surface. This method of
mechanically trapping interactions is widely applicable, due to its simplicity, and is,
in fact, compatible with methods described in Sections 7.2 and 7.3. The advantages
and disadvantages of each method are described in detail in their respective sections.
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7.2 Antibody-Based Detection
Antibody-based detection is the most direct adoption of ELISA, but instead of using
substrate turnover by an enzyme for signal generation, a more direct approach is
taken by labeling the primary or secondary antibody with fluorophores. Generally
two primary antibodies are required, one for immobilizing the bait to the surface, and
the second for detecting the prey. Both antibodies recognize common antigens such
as epitope tags (6xHis, S-tag, T7, Myc-tag, etc.) or proteins (GFP, GST, etc.), which
can be engineered into the bait and prey molecules.
Antibodies vary widely in specificity and affinity for their respective antigens.
Specificity to the antigen is generally not as important, as it is generally high for an-
tibodies recognizing short epitope tags. Specificity is more important in the context
of non-specific binding of the antibody to the surface. Even though seemingly identi-
cal, there is a difference between these two modes of non-specificity, namely whether
the Fab region recognizes other epitopes non-specifically or whether any part of the
antibody may bind non-specifically. An important metric of antibody performance is
its specific affinity, which should be at least in the high pM regime with slow off-rates.
A high affinity ensures that most of the synthesized antigen is surface localized and a
slow off-rate ensures that the antigens stay there. Antibody clonality can also play a
role, particularly in surface immobilization. A polyclonal antibody to GFP recognizes
multiple epitopes on GFP and thus may pull the GFP-fusion protein down in various
orientations, increasing the likelihood that a physiological interaction may take place
without steric hindrance.
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In most protein array methods, antibody selection becomes a limiting factor, espe-
cially when each antigen requires its own antibody pair. On-chip approaches require
a maximum of a handful of matched antibodies, and then only if multiplexing is re-
quired. Generally only two antibodies are needed to perform interaction assays: one
for surface immobilization and the second for detection of the bait protein. One very
useful antibody, used in essentially all experiments, is a anti-penta-Histidine Antibody
(Qiagen) labeled either with biotin for surface immobilization, or Cy5 for fluorescent
detection. Other useful antibodies include anti-T7 as well as anti-GFP antibodies,
also either labeled with biotin or fluorophores. A non-antibody option for pull-down
is described in Section 7.3.
In summary, antibody-based methods are easily implemented and give good results
in on-chip applications. The antibodies used here provide limited signal amplification
on the order of five- to tenfold, due to the multiple labeling of each antibody with
several fluorophores. More sensitive approaches include enzyme-based methods (see
Section 7.3), where a signal may be amplified several thousandfold. But these latter
methods also exhibit greater sensitivity to non-specific binding. Overall, antibody-
based methods with direct detection coupled to MITOMI (Section 7.4) are sufficiently
sensitive to detect most molecular interactions in high-throughput uses.
7.3 S-Tag Assay
A potentially useful method for both purification and detection of proteins is ribonu-
clease S, commercially available from Novagen. The ribonuclease S protein has been
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Figure 7.1: A fluorescent scan of an on-chip S-tag assay. Green intensities indicate
high substrate hydrolysis and therefore presence of a S-tagged protein. A pattern of
high and low intensities is observed correlating to the identity of expressed protein in
each unit cell; proteins with and without s-tag tags were expressed and pulled down.
engineered to yield an inactive S-protein and a short S-Tag peptide of 15 amino acids
in length. The S-protein can be used to pull-down and specifically bind to the S-tag
epitope with an affinity on the order of 10−9M [38], which is comparable to weak- to
medium-affinity antibodies. Additionally, and more importantly, binding of the S-tag
peptide to the S-tag protein reconstitutes its ribonuclease activity and thus can be
used as a sensitive assay for protein interactions in lieu of standard antibod-based
ELISA assays. The immediate advantage of the S-tag approach is the fact that the
S-protein is inactive if not bound to the S-tag. In the case of ELISA approaches, the
antibody-enzyme fusions are always functional and therefore very sensitive to non-
specific binding. If the S-protein were to non-specifically bind somewhere it would
remain inactive and thus won’t contribute to background signal. Kelemen et al. [39]
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developed a FRET-based assay for ribonucleases relying on the cleavage of a chimeric
oligonucleotide dual labeled with a 5’ fluorescein and a 3’ rhodamine as quencher. The
optimal sequence was a tetranucleotide of dArUdAdA, which exhibited the highest
ratio of product to substrate and a high turnover rate. To adjust this substrate for
use in high-throughput protein-protein interaction assays the FITC and TAMRA fluo-
rophores were replaced with Cy5 and Iowa Black RQTM -SP, a black whole quencher,
respectively. This moved the detection band of the substrate into the Cy5 region,
which is more sensitive and has a higher signal to noise ratio on the ArrayWorxE
than any blue-shifted band. To test whether the S-tag FRET assay could be used
on-chip for detection of protein-protein interaction, a proof of principle experiment
was set up to assay the interaction between yeast proteins fused with an N-terminal
6xHis tag and those with a C-terminal S-tag. The proteins were expressed on-chip
from spotted linear expression templates coding for the yeast proteasomal subunits
Rpt1-6. Once synthesized, the proteins bound to the surface localized antibodies via
the 6xHis-tag interaction. At this point MITOMI was performed to trap the inter-
actions in place, and, while the button was closed, the S-tag FRET assay mixture
(S-protein + 5 µM substrate) was introduced into the device. The buttons were then
opened, allowing the S-protein to bind to the C-terminal S-tag of the pulled down
proteins, activating it. The active S-protein then hydrolyzed the substrates, giving
rise to signal. The buttons were then closed once more to stop the reaction, and
the resulting signal intensities were measured using the ArrayworxE scanner (Figure
7.1). The pattern of high (green) and low (blue) signals seen in Figure 7.1 arises from
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positive and negative controls, the latter consisting of no-S-tag as well as no-His-tag
versions of the proteins being expressed.
All available substrate in each unit cell was turned over by the S-protein (about
4000 functional S-proteins will turn over all available substrate in a single unit cell
in 5 minutes). The results also indicated that the S-tag FRET assay is exceedingly
sensitive as non-specific binding of proteins lacking a His tag also gave rise to signal.
One partial solution to the non-specific binding problem was to use harsh wash steps
with 6M Guanidine HCl and/or NaOH prior to the assay step. This treatment is
possible because the button physically protects the detection area from these harsh
chemicals. But even though it solves the problem of non-specific sticking of proteins
surrounding the detection area, it cannot solve the problem of non-specific binding
or trapping of molecules in the detection area. One possible solution is to make the
S-tag FRET assay quantitative, which would be beneficial in any case. If the S-tag
assay is quantitative, it should be possible to detect the absolute number of bound
proteins in the detection area, which should vary as a function of affinity. Since
non-specific binding generally occurs in the low-affinity regime, these signals could be
removed from true positives by a simple signal intensity cutoff, selecting only for the
higher signals. Likewise, one could include a brief buffer wash prior to analysis, which
would ensure that only interactions with larger off-rates are retained. Unfortunately
any of these methods has the intrinsic problem that they would loose potentially
interesting low-affinity interactions. Other possible modifications to optimize the
assay lie in adjusting the substrate concentration as well as the substrate sequence
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itself; a substrate of the sequence dArGdGdA was tested and showed considerably
slower hydrolysis rates.
In summary, the S-tag assay is a viable and easily modified method for the ultra-
high sensitivity detection of molecular interactions. The modularity of the tags and
the substrate allows easy modification of parameters, such as the optimal detection
band, the affinities of individual components, and the substrate turnover rate. There-
fore, in the case where direct detection with a fluorescently labeled antibody is not
sufficient, the S-tag approach is a good follow-up candidate.
7.4 Mechanically Induced Trapping of Molecular
Interactions
Protein array platforms have two major shortcomings preventing them from being
broadly applied in Systems Biology. The first problem with protein arrays is the fact
that each individual protein spot has to be generated using bench-top expression and
purification approaches. Recently Ramachandran et al. [30] reported a method to
Figure 7.2: Plotted are off-rates for representative biological interactions spanning the
entire spectrum from very stable interactions such as streptavidin-biotin to extremely
transient ones such as Jun-Fos.
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Figure 7.3: (A–C) schematic of the process of MITOMI. The gray structure at the
top of each panel represents the deflectable button membrane that may be brought
into contact with the glass surface (blue). (A) His5 tagged TFs are localized to the
surface and TF-DNA binding is in equilibrium. (B) The button membrane is brought
into contact with the surface, expelling any solution phase molecules, while trapping
surface-bound material. (C) Unbound material not physically protected is washed
away and the remaining molecules are quantified. (D–F) Fluorescent intensity maps
of target DNA concentration from an actual device. Panels D–F correspond to the
top down perspective of Panels A–C.
rapidly synthesize protein arrays in situ. Improved methods based on similar ideas
are described in Chapters 4 and 6.
The second problem intrinsic to protein arrays is the issue of transience of molec-
ular interactions. For DNA array platforms this does not present a problem since
once DNA templates anneal to the array probes these interactions are extremely sta-
ble. Protein arrays, on the other hand, have to detect interactions amongst a wide
variety of proteins, whose affinities and kinetics vary over orders of magnitude (see
Figure 7.2). Stable interactions are much more readily detected than transient ones,
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Figure 7.4: Effect of button closing velocity on trapping efficiency. (A) Radial closing
velocities were measured at various pressures on two different devices, with slightly
different architectures. (B) The effect of the above closing velocities on trapping
efficiencies. Below 4µm/sec trapping is strongly dependent on button closing velocity.
This dependence disappears above 4µm/sec where the response plateaus off.
as transient interactions will rapidly dissociate during wash steps and thus cause
considerable loss of signal before an array can be analyzed.
To overcome the problem of transience, a method based on the mechanically in-
duced trapping of molecular interactions (MITOMI) was developed. MITOMI physi-
cally traps molecules between two surfaces, essentially freezing surface interactions in
place and preventing bound material from diffusing out of the detection area (Figure
7.3).
When trapping the interacting molecules, MITOMI preserves the equilibrium dis-
tribution of the molecules. This was tested by determining that the radial closing
velocity of the free-standing membrane has no effect on trapping efficiency at veloc-
ities above 4 µm/sec (Figure 7.4). At slower velocities surface-bound molecules are
able to dissociate and diffuse out of the detection area as indicated by a lower ratio
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Figure 7.5: Measurements illustrating the effectiveness of the mechanical trapping of
molecules. (A) Rate constants determined at four measurement intervals. (B) The
same rate constant averages as in (A) plotted as a function of inverse measurement
interval. The dependence on the measurement interval indicates that bleaching con-
tributes to the measured rate constants. The intercept represents the actual mass
loss rate (without the contribution of bleaching) with a value of 0.0009 minutes−1.
of bound material. To further assure that the measured affinities, reflect actual equi-
librium affinities previously reported affinities determined by EMSA were positively
compared to values determined by MITOMI ([7]).
A second measure of the effectiveness of MITOMI is how well it traps molecules
in place. To measure the effective rate loss, a molecular interaction consisting of a
transcription factor bound to labeled DNA was trapped with MITOMI and the loss of
bound DNA measured over time (Figure 7.5). Signal loss was dominated not by actual
mass loss of DNA, but by loss of fluorescence due to bleaching, as indicated by the
apparent dependence of the measured rate constant on the measurement interval. The
rate constant solely due to mass loss could be determined by plotting the observed rate
constants as a function of the inverse of the measurement interval and extrapolating
to 0, since 1/∞ = 0. The rate constant for mass loss measured in this system was
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determined to be 9 ∗ 10−4 minutes or 1.5 ∗ 10−5 seconds, which translates into a
half-life of 13 hours and is 4–5 orders of magnitude larger than the observed half-
life without trapping (refer to Figure 7.2). MITOMI is thus extremely effective in
trapping surface-localized material, giving ample time to image the device without
losing signal in the interim.
Not only does MITOMI preserve the equilibrium concentrations and effectively
trap interactions, it is also compatible with a wide variety of systems and detec-
tion methods. Literally any molecular interaction can be tested as long as one of
the components can be surface localized. Possible applications for MITOMI include
detecting interactions between: protein-protein, protein–DNA/RNA, protein–small
molecule, DNA/RNA–small molecule, and so on. Trapping itself is also not limited
to the free-standing membranes described above, but may be achieved with any two
surfaces exhibiting similar properties as the PDMS-glass interface used here. Finally,
one specific example of how MITOMI can drastically enhance sensitivity of existing
detection methods lies in combining MITOMI with the S-tag-based enzymatic assay.
Here MITOMI can be used to initially trap the prey molecules in place followed by
a buffer exchange, introducing the S-protein as well as the substrate without loss
of bound material. The enzyme reaction may then be started uniformly across the
device by opening the button, allowing S-protein to bind S-tags present on the prey
molecules. At this stage, prey will dissociate from the detection area, but remain
localized to the unit cell, therefore causing no net decrease on signal. This sequence
of steps ensures that the highest possible signal is obtained in each unit cell.
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Another intriguing possibility lies in determining the kinetic parameters of binary
interactions using MITOMI. Determining off-rates is particularly straightforward.
Standard valves can be actuated at frequencies of up to 100 Hz [6]. Therefore one
actuation cycle is on the order of 10 ms. Interactions can therefore be trapped in
place and allowed to dissociate with 10 ms time resolution by rapidly opening the
trapping membrane. The half-life for an interaction with an off-rate of 1 sec−1 is
700 ms. Therefore a 100 Hz actuation frequency of the membrane will collect 70
samples during a half-life, and even at a 10 Hz actuation frequency 7 samples can be
collected. The actuation frequency is thus sufficient to sample even extremely fast
dissociations. What is more important is the fact that MITOMI allows the sampling
of a large number of off-rates at high time resolution in parallel, as all unit cells are
sampled in parallel at the frequency determined by the actuation rate. The on-rate
can be deduced from knowing the equilibrium dissociation constant as well as the
off-rate of the system, but it could also be directly measured. Measuring the on-
rate relies on the same mechanism as measuring the off-rate. Instead of allowing the
bound molecules to disassociate, they are allowed to associate. What complicates
the on-rate measurement is the fact that the on-rate is concentration dependent.
The concentration of the prey molecules must therefore be known beforehand or
determined in situ.
MITOMI presents a highly integrated approach for quantitatively characterizing
not only the equilibrium constants of binary interactions, but also their kinetic pa-
rameters. As the topologies of biological networks are becoming well characterized
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the underlying parameters governing each interaction, and thus the entire network,
have been barely touched, and therefore have been described in binary terms. It is
becoming more and more apparent that these parameters need to be measured on
proteomic scales in order to understand biological networks in greater depth. Pa-
rameters have been lacking thus far due to the considerable technical difficulties in
obtaining these measurements. MITOMI provides one generically applicable answer
to this problem and should prove useful in a wide variety of applications attempting
to discern the properties of molecular interactions.
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Chapter 8
Helix-Loop-Helix Transcription
Factors
8.1 Introduction
Helix-loop-helix transcription factors form a structural family of important transcrip-
tional regulators mainly found in eukaryotes. A current InterPro search for the helix-
loop-helix domain returned 206 hits in human, 196 in mouse, 102 in the fruit fly,
and 12 in yeast, indicating its broad conservation across species. HLH transcription
factors are known to play important roles in differentiation, lineage commitment,
and sex determination. In yeast HLH transcription factors have been implicated in
phosphate regulation and phospholipid biosynthesis [40, 41].
The first HLH transcription factors identified were the E2A gene products E12
and E47 [42]. These proteins were shown to bind to a DNA sequence called κE2, a
canonical hexamer of CACGTG generically called E-box, found in the immunoglob-
ulin kappa chain enhancer. Other known E-box sites are located in the IgH gene
enhancer: µE1, µE2, µE3, µE4, and in the Ig kappa enhancer: κE1, κE2, κE3. Both
E12 and E47 were predicted to contain two amphipathic alpha helices required for
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dimer-formation and DNA binding. These helical regions aligned well with Daughter-
less, MyoD, and Myc resulting in identity or near identity of the hydrophobic residues
of the helices, supposedly of importance for dimerization.
Shortly after the discovery of this new class of transcription factors, other mem-
bers such as c-Myc were interrogated for DNA binding specificities. Blackwell et al.
used a newly developed technique: selected and amplified binding-sequence (SAAB)
imprinting [43] (SELEX is essentially the same as SAAB) to determine the sequence
specificity of C-Myc. In SAAB imprinting a suspected DNA binding protein is sub-
jected to a library of sequences. Any bound material is subjected to rounds of PCR
amplification and further selection. The final material is then sequenced to establish
the identity of the strongest binders. Using SAAB imprinting, it was determined
that MyoD and the E2A products bind a common consensus sequence, CANNTG,
but show little specificity for the two central and flanking bases. Similar results were
obtained for Myc and MAX [44, 45], which were shown to form functional homo- and
heterodimers both in vitro and in vivo [46, 47]. MAX was previously found to be
a binding partner of c-Myc using a comprehensive cDNA screen by Blackwood and
Eisenman [48]. Halazonetis et al. [49] screened a small library of E-box sequences
all containing the same E-box sequence flanked by various trinucleotides. The results
showed that in vitro translated c-Myc and TFEB do indeed discriminate between
sequences containing various flanking bases.
It was also established that phosphorylation of Max affects its dimer formation
and DNA binding preference [44, 50]. Both isoform A and B (p21/22 respectively)
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were shown to be specifically phosphorylated by casein kinase II (CKII) [47, 50].
Phosphorylation of the amino terminus of Max causes a reduction in DNA binding
affinity if bound as a homodimer, but had no effect on Max/Myc heterodimer affinity
to DNA. Interestingly, incubation with rabbit reticulocyte lysate causes phosphory-
lation of Max [44]; many early experiments were performed on in vitro transcribed
protein from rabbit reticulocyte [48], and thus were using phosphorylated versions
of Max and potentially Myc, which also contains CKII sites. A difference between
the two isoforms of Max was also detected; isoform A is more susceptible to affinity
changes caused by phosphorylation as compared to its shorter isoform B, which can
be explained by an additional phosphorylation site near the basic region present in
isoform A but not B. In yeast, phosphorylation also plays an important role in the
regulation of Pho4p. Pho4p is phosphorylated by a cyclin-CDK complex, Pho80-
Pho85, at four distinct sites. Differential phosphorylation of Pho4p affects its cellular
localization and in turn causes a change in gene expression patterns [51, 52]. In
the hyper-phosphorylated state, Pho4p is shuttled out of the nucleus and into the
cytoplasm by Msn5p [53] causing the de-activation of PHO5. Turning PHO5 off
causes inorganic phosphate concentrations to fall and Pho4 is de-phosphorylated,
transported back into the nucleus by Pse1p, and once again capable of turning on
PHO5. The underlying code specifying nuclear import and export is governed by
six serine-proline dipeptides SP-1-6, with SP2 and 3 being necessary for export and
SP4 for import out and into the nucleus [54], respectively. Phosphorylation of HLH
transcription factors thus seems to be an intimate part of their regulation in vivo.
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Helix-loop-helix proteins may be classified into various groups or families of pro-
teins [55, 56] (Table 8.1). Murre et al. [56] established 6 classes of HLH transcription
factors, whereas Atchley et al. [55] arranged the factors into 5 groups according to
E-box specificity, with each group containing several protein families. Murre’s group-
ing into classes puts the E proteins, E12, E47 into Class I. Class I proteins may
form homo- as well as heterodimers and are expressed over a wide variety of tissues
[56]. Class II includes MyoD and myogenin. Members of this class may only form
homodimers, mainly with members of Class I, and are expressed in tissue-restricted
patterns. Classes III and IV bHLH transcription factors contain a leucine zipper do-
main and may dimerize with one another or with themselves. Class V proteins are
negative regulators of Class I and Class II transcription factors, in that they may form
heterodimers with members of those classes, but since Class V proteins lack a basic
region, the resulting heterodimer has no DNA affinity. Finally, Class VI and Class
VII are characterized by containing a proline in their basic region and a bHLH-PAS
domain, respectively [56].
Extensive structural information is available on HLH dimerization and DNA bind-
ing interfaces obtained from crystal structures of MAX [57], E47 [58], Pho4p [59],
Myc-Max and Mad-Max heterodimers [60], and NMR solution structures of MAX
homodimers [61]. The crystal structures affirmed the proposed helical structure as
well as the importance of hydrophobic residues for dimer formation. A dimer consists
of a four-helix bundle with a basic region bundle making contact with the E-box
sequence. Each monomer contains the following regions starting at the amino termi-
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Table 8.1: Helix-Loop-Helix transcription factors
Groupings
Protein
Families
Included
Proteins
E-
box
Murre
et
al.[56]
LZ Function
AC-S ac, sc, ase,
l’sc, mash,
ash
A II Neurogenesis, determina-
tion of neuronal precursors
dHAND dhand,
ehand,
hxt, hed
A Rardiac morphogenesis, tro-
phoblast cell development
E12/Da e12, e47,
itf, pan,
G12, me2,
da
A I Neurogenesis, sex determi-
nation, regulation of myoge-
nesis
MyoD myod1,
myogenin,
myf5, myf6
A II Myogenesis
TWIST twist, ec2,
paraxis,
scleraxis,
dermo
A Specification of mesoderm
lineages
CBF cbf-1 B Rentromeric binding and
chromosomal segregation
HAIRY hlhm,
hairy, hes,
deadpan,
e(spl)
B VI Neurogenesis, segmentation
MAD mad, mxi1 B IV Yes Regulation of cell differenti-
ation
MYC c-myc,
n-myc,
l-myc, max
B III Yes Cell proliferation, differenti-
ation; oncogenesis
PHO4 pho4, nuc1 B Phosphate regulation in
yeast
TFE tfe3, tfeb,
mi
B III Yes Transcription activation
in immunoglobulin heavy
chain enhancer
ID id, heira,
emc,
hlh462
D V Negative inhibition of DNA
binding; myogenesis, neuro-
genesis
Table adopted from [55].
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Figure 8.1: Sequence-specific DNA protein contacts of Max and Pho4
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nus: basic region-helix1-loop-helix2. Max additionally extends the second helix into
a leucine zipper, which drives dimer formation by van der Waals interactions of hy-
drophobic residues. These residues are mainly leucines and isoleucines, are conserved
across the HLH family, and can be found in both helical regions of the HLH domain.
Differentiation of various binding pairs, be they homo- or heterodimer, seems to take
place in the second helical regions and zippers, if present. In MAX homodimers the
residues Asn92 and Gln91 form a stable tetrad, causing a bulge of the zippers and
non-optimal packing. This conflict is resolved in MAX/Myc and MAX/MAD het-
erodimers [60]. E-box base recognition is accomplished by a conserved glutamic acid
residue, an arginine residue, and a histidine residue (Figure 8.1). Glu makes contact
with C3 and A2, Arg contacts G1′ , and His makes a contact with G3′ . An additional
contact with G4′ or G5′ is only seen in PHO4 [59]. Bases are named according to
the scheme: C3A2C1•G1′T2′G3′ , where • denotes the dyad symmetry axis (Note that
N3N2N1•N1′N2′N3′ = N−3N−2N−1N1N2N3, a notation scheme used below). These
contacts are universally seen in structures of MAX [57] as well as Pho4p [59], and,
because of their conservation, are likely present in a large number of HLH transcrip-
tion factors. Additional contacts with DNA bases are seen in the Pho4p structure,
and an extensive network of contacts with the phosphate backbone is present in both
structures.
More recently, members of the HLH family of transcription factors have been
mapped to potential genomic binding sites. Orian et al. mapped the in vivo bind-
ing sites of the Myc/MAX/MAD network using a DAM methylation approach in
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Drosophila [62]. Cawley et al. mapped the binding sites for c-Myc and two other
non HLH transcription factors, p53 and Sp1, using chromatin immunoprecipitation
(ChIP) along chromosomes 21 and 22 [63]. The results are surprising in that c-Myc
seems to have up to 25,000 binding sites with roughly 18% of those lying in a defined
5’Exon, which is a 3.7-fold enrichment of what would be expected at random [63].
Another 24% of sites fall into known CpG islands, but over half of the binding sites
are located immediately within 3’ of known genes and strongly correlate with non-
coding RNA [63]. Because c-Myc was chosen as the target for immunoprecipitation,
the large number of sequences bound most likely stem from a combination of many
possible dimerization states of c-Myc with partners such as MAX, etc., making it
hard to extract exact binding characteristics of c-Myc alone. Similar results have
been obtained by Orian et al., who tested binding of the MAX network including
c-Myc and Mad/Mnt. Here binding sites were determined by DAM methylation fol-
lowed by hybridization of methylated sites to a Drosophila cDNA array. Because
a cDNA array was used, only sites binding in coding regions could be determined,
as opposed to the comprehensive screen performed by Cawley et al. [63]. Again it
was found that the tested HLH transcription factors interacted with about 15% of
transcribed regions of the genome. Furthermore it was found that modulating the
relative expression level of MAX changes the binding pattern for c-Myc, suggesting
that gene control is dependent on relative abundances of individual members of the
network [62]. Both approaches yield low-resolution information on potential binding
sites, but exact binding motifs are hard to extract. Orian et al. used the REDUCE
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algorithm to extract binding sites, which did indeed return the E-box motif for c-Myc
and Mnt, but not for MAX. Additional motifs found included CG-repeats, TATC-
GATA and GGTCACACT. Whether these results stem from a limit in resolution or
from potential tertiary interactions with other factors is unknown.
8.2 Energetics of DNA Recognition
DNA recognition by proteins, particularly transcription factors, lies at the heart of
gene regulation. Intricate topologies of transcription factor–DNA interactions, or
gene regulatory networks, arise from genes having multiple transcription factors as
their cis-regulatory input. Likewise one transcription factor can regulate a large
number of target genes. Deciphering these networks presents a giant leap towards
understanding cellular function; as literally every single cellular pathway converges
onto the regulation of genes, and therefore transcriptional regulatory networks.
In order to discern their target genes, transcription factors must physically read
out the genetic code base by base. Every DNA binding protein has an amino acid
motif that specifically binds or recognizes certain sequences but not others. The
major transcription factor families more or less use the same mechanism to achieve
this readout (Figure 8.2); the use of an alpha-helix, which fits into the major groove
of DNA, is the primary structural element for reading out DNA sequences. The alpha
helical pitch also allows every 4th amino acid side chain to be positioned in proximity
to the exposed nucleotide bases, while other side chains make secondary, non-specific
contacts with the phosphate backbone, increasing the overall stability of the complex.
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Figure 8.2: Panel A shows the number of transcription factors of each major family
found in a genomic screen of 4 eukaryotic genomes. Panel B–D are representative
structures of the 4 major transcription factor families. Shown are a Zinc Finger,
homeobox, bHLH, and bZIp in B–D, respectively.
But it is the base-specific contacts that impart a transcription factor with its sequence
specificity.
Understanding how transcription factors function is of primary importance in un-
derstanding transcriptional regulatory networks. A multitude of approaches have
been developed over the years based on physical in vitro and in vivo measurements,
as well as bioinformatic approaches. One of the earliest measurements on transcrip-
tion factor–DNA interaction, and an approach still widely used today, is the elec-
trophoretic mobility shift assay (EMSA). Here a transcription factor is mixed with a
specific target sequence. The mixture is then electrophoresed to separate bound com-
plexes from unbound components and the relative concentration of each is measured.
A second method is termed SELEX (for systematic evolution of ligands by exponen-
tial enrichment). SELEX, as the name implies, is based on screening a large pool of
sequences by passing them over a column preloaded with the transcription factor of
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interest. The immobilized transcription factor binds its target sequences, which are
consequently eluted from the column and amplified. This process is repeated until
the highest-affinity sequences are recovered. SELEX is primarily used for discovering
a transcription factor’s consensus sequence, but otherwise lacks quantitation due to
the large number of selection loops required and the exponential amplification of the
selected molecules between trials. Another and more recent method relies on dsDNA
microarrays, to which a labeled transcription factor is allowed to bind. This method is
known as protein-binding micro-arrays (PBMs). These micro-arrays may contain tens
of thousands to millions of features, and thus can cover a very large sequence space.
After a series of wash steps, the micro-array is imaged and the bound transcription
factor quantified. This method is extraordinarily useful for determining consensus
binding motifs. One of its major pitfalls is the need for wash steps, causing consid-
erable loss of signal due to the high dissociation rate of transcription factors. It is
nonetheless a powerful and semi-quantitative approach for understanding the physical
basis of transcription factor DNA recognition. An in vivo approach to discovering
what genomic regions are bound by transcription factors is ChIP-chip. ChIP-chip is
a combination of chromatin immunoprecipitation followed by a DNA micro-array for
identification of the pulled-down DNA sequences. Specifically, cells are permealized
and all contents, including transcription factors bound to genomic DNA, are cova-
lently cross-linked. Then genomic DNA is either physically sheared or enzymatically
digested. The short DNA segments that have transcription factor bound to them
are immunoprecipitated using a transcription-factor-specific antibody. After several
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clean-up steps, bound DNA is released, amplified, labeled, and eventually detected
on a DNA micro-array. ChIP-chip is an extremely powerful approach for determin-
ing the in vivo function of transcription factors. Several large-scale datasets have
been collected, including a comprehensive dataset of all yeast transcription factors
and high-resolution mapping of several eukaryotic transcription factors. ChIP-chip,
principally a powerful approach, falls short of the promised goals by returning rather
noisy datasets, making data analysis difficult at best and generally requiring the re-
cursion to bioinformatic methods for motif discovery. Furthermore the resolution
for localizing the actual sites a transcription factor is bound to is disappointingly
low, especially when one takes into account that transcription factors only bind short
segments of DNA spanning at most tens of bases.
In a similar spirit to the enzyme hunters of the earlier years of molecular biology
such as Arthur Kornberg, it should prove extremely useful to completely characterize
transcription factor function in vitro. But unlike enzymes, which bind to generally
only a single substrate and hydrolyze it, characterization of a transcription factor
involves understanding its binding affinity to all possible target DNA sequences. Thus,
instead of having to characterize a single interaction, several hundreds to millions of
possible targets need to be measured. In the case of bHLH transcription factors this
sequence space is rather small. The homodimer symmetry essentially reduces the
length of the recognized motif by half, such that only the CAC portion of the E-box
motif needs to be understood, instead of the entire CACGTG or 6mer space. The
ability to reduce the search space considerably—since the number of sequences grows
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exponentially with the motif length—made bHLH transcription factors an appealing
proof of principle system.
Finally, each individual sequence needs to be studied in sufficient detail to provide
a binding affinity. This generally entails generating saturation binding isotherms by
varying either the transcription factor or DNA concentration. Varying the DNA
concentration is generally the easier of the two and thus the preferred method. In
certain circumstances if PBMs are used it does become necessary to vary the protein
concentration instead.
8.2.1 E-box Libraries
As mentioned in the previous chapter, rather large libraries of dsDNA sequences
are required to comprehensively study transcription factor function. These target
sequences also need to be stoichiometrically labeled with a fluorescent dye so that
concentrations may be determined. Synthetic DNA is readily available from commer-
cial sources in the form of ssDNA oligomers reaching lengths of up to 150 bases. It
is financially not viable to order both the Watson and Crick strand of each sequence
to be tested and have one of the two strands labeled with a dye. Instead a generic
primer, labeled with Cy5, was used to extend a ssDNA target library of primers by
isothermal PCR using Klenow 3’-5’ exo− as the polymerase. This reaction achieves
both the synthesis of the complementary strand, as well as stoichiometric incorpora-
tion of a fluorescent label. Rather high concentrations of dsDNA can be achieved,
which is necessary to reach the high mM concentration ranges required for gener-
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5' 3'
Name -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 6 7 Members
NNCAC T T N N C A C G T G T T T T 16
NNNCAC T N N N C A C G T G T T T T 64
NNNNGTG T T G N N N N G T G G G T G 256
CACNNN T T G T C A C N N N A C T T 64
GTGNNN T T T T C A C G T G N N N T 64
NNCACGTGXX T T N N C A C G T G N N T G 240
Matrix Library T T G G N N N N N N G G T G 64
NNNx2 T T G G N N N X X X G G T G 64
NNNx2v2 T T T T N N N X X X T T T T 64
NNNx2v3 C C C C N N N X X X C C C C 64
CANXTG T T A A C A N X T G G T T G 16
SSS CAN C C C C C A N X T G C C C C 4
SSS CNC C C C C C N C G X G C C C C 4
SSS NAC C C C C N A C G T X C C C C 4
SSS NCAC C C C N C A C G T G X C C C 4
SSS NCAC C C C N C A C G T G X G C C 4
SSS NCCAC C C N C C A C G T G G X C C 4
Sum 1000
E-Box
Table 8.2: Table of target DNA libraries used for determining bHLH binding energy
landscapes. N indicates any nucleotide and X stands for the complementary base in
symmetric sequences.
ating complete binding isotherms. No further purification steps were necessary and
the PCR reactions could be spotted directly after adding a 1% solution of BSA in
dH2O to prevent covalent attachment of the synthesized DNA to the epoxy substrate.
Necessary dilutions were carried out bench-top in 384 well plates prior to spotting.
Figure 8.2 shows the libraries generated for characterizing the bHLH transcription
factor family. All libraries are centered around the E-box consensus motif. The first
set of libraries, such as NNNNGTG, simply consist of all linear combinations of the 4
bases indicated by N, where N is any base. Other libraries such as NNNx2v1 consist
of a symmetric 3mer sequence space NNN, with the symmetric bases indicated by
XXX. A few specific members of this library are CATAGT and GCATGC for exam-
ple. Simpler versions of the above library are the single-base symmetric substitution
libraries, such as SSS NAC. The resulting binding energy landscapes that were ob-
tained with these libraries are discussed in the following sections. Libraries can and
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should be adjusted to the particular transcription factor or transcription factor family
under study. Other libraries that were generated thus far include a set of libraries
covering the Gli motif, as well as one CREB library covering the CREB consensus,
both discussed in Section 8.6.
8.2.2 Transcription Factor Binding Energy Landscapes
Binding energy landscapes were determined for MAX isoform A and isoform B, both
human bHLH transcription factors, as well as Pho4p and Cbf1p from yeast. All
four of these transcription factors were tested against a comprehensive set of target
sequences, obtaining precise binding affinities for each. Kds are obtained from the
measured binding isotherms (Figure 8.3) by fitting a function of Y = Bmax[X]
Kd+[X]
, where
Bmax is the maximal binding and [X] is the concentration of free DNA required for
half-maximal binding. For obtaining precise affinities it is necessary to have at least
one sequence that reaches saturation, for which Bmax can be determined. The rest of
the data can then be globally fit using that parameter. As is obvious from Figure 8.3,
most sequences that fall in the low-affinity regime have a concentration-dependent
response in the linear regime.
Several datasets were cross-compared to learn the systems’ measurement error
(Figure 8.4). In Panel A, ∆∆G values for the NNNNGTG library of the two MAX
isoforms were compared to one another, including N- and C-terminally tagged ver-
sions. The isoforms themselves are identical except for a short 9-amino-acid insertion
in MAX isoform A just N-terminally of the basic region. Thus, sequence specificity
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Figure 8.3: Representative binding isotherms from MAX isoform A. Shown are the
first 16 sequences of a NNNGTG library. DNA concentrations are plotted on the
x-axis with the corresponding response shown on the y-axis.
is expected to remain unchanged, and in fact MAX iso A and iso B compare well
to one another. A comparison of the same isoforms across the two possible epitope
locations showed a similar error (Figure 8.4, Panel B). Interestingly, the C-terminally
tagged versions show enhanced binding affinities over all sequences, exhibited by a
slope of 1.33 and 1.25 for MAX iso A and iso B, respectively. Finally, comparing mea-
surements of Pho4p and Cbf1p for a 3-mer CACNNN library again shows a similar
experimental repeatability. To estimate a global measurement error all NNNNGTG
datasets of MAX iso A, iso B, Pho4p, and Cbf1p were compared using N- and C-
terminally tagged variants. The resulting data is shown in Panel D of Figure 8.4.
Here the Kd values are plotted, rather their respective ∆∆G values. The error was
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Figure 8.4: Dataset comparisons to determine measurement reproducibility and error.
Panel A compares datasets across the two MAX isoforms. Panel B shows the same
data as in Panel A compared across epitope tag location. Panel C shows a direct
comparison of equivalent datasets for Pho4p and Cbf1p taken on different days. Panel
D is a global error estimate comparing Kd values for all NNNNCAC datasets for MAX
iso A, iso B, Pho4p, and Cbf1p. Dotted and dashed lines show the 19% and 49% at
one and two σ, respectively.
determined to be 19% at 1σ and 49% for 2σ, respectively. This percent error trans-
forms to a constant error of 0.17 kcal/mol and 0.40 kcal/mol when applied to ∆∆G
values.
Figure 8.5 shows the binding energy landscapes for MAX iso A, iso B, Pho4p,
and Cbf1p covering 256 sequences of the 5’ end of the E-box motif or NNNNGTG.
It is immediately obvious that NCAC is the preferred sequence for all 4 transcription
factors. It can also be seen that there is diversity in base preference for the first
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Figure 8.5: Binding energy landscapes for transcription factors MAX iso A, iso B,
Pho4p, and Cbf1p. Kds in µM are shown for the sequences NNNNGTG. Sequences
NNNGTG are shown in the x-axis with four values each representing the fourth
flanking base, as indicated in the legend.
flanking position. Here MAX prefers a cytosine, while Pho4p and Cbf1p prefer a
guanine and thymine, respectively; already hinting at considerable differences in the
recognition profile of the flanking bases. The overall topographies of the transcription
factors also vary. MAX shows the most rugged landscape, with secondary and tertiary
peaks near the E-box sequence neighbors CAT and CTC, as well as CAG. Pho4p
and Cbf1p, on the other hand, show much flatter responses than MAX with no
considerable secondary peaks. Furthermore, MAX shows affinity spikes for sequences
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Figure 8.6: The flanking base specificity for bases N−5N−4CACGTG. Panels A–C
show the landscapes for Pho4p, Cbf1p, and MAX iso B, respectively. Panel D shows
a comparison of wild-type transcription factors to MAX iso B chimeras with the
indicated basic region substituted for the wild-type sequences.
CACG, CATG, CACC, and CATC, indicating plasticity in the E-box motif previously
not found using other methods. In other words, MAX can recognize a split E-box
motif with a central single base insertion. Whether this is accomplished through
structural changes in the loop domain, for example, or due to diffusional modes is
currently not known, but could be interrogated by using bZip transcription factors
which lack the loop domain. Also it should be noted that MAX and Pho4p are
known to have conserved amino acid residues that make base-specific contacts with
DNA. It is thus interesting to see considerable differences in the overall topographies
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Figure 8.7: Comprehensive 3-mer flanking base landscapes for Pho4p and Cbf1p,
Panel A and C respectively. Panel B and D represent a 2-mer subset extracted from
the 3-mer datasets for comparison to Figure 8.6.
of these two transcription factors, with MAX showing a more spiked response and
Pho4p a very specific response to only the E-box. Here again the reasons for the
differences are not known, but could potentially originate from higher-order structures
in the transcription factors. Because of the symmetry of the E-box structure and the
homodimeric nature of the transcription factors studied, the 4-mer landscape shown
in Figure 8.5 is a comprehensive measurement of the known sequence recognition
profile of these transcription factors.
In the case for Pho4p and Cbf1p it was interesting to see almost identical energy
topographies, which could not explain the differing in vivo function of the two tran-
scription factors. Pho4p is known to function in regulating phosphate metabolism
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[64, 65], whereas Cbf1p is supposed to regulate methionine synthesis, as well as chro-
mosome structure, by binding to kinetochores [66, 67, 68]. To understand the extent
to which these transcription factors recognize flanking bases, DNA libraries cover-
ing all possible 2-mer (NNCACGTG) and 3-mer flanking bases (NNNCACGTG and
CACGTGNNN) were tested. The observed differences in sequence recognition over
a 2-mer space are shown in Figure 8.6. Here all 16 sequences of positions N−5 and
N−4 (N−5N−5CACGTG) and their corresponding affinity values (in ∆∆Gs) are shown
for the transcription factors Pho4p (Panel A), Cbf1p (Panel B), and MAX isoform
B (Panel C). Marked differences in flanking base recognition are observable between
Pho4p and Cbf1p. The 3’ 3-mer library (Figure 8.7) showed the same trend as the 5’
2-mer library. These flanking base measurements extended the consensus sequences
for Pho4p and Cbf1p to CCCACGTGGG and [A/G]GTCACGTGAC[T/C], respec-
tively, effectively doubling the known motif in the case of Cbf1p.
To understand whether the basic region amino acid sequence was primarily re-
sponsible for these various recognition profiles, basic region chimeras were synthe-
sized. These chimeras consisted of the MAX iso B backbone and the basic regions of
Pho4p, Cbf1p, as well as MAX iso B as a positive control. The recognition profiles of
the chimeras to the 5’ 2-mer libraries were compared to the wild-type topographies
(Figure 8.6 D). Overall the chimeras recovered similar sequence-recognition profiles
as their wild-type counterparts, particularly Phop4 and, of course, the positive MAX
iso B control. Interestingly Cbf1 chimeras showed a considerably lower specificity
than their wild-type counterparts, again possibly indicating contributions of other
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domains of the protein to the binding, as the sequence topographies are not changed
but the elevations are changed proportionally. This experiment indicated that se-
quence specificities are defined by the amino acid sequence of the basic region, and
that the affinities can be modulated not only by the primary basic region sequence,
but also by the overall structure of the protein.
The biophysical properties for 4 bHLH transcription factors were comprehensively
determined in unprecedented definition. Absolute binding affinities were obtained for
hundreds of DNA sequences comprehensively covering the E-box motif, as well as
the bases flanking it. These affinities form a basic description of transcription factor
function, and present what sequences these transcription factors can bind. Not only
were the affinities determined for sequences covering the known E-box motif, but
the motif itself could be extended for all transcription factors tested. Indeed, for
Pho4p and Cbf1p, the flanking bases proved to be the most important feature of the
consensus motif, as the bases covering the central E-box showed no difference in their
topography.
8.2.3 Binding Site Prediction
8.2.4 Yeast Genomic Binding Site Prediction
Having obtained complete biophysical descriptions for the transcription factors Pho4p
and Cbf1p, it needed to be established whether these measurements could be used to
predict what target genes each transcription factor regulates in vivo. A very simple
model was used, based solely on the measured binding energy landscapes and the
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yeast genomic DNA sequence. Instead of using the affinity of the transcription factor
to a specific target sequence directly, probabilities of binding (Pi) were established
(Equation 8.4). Pis depend on Kd,i, the affinity of transcription factor X to sequence
i as well as on [X], the concentration of the transcription factor. As the in vivo
concentration of X is exceedingly difficult to establish, it is generally set equal to
Kd,ref , the affinity to the consensus sequence (Equation 8.5), yielding a Pref of 0.5. It
should be noted that this assumption lies within an order of magnitude of the known
concentration for Cbf1p. Cbf1p is reported to have a cellular concentration of 6890
molecules [69] or 5.5 nM, assuming a cell size of 2pL, which compares well to the
measured Kd,ref of 16.63 nM. Equation 8.5 can be rewritten in terms of the ∆∆Gi
(Equation 8.7) using the equivalents in Equations 8.1–8.3.
Kd,ref = e
−∆Gref/RT (8.1)
∆Gi = ∆Gref −∆∆Gi (8.2)
Kd,i = e
−(∆Gref−∆∆Gi)/RT (8.3)
Pi =
[X]
Kd,i + [X]
(8.4)
Pi =
Kd,ref
Kd,i +Kd,ref
(8.5)
=
e−∆Gref/RT
e−(∆Gref−∆∆Gi)/RT + e−∆Gref/RT
(8.6)
=
1
e∆∆Gi/RT + 1
(8.7)
To calculate a probability of binding to a regulatory region consisting of several
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hundred bases, individual probabilities of binding to each sequence window are calcu-
lated and then integrated to yield a probability of occupancy, Pocc (Equation 8.8-10).
Pocc = 1−
windows∏
i=1
(1− Pi) (8.8)
1− Pi = 1− ( 1
e∆∆Gi/RT + 1
) =
e∆∆Gi/RT
e∆∆Gi/RT + 1
=
1
1 + e−∆∆Gi/RT
(8.9)
Pocc = 1−
windows∏
i=1
(
1
1 + e−∆∆Gi/RT
) (8.10)
Poccs were calculated for each regulatory region of 5814 yeast ORFs, using binding
energy landscapes determined for Pho4 and Cbf1p and Equation 8.10. Initially the
method was tested on known target genes of Pho4p and Cbf1p by calculating Pis
over a a range of -800 bps to the start codon of each ORF. For Pho4p 29 target
genes, including the PHO and VTC family, were chosen. For Cbf1p a lax gene set
included 70 genes and a strict set consisted of 17 genes. For each of these gene sets,
binding sites with probabilities above 0.1 were plotted as histograms to visualize the
prevalence of binding predicted sites to occur in specific regions of the regulatory
sequence (Figure 8.8). For Cbf1p, binding sites can be found extending up to 800
bps away from the ORF start codon, but most sites fall within -600 bps of the start
codon. In Pho4p all sites are much more localized, and fall between -150 bps and
-350 bps. This is consistent with reported nucleosome-free regions [70] and a bona
fide transcription factor binding to these regions. Cbf1p’s binding sites are more dif-
fuse and span a broader region, which can be explained by the fact that Cbf1p has
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Figure 8.8: Binding site distributions for genes likely to be regulated by Pho4p or
Cbf1p. The Cbf1p lax gene set consisted of 70 target gene,s whereas the strict set
contained 19 genes. For Pho4p the set consisted of 29 genes. Shown are distributions
of binding sites with a Pi of 0.1 or higher. Panel D is a summed histogram for Cbf1p
and Pho4p from Panels A and C. The x-axis on all histograms indicates the distance
to the start codon of each gene tested.
been reported to function in chromatin remodeling and thus may not be required to
bind to regions already cleared of nucleosomes [66]. Therefore, Poccs were calculated
for Pho4p and Cbf1p on a genomic scale, ranging from the start codon of each ORF
to -600 bps and -800 bps, respectively. Using a cutoff criterion of a Pocc value of at
least 0.2, target genes were chosen for Pho4p and Cbf1p (Figure 8.9). For Pho4p
and Cbf1p, 38 and 24 genes were found, respectively. The first indication that these
datasets are of high quality is the fact that the Pho4p and Cbf1p gene sets have zero
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Figure 8.9: In vivo function prediction for Pho4p and Cbf1p. (A–B) Genes with
regulatory sequences determined to be bound by our in silico method. All genes
shown here have a Pocc of above 0.2 and a sensu stricto conservation score of 25%
or above. Pie charts show the functional distribution of the gene sets. (C–D) Venn
diagrams comparing our predicted gene sets to gene sets determined using expression
micro-arrays and ChIP-chip.
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43.01.03.05 budding, cell polarity and filament formation 6.56E-04
10.03.01.01.09 G2/M transition of mitotic cell cycle 6.98E-04
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43.01 fungal/microorganismic cell type differentiation 7.62E-04
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14.07 protein modification 9.14E-04
10.03.01.01 mitotic cell cycle 2.51E-03
01.02.01.14 conjunction of sulfate 3.56E-03
14.07.09 posttranslational modification of amino acids (e.g. hydroxylation, methylation) 3.75E-03
14.07.03 modification by phosphorylation, dephosphorylation, autophosphorylation 3.88E-03
14 PROTEIN FATE (folding, modification, destination) 4.01E-03
Figure 8.10: Functional enrichments of the gene sets shown in Panels A and B of
Figure 8.9 for Pho4p and Cbf1p. Shown are the significant enrichments returned by
the MIPS FunCat server. Blue entries refer to functions consistent with Pho4p and
red entries stand for Cbf1p-relevant functions.
overlap. In other words, the measured binding energy landscapes, particularly the
landscapes describing flanking base specifities, were sufficient to separate the func-
tion of the otherwise very similar transcription factors. Furthermore, when looking
at the functional enrichment of these gene sets using Munich’s information center
for protein sequences (MIPS) yeast functional catalogue (FunCat), the results show
that each transcription factor regulates a very defined subset of target genes with
similar function (Figure 8.10). For Pho4p, genes involved in phosphate metabolism
predominate the predicted gene set–particularly the PHO and VTC familes, with the
latter involved in vacuole regulation. Other enriched functional categories are ionic
homeostasis and C-compound metabolism. For Cbf1p, genes involved in chromosome
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structure and budding predominate. Two genes involved in methionine synthesis,
MET3 and IDH1, are also found. Finally, the datasets were compared to existing
experiments based on gene expression arrays [64, 65] and large-scale ChIP-chip ex-
periments [71]. For Pho4p these two datasets only find 7 genes in common, whereas
the gene sets determined here cover those 7 genes as well as agree with 8 additional
genes in the gene expression analysis and 3 additional genes in the ChIP-chip set. For
Cfb1p only the ChIP-chip set was available and here overlap between the datasets is
minimal, with the ChIP-chip dataset finding a large number of probably erroneous
targets. The approach described here thus presents an accurate method for unbi-
ased determination of target genes for transcription factors. It should be mentioned
that the gene expression analysis and ChIP-chip methods are inherently different ap-
proaches in that they rely on data obtained from in vivo measurements. It should
be of interest that the ChIP-chip gene sets predicted by Harbison et al. [71] were
obtained by generating position weight matrices (PWMs) from the observed DNA
fragments pulled down by the transcription factor. These PWMs where then used in
a very similar fashion to the binding energy landscapes determined here. It is thus
obvious that PWMs obtained from ChIP-chip data are not as efficient in predicting
transcription factor function as binding energy landscapes based on physical binding
affinities, a point that will be discussed in more detail in Section 8.2.5.
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Figure 8.11: Panel A–D show comparisons of PWM predictions versus measured val-
ues for NNNNGTG sequences and transcription factors MAX iso A, iso B, Pho4p,
and Cbf1p, respectively. Panels E and F show flanking bases sequences GTGNNN
measured for Pho4p and Cbf1p, respectively. The number of substitutions of each
sequence respective to the consensus sequence is indicated, where the single substi-
tutions represent the PWM training set.
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8.2.5 Position Weight Matrices Versus Binding Energy Land-
scapes
There are several approaches to describing how a transcription factor recognizes and
binds DNA. The first-order approach is to argue that a transcription factor binds to
one sequence, namely its consensus sequence. Finding consensus sequences of tran-
scription factors was and still is a primary goal in understanding the biophysical
properties of transcription factors. The consensus sequence can be defined as the
DNA sequence to which a transcription factor binds most strongly. But transcrip-
tion factors can also bind to consensus sequence neighbors with considerable affinity.
Takeda and Sarai studied Cro and λ repressor of E.coli, measuring the affinities to
various substitutions of the consensus sequence [72, 73]. They also found that a
simple addition of ∆∆Gs for each substitution was predictive of the experimentally
determined value of the double substitution. This gave rise to the assumption that
position weight matrices (PWMs) [74, 75, 76, 77] or WebLogos [78, 79] could be used
to describe how a transcription factor binds to all possible sequences. A PWM con-
sists of four entries describing the base preference of a transcription factor at each
position of its binding site. To calculate the affinity to any sequence, the entries
describing the affinity of the specific base of the new sequence at each position are
added together. More recently, with the advent of higher throughput technologies,
the assumption that bases are independent and thus can be described as a simple
two-dimensional matrix has been contested [80, 81, 82].
Having measured a complete 4-mer space for MAX iso A, iso B, Pho4p, and Cbf1p,
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it was possible to test whether bases are recognized dependently or independently by
the transcription factors. Since a complete 4-mer space contains all possible single
base substitutions, a PWM containing actual affinity values could be extracted from
the datasets. These PWMs were then used to calculate the affinity of every possible
sequence in the 4-mer set. These values, calculated based on the assumption that
bases are independent of one another, were then compared to the actual biophysical
affinities of these sequences (Figure 8.11). Panels A–D of Figure 8.11 show the results
for both MAX isoforms, Pho4p, and Cbf1p for the sequence library NNNNGTG. In
all four cases only a fraction of predicted values actually agree with the values deter-
mined experimentally. One major region of the graph lies in the low-affinity domain
of about 10 µM or ∆∆G of 2.5–4.5 kcal/mol. The plateau seen in Figure 8.11 relates
to the non-specific binding regime observed in the binding energy landscapes. In
other words, a transcription factor retains a certain nominal affinity to DNA domi-
nated by non-specific electrostatic interactions with the DNA backbone that is not
predicted by PWMs. Most if not all predictions of Cbf1p fall into this regime since
there were no additional secondary peaks observed in the binding energy landscape.
In the MAX datasets, and to a lesser extent in the Pho4p dataset, a second regime of
affinities that lie perpendicular to the diagonal and in intermediate affinity ranges is
apparent. These cases are the most interesting, as here the PWMs predict a consid-
erably lower affinity (up to 2–3kcal/mol) than is experimentally observed, indicating
that transcription factors can adjust their modes of binding to certain families of
sequences and as a result bind them more strongly than predicted. The same trend
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is observed in the flanking base 3-mer dataset for Pho4p and Cbf1p, only here the
erroneous predictions are observed starting in the high-affinity regimes. Addition-
ally, and supporting the idea that a transcription factor can find additional modes
of binding, is the fact that PWMs always over-predict the loss in affinity. In other
words, the observed physiological affinity of a transcription factor is always equal to
or higher than the predicted affinity assuming independence.
8.3 The Basic Region
The basic region is the structural section of a bHLH transcription factor making
sequence-specific contact with DNA. The basic region structure is an alpha-helix
inserted into the major groove of DNA, a common method used by proteins to read
out the genetic code of DNA (see Figure 8.2). An alpha-helical turn is roughly 3.6
amino acids long, therefore every fourth to third amino acid sidechain points in the
same direction. In the case of the basic region it is these residues that make sequence-
specific contact with DNA. It should thus be possible to learn the DNA recognition
code of bHLH transcription factors by an exhaustive screen of the effects of amino
acid substitutions over a reasonably large DNA sequence space. As there are only
approximately 4–5 amino acids that make base-specific contact, the number of single
amino acid mutations is in the range of 80–100 mutants. To first understand what
basic regions are naturally occurring, all known bHLH transcription factor sequences
were collected from databases, the basic regions extracted, and a sequence alignment
performed (Section 8.3.1). To understand the function of each position in the basic
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region and the consequence of each possible single residue mutation, an exhaustive
experimental screen was run on the basic region mutants (Section 8.3.2).
8.3.1 Bioinformatic Sequence Alignment
To understand the naturally occurring basic region diversity, all 206 catalogued human
bHLH transcription factor amino acid sequences were obtained and their basic regions
extracted. These basic regions were then aligned according to sequence similarity
(8.12). This initial analysis contained a number of duplicate basic region entries
sometimes due to actual duplicate transcription factor entries, but often because
two transcription factors have identical basic regions but different dimerization or
activation domains.
To then further distill the dataset, all duplicate basic regions were removed and
the remaining basic regions re-aligned, again according to sequence similarity. The
resulting basic-region-sequence similarity tree is shown in Figure 8.13. In this tree,
nine major branches of similar basic regions are apparent. A table shows the basic
regions of each branch and the observed residue conservation amongst these sequences.
Conserved residues are shown in yellow in each table. Blue and green colors indicate
partially conserved residues. To further reduce the information content of this basic
region alignment tree, each branch is summarized in a table (Table 8.3) showing
the branch number, the consensus sequence, and the residues that likely make base
specific contact (denoted by a ’C’). Well-known members are also shown for each
branch.
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NEUROG2
PHTF1
EBF2
Q53XP6
MGA
NCOA2
Q53EU0
EPAS1#2
Q53H99
ID1
NCOA2#2
AHRR
TCF3#2
MYCN#2
Q96K34
BHLHB5
Q7RTU4
NCOA3
KIAA0518
MXI1#2
DKFZp434F1815
FLJ00110
ATOH8
Q58A43
Q6LBK7
Q5TGS0
EBF4
MLX
HES5
HES7
KIAA0867
NCOA1#2
Q59EE8
TFEB
SIM1
SIM2
ID3
ID4
AHR
HEY2
NPAS1
DKFZp451F163
NCOA1
MIST1
FLJ20449
Q9NX45
NPAS2#2
Q5TA89
Q59G74
WBSCR14
EBF3
HAND1
EPAS1
HIF1A
NPAS3
Q9UPH7
BHLHB2
HES6
MESP1
CLOCK
NPAS2
MNT
HEY1
HES2
Q5JUK2
TCFL5
Q96ME3
HEY2#2
HEYL
HES1
HES4
TAL2
MYOG
ARNT
ARNT2
ARNTL
MITF
Q8N6J9
SREBF1
SREBF2
MAX
MYC
USF1
USF2
MXD1
ASCL1
ASCL2
Q6XD76
NHLH1
NHLH2
FIGLA
LYL1
TAL1
MYF6
Q9H2M4
MYCL1
MYCL2
MYCN
Q7Z7Q9
MXD4
MXI1
NEUROD2
Q7RTU5
Q7RTU0
TCF23
TCF12
TCF3
HAND2
MYF5
MYOD1
ARNTL2
BMAL2
BHLHB4
DKFZp761E2117
TFAP4
TFAP4#2
FERD3L
SCX
TCF15
TWIST1
TWIST2
NEUROD4
ATOH1
ATOH7
PTF1A
Q9HC25
MSC
TCF21
OLIG1
Q59EM0
OLIG2
OLIG3
NEUROD6
NEUROG1
NEUROG3
NEUROD1
NEUROD2
Figure 8.12: Phylogenetic alignment of all obtained bHLH basic regions
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Figure 8.13: Phylogenetic representation of all tested basic regions. Here all redun-
dant names as well as basic region sequences were removed from the alignment
A glutamate in position 10 is conserved in all branches except for branches 4 and
5. These two branches contain basic regions of bHLH transcription factors that do
not bind to DNA, such as the Id family. As these transcription factors lack a basic
region, the sequence alignment returned only noise, with no residue conservation in
either branche. For all other branches the basic region sequence is expected to bind
DNA. The presence of a glutamate in position 10 is indicative of this, as E10 must be
present in order for the basic region to bind DNA. In branch #1, residues contacting
DNA are: R3, H6, E10, and R14. MAX and Pho4p fall into this category, and Cbf1p
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Branch # 1 Position 14 Members
C C C C C C C C
1 -K|R|-N|H|N-L|E|RRR|R| R H E R MAX, MYC, TFE3
2 A-|R|-L|-|--L|E|K-R|R| R - E R HES2, MNT, TEB1
3 NS|-|D-|-|---|E|S--|-| - - E - MLX, NRC3
4 --|-|--|S|--A|A|RKR|R| - S A R AHR, NPAS1, SIM1
5 --|-|-V|-|---|-|L--|-| - - - - ID2, NEUROG2,PHTF1
6 RR|R|R-|H|-SA|E|QKR|R| R H E R MIST1, WBS14, TFP4
7 -R|R|L-|A|NAR|E|R-R|M| R A E M TWIST1, NEUROD1, MSC
8 --|-|-K|R|NER|E|RQR|V| - R E V TCF4, ASCL1, ASCL3
9 DR|R|RA|A|--K|E|RRR|L| R A E L MYOG, HAND1, FIGLA
Table 8.3: Table showing the consensus sequences of the 9 branches of the above tree.
All residues making specific contact with the E-box are denoted by C on top of the
column.
is a close sequence neighbor with a K3 instead of a R3. It should be noted that branch
#6 is essentially the same as branch #1 in respect to residues contacting bases, except
for MIST1, which caused the alignment to be more distant than it should have been.
Branch #2 is similar to branch #1 but shows more variation in positions 3 and 6.
Branch #7 shows conserved residues in positions 3 and 10, but allows a variety of
residues in positions 6 and 14. Interestingly branch 8 shows a conserved valine and
arginine in positions 14 and 6 instead of a arginine and histidine. The basic region
sequence is also quite unstructured anterior to position 6. And finally branch 9 has
residue E10 shifted by one position in respect to the conserved arginine residues in
positions 2 and 13, which should be 3 and 14.
This bioinformatic analysis showed that the glutamate in position 10 is ultra con-
served and thus must be absolutely required for DNA binding by bHLH transcription
factors. Aside from position 10 the other 3 positions expected to make base spe-
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cific contact are not as restricted and several amino acids are used, possibly changing
which sequence is recognized, as well as varying the affinity to any given sequence. To
understand this recognition code an experimental approach was required to elucidate
the function of each position and is described in Section 8.3.2.
8.3.2 Mutagenesis Screen
To understand the DNA recognition code of the basic region two approaches were
envisioned. Both approaches were based on using the MAX isoform B backbone,
which readily homo dimerizes and expresses well in wheat germ extract. Furthermore
the basic region in MAX iso B is immediately N-terminal and could thus be easily
exchanged for any sequence using an overhang extension PCR. The first approach
attempted to use all non-redundant basic regions shown in Figure 8.13 and to substi-
tute these for the wild-type MAX iso B basic region. The synthesis of the chimeras
was successful, but it became apparent that it was exceedingly difficult to determine
whether the pitch of the inserted basic region was correct, and with an incorrect pitch
the function of each basic region could not be guaranteed. In retrospect, each basic
region should have been centered by using the conserved glutamate at position 10,
which should ensure that the inserted basic regions have the correct helical pitch.
The second approach taken was to specifically perform a saturation mutagenesis of
positions 2, 3, 6, 10, and 14 by substituting all possible 19 non-wild-type amino acids
and testing these novel basic region mutants for function. Each approach has its
own intrinsic advantages. The use of naturally occurring basic regions would have
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given direct insight into the function of each transcription factor, assuming that only
the basic region participates in DNA recognition. The mutagenesis approach, on the
other hand, represented a more controlled study of the function of each position with
an exhaustive coverage of amino acids. It however does not take into account the
identity of the unchanged residues, which, even though they do not contact DNA
specifically, may still contribute to the overall binding characteristic.
In a pilot experiment, each of the 100 basic region mutants was screened against
the 4 possible base substitutions in the position where the modified amino acid is most
likely to make base-specific contact (Figure 8.14). Therefore each set of 20 mutations
per position was tested against 4 possible target DNA sequences. To obtain high-
quality data each of these 400 possible combinations was tested at 8 target DNA
concentrations. The resulting data could then be fit with a linear regression, as
the target DNA concentrations were chosen to fall in the regime where the binding
response is linear. The data shows that each position in the basic region that is
predicted to make contact performs a unique function. Position 14 is responsible
for dialing in the specific sequence recognized by the basic region. The wild-type
amino acid arginine recognizes a cytosine most specifically. Changing this residue to
either leucine, asparagine, glutamine, tryptophan, or tyrosine changes the recognition
from a cytosine to a thymine. This list includes the three largest hydrophilic-neutral
amino acids (N,Q, and Y). Furthermore, when comparing tryptophan with histidine,
a similar trend in specificity can be observed, albeit at different relative affinities.
Guanine is only recognized by one amino acid, namely methionine. Alanine also
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A) B)
C) D)
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Figure 8.14: Shown are the base specificities of all 20 amino acids for the 5 positions
in the basic region predicted to make base-specific contact. The basic region position
and target base are indicated in the title of each graph. An asteriks denotes the wild
type amino acid in each position.
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primarily recognizes guanine but at very low relative affinities. Finally, thymine
could not specifically be recognized by any of the 20 possible amino acids, essentially
limiting the recognizable sequence space for the central nucleotide to CA[C/A/G].
The binding response of amino acid substitutions in position 10 was markedly
different than the response observed for position 14. Here essentially all mutations
caused a considerable drop in binding affinity, making E10 an essential component
for basic region binding. Several substitutions, including cytosine, aspartate, glycine,
asparagine, and serine, caused a recognition change from alanine to guanine. Here
small amino acids such as A, S, C, and G dominate, with N and D being slightly
larger.
Starting with position 6 no amino acid substitution was able to change the se-
quence recognition of the basic region. The mutants did exhibit varying degrees of
affinity to the wild-type E-box sequence. In position 6, wild-type histidine and lysine
showed similar affinities, with arginine being the third-strongest binder. All other
amino acids were roughly equal in their affinity, with proline being the least stable.
Proline does serve as a negative control as it can not attain the backbone conformation
required for helix formation.
Arginine in position 3 shows a similar trend in affinities as position 10, but with
different amino acids causing affinity modulation. Here the wild-type residue has
the largest affinity, followed by lysine. Alanine, histidine, asparagine, and glutamine
show intermediate affinities. Moving out one more position to lysine, affinities change
considerably, with all amino acids, including proline, having high affinity to the con-
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sensus. On the one hand this indicates that position 2 does not contribute consider-
ably to the overall binding affinity of the basic region. But certain residues such as
lysine and arginine are still preferred, most likely because they can form non-specific
interactions with the negatively charged DNA backbone. Interestingly, for positions
3 and 2, changing the base in position N−4 from cytosine to any of the other three
bases caused a complete loss of affinity. This could be due to the fact that position
N−4 is in fact recognized by a residue other than those in position 3 and 2. It is also
possible that the presence of an arginine and a lysine in position 3 and 2 respectively
can recover the sequence recognition profile observed for Cbf1p.
Summarizing the above data it became apparent that position 14 functions as the
only sequence sensor in the basic region. Here 3 possible bases can be recognized
including cytosine, guanine, and adenine. Glutamate in position 10 appears to be
essential to basic region function, with a few amino acids seemingly being able to
change the base recognized from an adenine to a guanine. In positions 6, 3, and 2
it was not possible to modulate sequence recognition, but affinity could readily be
changed by substituting certain amino acid residues. These measurements provided a
glimpse into the functions of the various positions on the basic region known to make
base-specific contact with DNA. It should be noted that a larger DNA sequence space
has to be tested to ascertain that no sequences are missed that might recover binding,
as it is most likely that amino acid side chains may contact more than one base at
a time. The next phase of the experimental series therefore constitutes testing each
mutant against a complete 3-mer DNA library. Up to 6 basic region mutants may
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be screened on a single 2400-unit cell device against all 64 possible DNA sequences
at 6 concentrations. It will be interesting to see whether this extended screen will
reconstitute the intriguing sequence recognition difference observed between wild-type
Pho4p and Cbf1p (Figure 8.6). Here Pho4p and Cbf1p prefer CC and GT in positions
N−5N−4, respectively. The basic region sequences are remarkably similar and the
difference in recognition can be essentially limited to residues 2–4 which are KRE
and RKD in Pho4p and Cbf1p, respectively. Position 4 is most likely not involved in
base recognition since the helical position is phase shifted by roughly 180◦, leaving
the switch of lysine and arginine in positions 2 and 3. It remains to be seen whether
changing one of these positions, but measuring it against a larger sequence space, will
affect the switch in sequence recognition, or whether a double mutation is required. If
the latter possibility should hold true (as it well might) then the necessary sequence
space to be explored will explode exponentially, making the problem experimentally
intractable. Nonetheless, testing of each mutant against a larger DNA sequence space
will provide a good picture of how bHLH transcription factors, and by extension bZIP
transcription factors, recognize DNA. Finally similar experimental approaches can be
used with the two other main families of transcription factors, namely the Zinc finger
and Homeobox family.
8.4 bHLH Heterodimers
An intricate aspect of bHLH transcription factor function is their ability to form not
only homodimers, but heterodimers as well. Heterodimer formation not only allows
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Figure 8.15: Fluorescent scan of a subsection of a DTPAx10 device programmed
combinatorially with linear expression templates coding for the transcription factors
according to the column and row labels. The fluorescence intensity shows the presence
of the a target dsDNA probe labeled with Cy5 pulled down by functional homo- and
heterodimers (green-red represent low-high concentrations, respectively).
for a combinatoric sequence space to be explored, but also allows transcription fac-
tors to recruit various activation domains. Heterodimer formation was tested on-chip
by co-spotting linear expression templates coding for the two transcription factors
to be tested, with one of them lacking an epitope tag so that it can only localize to
the surface through specific interactions with the second transcription factor, which
carries a 6xHis tag. Heterodimers can be detected by directly visualizing the prey
transcription factor with a second epitope tag. It is also possible to measure het-
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erodimer formation through target DNA pull-down. This second approach is possible
as many bHLH transcription factors fail to form homodimers and only bind to DNA
if they heterodimerize with a partner bHLH transcription factor. C-Myc for example
predominantly forms heterodimers with MAX as well as other members of the family.
To test the ability of c-Myc to heterodimerize with MAX, Mxi1, and itself, a combina-
toric array of the transcription factors MAX iso A, MAX iso B, c-Myc, C-Myc∆N189,
C-Myc∆N320, C-Myc∆N346, and Mxi1 iso B was spotted. C-terminally tagged ver-
sions of each transcription factor were co-spotted in all possible combinations with
un-tagged versions. In this instance a chip design (Figure C.21) was used that allowed
for neighbor spotting rather than having to co-spot each template. The transcription
factors were then synthesized using wheat germ ITT in the presence of a target ds-
DNA oligo labeled with Cy5. Every c-terminally tagged transcription factor localized
to the surface and could interact either with itself or with the second transcription
factor. If a functional dimer was generated, it pulled down the target DNA, which
could be detected on the ArrayworxE (Figure 8.15). It can be seen that both MAX
isoforms are able to homodimerize and functionally bind target DNA. C-Myc, on
the other hand, shows the highest DNA pull-down in the presence of its heterodimer
partners MAX iso A and iso B. This is particularly obvious for the truncated c-Myc
versions ∆N189 and ∆N346, where only the presence of MAX iso A and MAX iso
B gave rise to signal. Interestingly, the intermediate truncation ∆N320 showed no
pull-down across the board. Whether this is due to a structural reason, or simply
an experimental artifact due to low expression, could not be ascertained. It should
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be noted that the bHLH domain of c-Myc resides in the c-terminal portion of the
transcription and remained unchanged by all three truncations. Mxi1, surprisingly,
failed to be functional in any transcription factor combination, despite expectation
that it would be functional in the presence of c-Myc. Upon closer inspection it was
realized that the Mxi1 version used in this experiment was isoform B, which lacks a
basic region resembling the Id bHLH transcription factors and thus is indeed expected
to be non-functional.
On-chip co-expression of proteins can therefore be used to study binary protein-
protein interactions. The experimental approach described here uses the binding of
a target dsDNA sequence as a detection mechanism. A more generalizable approach
would have been to detect the binding of the prey transcription factor directly using
a second epitope tag such as the S-tag approach described in Section 7.3. Another
intriguing possibility lies in multiplexing the dsDNA target by introducing a set of
closely related sequences varying CANGTG, for example, and using a different fluo-
rophore for each possible sequence. Then, the presence of a functional dimer could be
measured as well as its sequence preference. Since it was shown in Section 8.3.2 that
the sequence space recognized by the basic region is considerably restricted, only a
library consisting of the sequences comprising CANNTG has to be interrogated.
In order to perform a full combinatoric interaction screen of the roughly 200 human
bHLH transcription factors, a good cDNA clone source is needed. Many clones are
available from OpenBiosystems, but it became apparent that the annotation of those
clones is lacking–the inaccurate annotation of Mxi1 being one example. A second
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problem with the OpenBiosystems source is the fact that the clones are harbored in a
variety of vectors, making design of a standard PCR method non-trivial. Additionally,
each vector has resistance to either Amp or Cam, which also complicates the high-
throughput handling of these libraries. A second possible source is available from
Invitrogen, where the above problems are non-existent. Unfortunately at a cost of
about $800 per clone the Invitrogen clones are also prohibitively expensive.
8.5 bHLH Kinetics
Kinetic experiments were run to determine the off-rate of the MAX iso A–target
DNA interaction. Briefly, MAX was localized to the chip surface and allowed to bind
target DNA containing an E-box sequence. Once DNA was bound by the transcription
factor, buffer was exchanged and the dissociation of bound DNA was observed using
an inverted fluorescent microscope equipped with a PMT (E717-21, Hamamatsu).
The PMT output was measured roughly every 50 ms. Controls included measuring
the buffer exchange rate, or flush rate, and the bleach rate, yielding 1.614 sec−1 and
1.4 ∗ 10−2sec−1, respectively (Figure 8.16). A flush rate of 1.614 sec−1 is reasonably
fast for most transient interactions, but could be improved upon. The bleach rate is
less important, as it is slow enough and simply adds to the observed loss of stable
interactions. Using these two rates provides a function of the form y = A ∗ e−kd∗x +
e−kbleach∗x+e−kflush∗x+B, where the function decays to a plateau B from a height of A
and with a time constant of kd. With this method, duplicate off-rates of 2.2∗10−1sec−1
and 2.6∗10−1sec−1 were measured for MAX iso A and E-box DNA. Reported off-rates
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Figure 8.16: The fluorescent intensity of target DNA was measured in real-time using
a PMT, so that the relative fluorescent units have the unit of Volts. Two control
measurements were taken. First a bleach rate of the Cy5 fluorophore was determined
without active flushing. A flush rate was determined by washing away unbound solu-
tion phase target DNA. An actual off-rate measurement of MAX - DNA is shown by
the blue trace, where DNA was allowed to bind to surface localized MAX transcrip-
tion factors. All traces were fit with exponential decays (solid lines) as described in
the text.
for bHLH transcription factors and DNA vary widely. Spinner et al. report a koff of
0.875–12.3 sec−1 for E12 [83], Grinberg et al. 1.4 ∗ 10−3sec−1 and 1.1 ∗ 10−2sec−1 for
TFE3 and E47 [84], respectively, and Park et al. use off-rates of 3.2–3.4 ∗ 10−2sec−1
for Myc/MAX-DNA and MAX/MAX-DNA [85].
The above described real-time approach to measuring off-rates is easily imple-
mented on a microfluidic device. It would be possible to automate the interrogation
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of the device and thus increase the throughput to dozens of interactions. Using MIT-
OMI for measuring off-rates, as described in Section 7.4, would be more appropriate
to understand larger numbers of interactions, particularly if individual interactions
are long-lived. For permanent interactions, long interrogation durations are neces-
sary, which considerably slow down serial approaches. Interestingly MITOMI-based
measurements may also be able to capture faster dissociations, as the flush rate can be
decoupled from the actual measurement. The above-measured flush rate of 1.6sec−1
lies within the expected range for non-consensus target DNA sequences. Overall the
microfluidic methods described are well suited for kinetic measurements of bHLH–
DNA interactions and can be adjusted to the specific requirements of the interaction
to be investigated.
8.6 Other Transcription Factors
8.6.1 CREB
The cAMP response element-binding protein (CREB) is a member of the bZIP family
of transcription factors (see Figure 8.2) and is implicated in a wide variety of cellu-
lar functions, as cAMP is a major transducer of signals received by surface receptors.
CREB1 was chosen not only because of its general importance in cellular function, but
also because it extends the applicability of MITOMI to a second major family of tran-
scription factors. CREB1 is known to bind a palindromic sequence of TGACGTCA
[86, 87]. Interestingly here N−3 is a guanine, not a cytosine, indicating that the basic
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Figure 8.17: The halfsite specificity of CREB was tested using a GACNNN library.
Here the surface-bound DNA concentration is plotted, instead of actual affinity con-
stants.
region conserved in bZIPs was able to find a sequence specificity that could not be
recovered using the bHLH basic region mutants (see Section 8.3.2). Whether this
is due to the slightly different overall structure of the transcription factor (lack of a
loop) or is due to different conserved amino acid residues in the basic region needs
to be determined. Additionally, CREB1 was an interesting candidate as an unbiased
genome-wide location study was available [88]. Here the authors fused ChIP with
SAGE, creating an alternative to ChIp-chip. Results obtained with MITOMI could
therefore be compared to existing datasets.
To test whether CREB1 could be characterized with MITOMI, a small 64-member
library was generated covering the bases TGACNNNA. Instead of spotting concen-
tration gradients, this library was spotted at a uniform concentration. From this a
relative affinity could easily be determined, which is a direct function of surface-bound
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target DNA. The results are shown in Figure 8.17. The highest affinity sequence was
GAC, indicating that the experiment was successful–meaning that not only bHLH
transcription factors but bZIPs as well can be measured with MITOMI, covering two
of the four largest families. Furthermore, the obtained landscapes differ considerably
from those obtained for the bHLH transcription factors. Together this short exper-
iment showed that MITOMI can be applied to other transcription factors and that
landscapes can be obtained that differ from those observed previously.
8.6.2 Gli Transcription Factors
The hedgehog (Hh) signalling pathway controls many aspects of development, as
well as maintains stem-cell populations in adults [90]. On a molecular basis, Hh
signalling converges onto the Zinc finger transcription factors Gli1, Gli2, and Gli3 in
vertebrates, and their homologue Cubitus interruptus (Ci) in the fly D. melanogaster.
These Zn finger transcription factors in turn control the expression of decapentaplegic
(dpp), patched (ptc1), engrailed (en), collier (col), and iroquois (iro). Ptc1 is a 12-
transmembrane protein and serves as the receptor for Hh. Hh-binding inactivates
Ptc1, which in turn activates smoothed (Smo), another membrane protein. This signal
then is transduced to Ci. In flies Ci can serve both as a transcriptional activator, CiA,
and as a repressor, denoted by CiR. Which function Ci fulfills is dependent on its
cleavage state. Hh signalling causes the translocation of CiA into the nucleus where it
associates with CREB-binding protein (CBP), which is also known to activate CREB
(see previous Section 8.6.1), and together Ci and CBP activate target gene expression.
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NNNTGGGTGGTC
NNNGTGGTC
TGGNNNGTC
TGGGTGNNN
TGGGTGGTCNNN
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D)
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F)
Figure 8.18: The Gli3 motif was tiled into 3-mer sections (A–E) and the measured
affinities are displayed in nM. Panel F shows a Weblogo calculated from data displayed
in Panels A–E.
In vertebrates the function of Ci has been split into three components: GLI1, GLI2,
and GLI3. GLI1 functions as transcriptional activator and GLI3 as the repressor.
GLI2 may function both as repressor and activator, but performs mainly the latter
function.
Hallikas et al. semi-quantitatively measured the PWM for Gli1–3 and Ci using
a pull-down-based competition assay [89]. They then used the established PWMs
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Figure 8.19: The PWMs reported by Hallikas et al. [89] and measured here in Panels
A and B, respectively. All values of the PWMs were also cross-compared (Panel C).
to predict genomic binding of these and other transcription factors with a novel
algorithm they term ’enhancer element locator’ (EEL). EEL takes into account the
relative affinity of a transcription factor to a target sequence, target site clustering,
as well as conservation. Using EEL the authors were able to find known GLI targets
such as Ptch1 and Gli1 out of a total of 42 elements that met selection criteria.
To understand the sequence recognition profile of the GLI transcription factors,
they were tested against a library of target DNA sequences permuting 3-mer sections
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Figure 8.20: As with the bHLH transcription factors in Section 8.2.5 a PWM was
used to predict the measured values. A picture very similar to Figure 8.11 can be
seen.
tiled over the known GLI motif of TGGGTGGTC. These three core libraries consist-
ing of NNNGTGGTC, TGGNNNGTC, and TGGGTGNNN were supplemented with
libraries covering the flanking bases, including NNNCCCTGGGTGGTC, NNNTGGGTG-
GTC, and TGGGTGGTCNNN. Gli1–3 as well as Ci were obtained and cloned by
Tyler Hillman (Scott Lab, Stanford CA). Instead of relying on in situ synthesis of
the transcription factors, they were expressed bench-top in 25–50 µL rabbit ITT
reactions. The ITT reaction was then loaded onto the device to flow deposit the
transcription factor. This step produced good surface coverage, despite possible sub-
optimal synthesis yields. The first target tested was GLI3 and the results for all but
one library are shown in Figure 8.18. The data confirms the known consensus motif
while increasing the depth of information which can be used in in silico prediction
of target genes. To more closely compare the absolute affinities determined with
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Figure 8.21: A snapshot of the USGS genome browser output for the mouse chromo-
some build mm7 centered on Ptch1, a known GLI target. A custom track was added
showing the calculated high probability binding sites of Gli3 as black peaks in the
first track of the figure. The Pocc values are shown to the left of each peak.
MITOMI to the PWM values obtained by Hallikas, a PWM was calculated using the
single substitution data obtained with MITOMI (Figure 8.18, Panel F). The weblogo
was calculated following Schneider and Stephens [78] by calculating the difference
between the maximum entropy and observed entropy at each base position:
Rseq(l) = log2B − (−
B∑
b=a
f(b, l)log2f(b, l)) (8.11)
where Rseq(l) is the information content at position l, b is any of the 4 possible bases
(A,C,G, or T), B the total number of possible bases, and f(b, l) is the frequency of
base b at position l. The frequencies can be obtained from the experimental data
by calculating a probability of observing a base b at position l from the measured
affinity ∆∆G(b, l).
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P (b, l) =
1
e∆∆Gb,l/RT + 1
(8.12)
f(b, l) =
P (b, l)∑B
b=a P (b, l)
(8.13)
The frequency f(b, l) is then taken as the adjusted probability, as the sum of the
probabilities at a position has to be 1. Rseq(l) defines the total information content
in each position l. The contribution of each base to the total information content is
the product of the frequency of the base and Rseq(l):
contribution(b, l) = f(b, l)Rseq(l) (8.14)
.
As a control, the calculated PWM was compared to the PWM obtained by Hallikas
et al. [89]. Hallikas et al. reported their PWM adjusted to a relative value of one
(Figure 8.19, Panel A), therefore the PWM from Figure 8.18, Panel F was adjusted
as well (Figure 8.19, Panel B). These two PWMs are essentially identical, more easily
seen by a direct comparison of all PWM values (Figure 8.19, Panel C). MITOMI
therefore successfully measured the relative single base preference of GLI3.
Not only were the single base substitutions measured but complete 3-mer libraries.
To again understand whether individual base contacts were non-independent, as was
the case with the bHLH transcription factors (Section 8.2.5), measured affinities were
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again compared to values calculated from single base substitution data (Figure 8.20).
Again, most of the predicted values don’t agree with the experimentally determined
affinities. Indeed the prediction accuracy was worse for Gli3 than for the bHLH
transcription factors, with the flanking 3-mer libraries being particularly erroneous.
Similar to the approach taken by Hallikas et al., the binding energy landscapes
determined by MITOMI were used to predict likely genomic target sites [89]. GLI3
measured here was obtained from the mouse, therefore all calculations were performed
on the mouse genome builds mm7 and mm8. The in silico approach taken here is
essentially the same as used for determining Poccs in yeast (Section 8.2.4). But instead
of calculating Poccs for a certain region upstream of every ORF, Pocc windows of 500
or 1000 bps in length covering the entire genome were calculated. To assure that
no binding sites were missed, the windows had a 15 bp overlap. The resulting Pocc
windows could then also be centered onto the highest individual 15 bp transcription
factor binding site. Figure 8.21 shows calculated high-affinity binding sites near Ptch1
on chromosome 13, a known GLI target. Interestingly, CpG island locations seem to
coincide with all three predicted GLI binding sites, just upstream of Ptch1.
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Chapter 9
Proteasome
The proteasome is a large multi-unit complex involved in the non-lysosomal ATP-
dependent proteolysis of proteins in eukaryotic cells. Substrate proteins for the pro-
teasome are abundant and derived from all types of cellular processes. Proteins are
targeted to the proteasome via introduction of polyubiquitin chains on lysine residues
by the enzymes E1, E2, and E3.
Structurally, the proteasome is a 26s complex (2000 kDa) consisting of 2 ma-
jor subcomplexes–the 20s proteolytic core complex and the 19s regulatory particle.
The proteolytic core consists of a homodimer of two 7α7β symmetric subcomplexes
arranged in a barrel shape (Figure 9.1). The 19s subcomplex, on the other hand,
is less structured and various subunits have been associated with it. There are 6
non-ATPase and about 11 ATPase dependent subunits in the 19s regulatory particle
(Figure 9.1).
A high-resolution crystal structure is available for the yeast 20s particle [93]. Nei-
ther the 19s regulatory particle nor the full 26s complex could be solved with x-ray
diffraction as of yet, likely due to the fact that growing crystals of the unstructured
19s particle is difficult. Walz et al. did report a low-resolution electron microscopy
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Figure 9.1: The left diagram depicts the overall structure of and function of the 26s
proteasome holoenzyme. The right diagram shows the specific proposed interactions
taking place in the 19s regulatory particle. (Taken from [91])
structure of the entire 26s proteasome complex [92] (Figure 9.2).
The exact location of the individual 19s subunits is unknown, due to the low
resolution of the EM structure. It might be possible to build a map of subunits by
determining the interconnectedness of the subunits and fitting the established network
into the EM structure. Knowing the position of each subunit would give insight into
the possible function of the individual subunits, as well as of the particle at large.
Establishing the 19s subunit network requires testing of all possible binary interactions
of the subunits, of which there are 18 (Rpt1–6 and Rpn1–12). Linear expression
templates were designed for the on-chip expression of the subunits. Several linear
expression templates were generated for each subunit, including versions carrying N
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Figure 9.2: A EM structure of the 26s proteasome obtained by cryo-EM (Taken from
[92])
and C-terminal 6xHis, T7, and S-tags, as well as versions carrying no epitope tag. All
synthesized linear expression templates are listed in Table 9.1. Genomic DNA from
yeast S.cerevisiae strain S288C (Invitrogen) served as template for all PCR reactions.
Bait and prey experiments can be set up with any combination of the various tagged
and un-tagged subunits. Generally the 6xHis tagged versions are used for surface
localizing the bait. The prey can be detected using the T7 or S-tag (Section 7.3) using
fluorescent or enzymatically labeled anti-T7 antibodies or S-protein, respectively.
His tagged versions of a few subunits were expressed on-chip from spotted linear
expression templates, using residue-specific incorporation of a tRNALys−bodipy−fl for
detection. The resulting intensities, after localizing the synthesized proteins to the
detection area, are shown in Figure 9.3. Yeast proteins generally express well in
wheat-germ-based ITT systems, including the proteasome subunits studied here. It
should be noted that most subunit sizes fall within 30–50 kDa, with the exception of
Rpn1–2 which have weights above 100 kDa and thus lower expression yields. Even
though the subunits were easily expressed on-chip, only limited time and effort was
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No Tag N-His C-His N-T7 C-T7 N-S-tag C-S-tag
19s Rpt1 ✔ ✔ ✔ ✔ ✔ ✔
Rpt2 ✔ ✔ ✔ ✔ ✔ ✔
Rpt3 ✔ ✔ ✔ ✔ ✔ ✔
Rpt4 ✔ ✔ ✔ ✔ ✔ ✔
Rpt5 ✔ ✔ ✔ ✔ ✔ ✔
Rpt6 ✔ ✔ ✔ ✔ ✔ ✔
Rpn1 ✔ ✔ ✔ ✔
Rpn2 ✔ ✔ ✔ ✔
Rpn3 ✔ ✔ ✔ ✔
Rpn4 ✔ ✔ ✔ ✔
Rpn5 ✔ ✔ ✔ ✔
Rpn6 ✔ ✔ ✔ ✔
Rpn7 ✔ ✔ ✔ ✔
Rpn8 ✔ ✔ ✔ ✔
Rpn9 ✔ ✔ ✔ ✔
Rpn10 ✔ ✔ ✔ ✔
Rpn11 ✔ ✔ ✔ ✔
Rpn12 ✔ ✔ ✔ ✔
20s alpha-1 ✔ ✔ ✔
alpha-2 ✔ ✔ ✔
alpha-3 ✔ ✔ ✔
alpha-4 ✔ ✔ ✔
alpha-5 ✔ ✔ ✔
alpha-6 ✔ ✔ ✔
alpha-7 ✔ ✔ ✔
Table 9.1: Inventory of linear expression templates coding for the subunits of the
proteasome and their respective epitope tags
expended on determining binary interactions. Initially the interactions were tested
using standard protein array methodology without the use of MITOMI. Not only
was the detection mechanism flawed, it also became apparent that even though the
entire complex, as well as the base and lid portion of the 19s regulatory particle, were
stable in solution, this did not necessarily extend to individual binary interactions.
Using MITOMI in combination with an optimized detection method should allow
for the determination of the correct binary interactions. A second possible solution
would have been to attempt to measure ternary interactions instead, which might
result in more stable complexes if the correct 3 subunits were investigated. Of course
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Figure 9.3: Examples of expression efficiencies of proteasomal subunits on-chip
testing ternary interactions would require measuring a total of 5832 possible subunit
combinations instead of 324 binary combinations.
Another intriguing possibility presented itself in the fact that with MITOMI it
may have been possible to measure not only relative affinities, but absolute affinities,
as well as dynamics. Section 7.4 describes in detail the approaches that may be
taken to measure the dynamics of molecular interactions, including on- and off-rate
measurements of two body systems. Knowledge of the dynamics of individual binary
interactions should allow one to simulate complex assembly in silico, which in turn
should give insight into how complexes assemble and function. The 19s regulatory
particle is particularly interesting, as it is a rather complex, asymmetric structure
with large possible structural deformations taking place.
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Chapter 10
Cell Arrays
10.1 Introduction
Proteomic and Systems Biology efforts have resulted in the creation of large libraries
of ORF clones, as well as knockout strains. With these libraries it is possible to
dissect large biological networks by measuring or perturbing one element at a time.
These libraries generally cover the entire proteome and thus have sizes ranging in the
thousands for yeast ORF clonal libraries. A variety of libraries are available for yeast,
including knockout strains [94], genomic TAP fusion libraries [69], plasmid-based ORF
libraries [95], and genomic GFP fusions [96]. One problem with these libraries is the
fact that they are difficult to interrogate due to their sheer size. Efforts to date
include brute force approaches based on classical bench-top techniques [69, 96, 95],
as well as more technologically advanced experiments based on FACS sorting [97].
Yet these libraries can be readily used in conjunction with microfluidics and spot-
ted micro arrays for programming. Libraries harbored in resilient hosts, such as yeast
and bacteria, may be spotted just as any other solution, followed by alignment to a
device. The resulting microfluidic device may house the entire library with thousands
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of individual elements, and complex fluidic manipulations may be performed, such
as fluid exchange and generation of molecular gradients. Furthermore, the cells are
still viable and may be grown in situ. Use of a microscope then allows single cells to
be followed with high time resolution, so that the response of protein concentrations
and localization in the cell as a function of some perturbation may be characterized.
This provides unprecedented control over the most important factors, such as the
ability to control the introduction of the perturbing agent, as well as a high temporal
and spatial resolution down to minutes and single cells. It is also possible to lyse the
cells rather than attempt to grow them. When the cells are lysed the fusion protein
expressed intracellularly may be purified in an adjacent chamber, providing one of
the most rapid and facile methods for generating large-scale protein arrays.
10.2 Live Yeast Cell Arrays
As mentioned in the previous chapter, proteome-wide ORF and knock-out libraries
are available for many model organisms, such as E.coli and yeast. Studying these
libraries on a proteomic scale has been challenging though. Micro-arraying these
clonal libraries, followed by in situ growth and investigation on microfluidic devices,
provides a unique opportunity to rapidly screen these libraries. The first instantiation
of this approach was tested with the yeast genomic GFP fusion library generated by
Huh et al. [96]. The first 96 clones of the library (Invitrogen) were grown in 96-
well plates using YPD as the growth medium. After overnight growth at 30◦C and
agitated at 300–400 rpm the cells are allowed to settle. Optionally the cells may
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Figure 10.1: Time series of a yeast life cell array. Device chambers were programmed
with 96 different yeast–GFP fusion strains from a spotted micro-array. Images were
taken every 2 hours, while the growth chambers were continuously perfused with
media via the horizontal flow channel. Cell density can be seen increasing in several
growth chambers during the 14-hour period.
also be pelleted by centrifugation. The pelleted cells are then micro-arrayed using a
standard dip pen method. Here use of v-shaped 96-well plates is advantageous, due to
better pellet formation. To ascertain that there is no cellular carryover between spots,
a test array was spotted in which every other spot was a blank. This test array showed
no cross-contamination between spots due to spotting. A cell array is then aligned to
a microfluidic device and bonded to the epoxy substrate at 40◦C for 30 to 120 minutes.
The duration of bonding is intentionally kept short to keep cell viability as high as
possible. Once the device is bonded it can be operated and cells infused with media
to re-start growth of the clones. First the entire device is dead-end filled with media
followed by continuous flow of medium through the parallel flow channels. The cells
167
are then grown either in YPD or SC-His, with the chip placed on a hot plate set at
30◦C. SC-His was chosen to insure the integrity of the GFP fusion for the duration of
the experiment. SC-His does show retarded growth performance over YPD, a problem
that may need to be addressed in future experiments. The cells, regardless of medium
used, show a day or more of lag before they start growing. This long lag is likely due
to the rather stressful spotting procedure and possibly due to the intrinsically low
cell numbers in each chamber. The time it takes for the cells to completely suffuse
a unit cell is also, and not surprisingly, strongly dependent on the seeding density,
as well as the clonal construct (Figure 10.2.) Once the cells are growing they can be
kept in an exponential growth phase by continuous removal of overflowing cells at the
shear interface. It was also shown that no contamination occurs between unit cells
despite use of a passive device where all unit cells are interconnected at all times. The
above-mentioned control array was used, in which every other unit cell was lacking a
seed spot. Even after a day or more of growth, the negative unit cells remained free
of cells. Care must be taken to avoid clogging of cells at any point in the device, as
this stops the flow in one of the parallel channels, at which point the entire channel
will become overgrown with cells.
Once cells are growing steadily, experimental conditions may be changed and the
response observed. Observations may include optical interrogation of growth rate,
protein abundance, and location, as well as other accessible parameters. In order
to obtain optimal interrogation conditions changes to the current chip design are
required. Mainly the flow channel height should be dropped to about 2–4 µm to
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restrict the growing yeast cells and have them grow in a monolayer, allowing single-
cell studies to be performed with greater ease. Studying cellular dynamics is one
primary application for this method, which requires relatively high time resolution
on the order of minutes (compared to cell division times of 20–40 minutes.) The
measurement rate depends both on the camera sensitivity, as well as stage velocity;
with current technologies a reasonable rate is about 4 Hz. On the current 2400-
chamber device a time resolution of 600 seconds or 10 minutes can thus be achieved.
A time resolution of 10 minutes is reasonable and will provide good response curves.
Higher resolutions of about 1 minute can be achieved by interrogating only part of an
array at any given time. A total of 240 chambers, for example, may be interrogated
with a time resolution of one minute.
Experimental conditions can easily be changed by addition of one or more com-
ponents to the culture medium to affect certain aspects of the cellular environment.
Likewise, concentration gradients of these components can also be easily set up [98].
Other interesting but technically more challenging manipulations include genetic en-
gineering or the use of RNAi to introduce new genes or specifically perturb genes
already present. Finally, and mentioned in greater detail in the next section, the
growing cells may be lysed and their contents purified in situ to be analyzed on a
molecular level.
Specifically, one experiment that can be run on this platform would be an investi-
gation of the dynamic response of protein levels and location on a single-cell level as
a function of a DNA modifying drug such as the methylating agent methylmethane
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sulfonate (MMS), ionizing radiation [99], or histone depletion [100]. But essentially
any method thus far applied to obtain differential gene expression experiments is
applicable here.
10.3 Yeast Protein Arrays
It was shown in the previous chapter that spotted yeast cells are viable and can be
cultured in situ on a microfluidic device. This same approach can also be used for
generating protein arrays directly from spotted yeast clones by lysis of the cells and
consequent purification of the cellular contents. The process for generating a protein
array is quite simple. Yeast cells such as the yeast–GFP clones are grown off-chip
using 96- or 384-well plates. If other cell types are used carrying ORFs under the
control of inducible promoters for example, protein expression can be induced just
prior to spotting. The cells are spotted directly from the plate from which they
were grown or may be washed with buffer to reduce contaminations contained in the
media. Once the cells are spotted, a device is aligned to the array and bonded for
a minimum of 2 hours at 40◦C. As mentioned in the previous chapter, the cells may
then be suspended in media to allow cultivation. Growing each clone on-chip has the
advantage that cells multiply and thus will produce more protein to be purified. A
second advantage of on-chip growth of the culture before purification is that the cells
may be induced in situ rather than off-chip, also potentially resulting in better yields.
A final advantage is that the cells are shown to be viable and thus concerns about
the state of the protein to be purified is minimal.
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Figure 10.2: Time series of yeast spheroplast formation. Zymolyase was introduced
into the chamber by passive diffusion, causing the disintegration of the yeast cell wall
over a period of 10 to 20 minutes. The resulting spheroplasts could then be lysed
using standard detergent-based methods.
Thus far, growth and purification were not combined and all data taken on pro-
tein purification is based on lysing yeast–GFP cells immediately, without additional
growth periods. One reason for this is that extensive growth may foul the surface
chemistry. The button may be used to prevent surface fouling by physically protect-
ing the surface during culturing. Figure 10.3 shows yeast–GFP cells contained in a
unit cell and suspended in a solution of 10 mg/mL Zymolyase, 1% BME, in 0.1 M Tris
HCl. This first step breaks down the yeast cell wall, generating yeast spheroblasts
which can then easily be lysed using a detergent solution such as Y-PER (Pierce).
Similarly these two steps can be combined by dissolving 10 mg/ml Zymolyase, 1%
BME in Y-PER directly.
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Figure 10.3: The left graph shows the pull-down efficiency of the first 96 yeast–GFP
fusion proteins extracted on-chip from yeast cells. The percentage of clones giving a
minimal RFU value of 20, 50, 100, and 500 is plotted, with about 75% of the clones
giving a signal of 50 or above. The graph on the right shows the reproducibility of
the pull-down between on-chip experiments, hinting that the method could be used
to quantitatively measure intracellular protein concentrations.
The cellular contents, including the GFP-tagged protein specific to the clone, are
now free to diffuse. Surface deposited anti-GFP antibodies capture and localize the
GFP-tagged protein, generating a homogeneous spot for interrogation. This of course
takes place in every unit cell on the device, generating a unique protein spot for each
yeast–GFP clone deposited.
Once capture is complete, all non-specific cellular material is washed away and the
resulting GFP fluorescence on each spot may be measured. This fluorescent intensity
is directly proportional to the protein concentration of the tagged protein. There is
a large amount of intrinsic variability in protein expression of these GFP-tagged pro-
teins, since they have been genomically tagged with GFP and thus are still under the
control of their wild-type promoters. It was determined that over 90% of all proteins
tested expressed amounts corresponding to at least 20 RFUs, and that about 75% of
all clones showed at least 50 RFUs (Figure 10.3, Panel A). The latter concentration
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Figure 10.4: Yeast on-chip protein values were compared to values determined by
Ghaemmaghami et al. [69] by Western blotting TAP-tagged fusions. A reasonable
correlation can be observed, despite the fact that the on-chip data was not adjusted
to the number of cells giving rise to the signal.
should be sufficient to perform basic protein–protein pull down assays using these
protein arrays. Pull-down is also considerably robust across on-chip experiments as
shown in Figure 10.3, Panel B and a dynamic range in protein concentrations of al-
most five orders is observed. Furthermore the amounts of pulled-down protein from
these cultures correlated well with the measured in vitro concentration using Western
blots on TAP-tagged clones. This is encouraging, as the protein amounts detected
on-chip were not normalized in any form. A sensible normalization, such as adjusting
the detected on-chip protein intensity by the number of cells giving rise to it, should
further increase the correlation between the on-chip determined values and the bench-
top measurements. It thus seems possible to perform accurate determinations of in
vivo protein content on a very small number of cells in a high-throughput format.
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Appendix A
cDNA clone library
Common Name NCBI Accession Clone ID Item Vector Resistance Host
MAX BC036092 5299106 EHS1001-18380 pBluesscriptR Amp DH10B
TFE3 BC026027 4576858 EHS1001-5058351 pOTB7 CAM DH10B (phage-resistant)
TFE3 BC026027 4576858 EHS1001-44637 pOTB7 CAM DH10B(phage-resistant)
TFEB BC032448 5180066 EHS1001-24335 pCMV-SPORT6 Amp DH10B
TFEC BC029891 5179088 EHS1001-19568 pCMV-SPORT6 Amp DH10B
C-Myc BC000917 3048750 EHS1001-953 pCMV-SPORT6 Amp DH10B
Mxi 1 BC012907 3882557 EHS1001-4364050 pCMV-SPORT6 Amp DH10B(phage-resistant)
ID1 BC000613 3346009 EHS1001-3884718 pOTB7 CAM DH10B(phage-resistant)
ID2 BC030639 4820416 EHS1001-12292 pBluescriptR Amp DH10B
ID3 BC003107 3543936 EHS1001-4082645 pOTB7 CAM DH10B(phage-resistant)
ID4 BC014941 4552357 EHS1001-5033850 pOTB7 CAM DH10B(phage-resistant)
Myogenin (Myf4) BC053899 6170028 EHS1001-6519041 pCMV-SPORT6 Amp DH10B(phage-resistant)
MyoD (Myf3) BF219762 2961494 MHS1011-58728 pOTB7 CAM DH10B(phage-resistant)
TWIST H1 BC036704 4125830 EHS1001-35100 pOTB7 CAM DH10B(phage-resistant)
HEB BC050556 5767579 EHS1001-6128112 pCMV-SPORT6 Amp DH10B
Myf6 BC017834 4288735 EHS1001-42241 pDNR-LIB Cam DH10B(T1 phage-resistant)
MyoD (Myf3) BC064493 5022419 EHS1001-5503912 pOTB7 CAM DH10B(phage-resistant)
Myf5 CB856774 5793748 EHS1001-6154281 pAMP1 Amp DH10B
MAX isoform A BC004516 3937573 EHS1001-4419066 pOTB7 CAM DH10B(phage-resistant)
MAX isoform B BC003525 3607261 EHS1001-4145970 pOTB7 CAM DH10B(phage-resistant)
Mxi 1 isoform B BC035128 5263647 EHS1001-27831 pBluescriptR Amp DH10B
E12 BC011665 4110737 EHS1001-38433 pOTB7 CAM DH10B(phage-resistant)
E47 AA876062 1338894 EHS1001-1971203 pT7T3D-PacI Amp DH10B
E47 BE514178 3635031 EHS1001-4173740 pOTB7 CAM DH10B(phage-resistant)
MAD 3 BC000745 2821596 MHS1011-58805 pOTB7 CAM DH10B(phage-resistant)
MAD BC069377 7262252 MHS1768-9143888 pPCR-Script Amp SK(+) Amp XL10 Gold
MAD 4 BC068060 6538192 EHS1001-8947018 pOTB7 CAM DH10B(phage-resistant)
EBF BC041178 6045572 MHS1010-9204744 pCMV-SPORT6 Amp DH10B (phage-resistant)
EBF3 BC011557 4561018 MHS1011-75946 pOTB7 CAM DH10B (phage-resistant)
Table A.1: cDNA clone inventory. All clones were obtained from OpenBiosystems.
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Appendix B
MPEP primer library
Eukaroyotic 5'ext
gatcttaaggctagagtac  TAATACGACT CACTA TAGGGAAT 
ACAAG CTACT TGTTC TTTTT GCActcgagaattcgccacc
3'ext1
GTAGCAGCCTGAGTCGACTCTAGATTATTAATGATGA
TGATGATGATGGCCGCTGCTGCCTTGGAAGTAGAGG
TTCTCGGCGGCGGTCTTGAGGCT
3'ext2
CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAG
GGGTTATGCTAGTTTTTTTTTTTTTTTTTTTTTTTTTTT
TTTGTAGCAGCCTGAGTCG
5'final gatcttaaggctagagtac
3'final CAAAAAACCCCTCAAGAC 
Prokaryotic 5'ext_kim
gatcttaaggctagagtacATTAAT ACGACTCACT ATA G 
GGAGAC CACAACGGTT TCCCTCTAGA 
GATCATTTTGTTTAACTTTA AGA AGGAGA T ATAGAT
5'ext_roch
e
gatcttaaggctagagtacT AATACGACTC ACTATAGGGA 
GACCACAACG GTTTCCCTCT AGAAATAATT 
TTGTTTAACT TTAAGAAGGA GATATACC
MAX basic region 
switch
5'ext
gatcttaaggctagagtac  TAATACGACT CACTA TAGGGAAT 
ACAAG CTACT TGTTC TTTTT GCActcgagaattcgccacc 
atgagcgataacgatgacatcgaggtggagagcgacgct
Table B.1: Primer inventory for various 2 step PCR approaches
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Appendix C
Chip design gallery
Figure C.1: Serpentine Enrichment Chip
Figure C.2: Serpentine Enrichment Chip G4
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Figure C.3: Binary Interaction Chip v2
Unit Cells: 124
Area: 2.5 x 3.5 cm2
Number of Valves: 826
Valve density: 94 valves/cm2
Notes: first device with a membrane to be used for MITOMI
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Figure C.4: Binary Interaction Chip v2
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Figure C.5: DNA to Protein Array optimized
Unit Cells: 90
Area: 2.5 x 2.5 cm2
Number of Valves: 612
Valve density: 98 valves/cm2
Notes: spotting and surface chemistry test device
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Figure C.6: DNA to Protein Array optimized
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Figure C.7: DNA to Protein Array x2
Unit Cells: 200
Area: 2.5 x 2.5 cm2
Number of Valves: 1832
Valve density: 293 valves/cm2
Notes: device for testing binary protein interactions by coupling two chambers to
one detection area
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Figure C.8: DNA to Protein Array x2
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Figure C.9: DNA to Protein Array x4
Unit Cells: 200
Area: 2 x 2 cm2
Number of Valves: 1208
Valve density: 302 valves/cm2
Notes: first test design for MITOMI and specific surface chemistry
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Figure C.10: DNA to Protein Array x4
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Figure C.11: DNA to Protein Array x5
Unit Cells: 200
Area: 2 x 2 cm2
Number of Valves: 1428
Valve density: 357 valves/cm2
Notes: as DTPAx4 with additional valves for segregating unit cells
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Figure C.12: DNA to Protein Array x5
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Figure C.13: DNA to Protein Array x6
Unit Cells: 200
Area: 2 x 2 cm2
Number of Valves: 1468
Valve density: 367 valves/cm2
Notes: as DTPAx5 but allowing for parallel rather then serpentine based flow
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Figure C.14: DNA to Protein Array x6
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Figure C.15: DNA to Protein Array x7
Unit Cells: 200
Area: 2 x 2 cm2
Number of Valves: 627
Valve density: 157 valves/cm2
Notes: test device for round free-standing MITOMI membrane
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Figure C.16: DNA to Protein Array x7
190
Figure C.17: DNA to Protein Array x8
Unit Cells: 640
Area: 1.5 x 4 cm2
Number of Valves: 1987
Valve density: 331 valves/cm2
Notes: device employs round MITOMI membrane and a multiplexer for addressing
rows, parallel adjusted flow design
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Figure C.18: DNA to Protein Array x8
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Figure C.19: DNA to Protein Array x9v1
Unit Cells: 2400
Area: 2 x 5 cm2
Number of Valves: 7233
Valve density: 723 valves/cm2
Notes:
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Figure C.20: DNA to Protein Array x9v1
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Figure C.21: DNA to Protein Array x10
Unit Cells: 320
Area: 1.5 x 4 cm2
Number of Valves: 1044
Valve density: 174 valves/cm2
Notes:
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Figure C.22: DNA to Protein Array x10
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Figure C.23: DNA to Protein Array x11
Unit Cells: 128
Area: 1.5 x 1.5 cm2
Number of Valves: 453
Valve density: 201 valves/cm2
Notes:
197
Figure C.24: DNA to Protein Array x11
198
Figure C.25: Wheat Germ revised
Unit Cells: 200
Area: 2 x 2.5 cm2
Number of Valves: 524
Valve density: 105 valves/cm2
Notes:
199
Figure C.26: Wheat Germ revised
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Appendix D
Sequencing Results
A representative group of PCR derived linear expression templates was bulk se-
quenced. Both the human and yeast bHLH LTs underwent a total of 70 cycles of
PCR, 30 during the 1st step followed by 40 cycles in the second step. The human
first step synthesis was performed on 04/14/2005 and the yeast bHLHs were amplified
on 07/26/05. The second step was performed on 08/15/2005 and finally purified and
sequenced on 12/13/2005.
The resulting sequences were then entered into a discontiguous megablast search
and the top matches are shown below.
Query = C-Myc NoTag LT
>gi|12803004|gb|BC000917.2|
Homo sapiens v-myc myelocytomatosis viral
oncogene homolog (avian), mRNA
(cDNA clone MGC:5184 IMAGE:3048750), complete cds
Length=2047
Score = 564 bits (293), Expect = 9e-158
Identities = 303/311 (97%), Gaps = 0/311 (0%)
Strand=Plus/Plus
C-Myc deltaN249 C-His LT
>gi|12803004|gb|BC000917.2|
Homo sapiens v-myc myelocytomatosis viral
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oncogene homolog (avian), mRNA
(cDNA clone MGC:5184 IMAGE:3048750), complete cds
Length=2047
Score = 604 bits (314), Expect = 7e-170
Identities = 315/316 (99%), Gaps = 0/316 (0%)
Strand=Plus/Plus
Query = Cbf1 N-His LT
Subject = YJR060w (Cbf1)
Score = 1148 bits (597), Expect = 0.0
Identities = 623/631 (98%), Gaps = 2/631 (0%)
Strand=Plus/Plus
Query = MAX iso A NoTag LT
>gi|33871245|gb|BC004516.2|
Homo sapiens MYC associated factor X,
transcript variant 1, mRNA
(cDNA clone MGC:11225 IMAGE:3937573), complete cds
Length=1566
Score = 923 bits (480), Expect = 0.0
Identities = 482/483 (99%), Gaps = 0/483 (0%)
Strand=Plus/Plus
MAX iso B C-His LT
>gi|13097617|gb|BC003525.1|
Homo sapiens MYC associated factor X,
transcript variant 2, mRNA
(cDNA clone MGC:10775 IMAGE:3607261), complete cds
Length=1963
Score = 860 bits (447), Expect = 0.0
Identities = 451/453 (99%), Gaps = 0/453 (0%)
Strand=Plus/Plus
Query = Mxi 1 iso B NoTag LT
Alignments
>gi|23272476|gb|BC035128.1|
Homo sapiens cDNA clone IMAGE:5263647, partial cds
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Length=2756
Score = 621 bits (323), Expect = 4e-175
Identities = 330/331 (99%), Gaps = 1/331 (0%)
Strand=Plus/Plus
>gi|57242780|ref|NM_130439.3|
Homo sapiens MAX interactor 1 (MXI1),
transcript variant 2, mRNA
Length=3470
Score = 621 bits (323), Expect = 4e-175
Identities = 330/331 (99%), Gaps = 1/331 (0%)
Strand=Plus/Plus
Query = Pho4 C-His LT
Subject = YFR034C (PHO4)
Score = 1044 bits (543), Expect = 0.0
Identities = 584/592 (98%), Gaps = 7/592 (1%)
Strand=Plus/Plus
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Appendix E
Protocols
E.1 Photolithography
Purpose:Generate 5740 molds for chip fabrication with a rough elevation of 6-10µm
to be used for both the flow as well as the control layer.
Photoresist: Shipley 5740
Developer: Shipley 2401
Substrate: 3’ silicon wafers
Method:
• Vapor deposit hydroxy-methyl disilane (HMDS) on wafers for 2-4 minutes.
• Spin coat wafers with 5740 in two steps:
Step Speed (RPM) Time (seconds)
1 500 10
2 3000 60
• Bake wafer at 105◦C for 90 seconds.
• Expose on UV source for 40 seconds.
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• Develop in 3:1 (dH2O:Developer) until background disappeared.
• Quench reaction in a distilled water bath and rinse with dist. water.
• Anneal flow layer at 180◦C for 30 minutes.
• Check the flow layer for a correct height of 8µm ±2µm.
• Check the control layer for any interconnects between individual control lines.
E.2 Chip Fabrication
E.2.1 Standard 2-Layer PDMS Push-Down Device
Purpose: Fabricate a standard two layer push down device from PDMS.
PDMS: Sylgard
Method:
• Clean both flow and control layer mold of any residual polymerized PDMS.
• Clean both mixing cups of any residual polymerized PDMS.
• Place the control layer mold in a petri dish covered with aluminum foil to
facilitate easy removal.
• Vapor deposit TMCS onto both the control and flow mold for 1-2 minutes.
• Prepare 36g of 5:1 Sylgard (30g Part A: 6g Part B) for the control layer and
mix for 1 minute followed by degassing for 2 minutes.
• Prepare 15.75g of 20:1 Sylgard (15g Part A: 0.75g Part B) for the flow layer
and mix for 1 minute followed by degassing for 2 minutes.
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• Pour the mixed 5:1 mixture onto the control layer mold and start degassing.
• Spin coat the 20:1 mixture onto the flow layer with a 15 second ramp, 30 second
spin at 3000rpm.
• Remove control layer from vacuum chamber and destroy any residual surface
bubbles by blowing on top of the PDMS layer. Carefully remove any visible
particles on top of the control channel grid using a toothpick.
• Cure both layers for 30minutes at 80◦C.
• Remove both layers from the oven and dice the control layer with a scalpel.
• Punch control input holes.
• Thoroughly clean the channel side of the control layer with tape.
• Align control layer to flow layer.
• Bond devices for 90 minutes at 80◦C.
• Remove flow layer from the oven and cut flow layer around each individual chip
using a scalpel.
• Peel chips off flow layer and punch flow layer input holes.
• Clean flow channel side thoroughly with tape before bonding to glass substrate.
206
E.3 PCR Methods
E.3.1 Linear Template Generation
The following two subsections describe protocols for the generation of linear expression
ready templates for use in wheat germ or rabbit reticulocyte based ITT. Each protocol
can be roughly subdivided into the 1st and 2nd PCR step. The initial PCR step
amplifies the target and adds epitope tags which is used as a source for the second
generic PCR step. Thus the product of the initial PCR step may seed up to 50
consequent second PCRs.
E.3.1.1 cDNA Source
Purpose: Generate linear expression ready templates for wheat germ or rabbit retic-
ulocyte based in vitro transcription/translation from cDNA clones harbored in E.coli.
Template source: E.coli colonie/s
Polymerase: Expand High Fidelity Polymerase (Roche)
Primers: Gene specific primers at 50µM (possible to dilute to 200nM in dH2O)
Method:
• Pick colonies and suspend in 2.5µL of Lyse’n Go (Pierce) buffer.
• Heat suspension to 95◦C for 7 minutes on thermal cycler then cool to 4◦C.
• Add 46.5µL PCR mix (see below) and 1µL of the correct gene specific primer
pair to each suspension and cycle.
• Purify each reaction using Qiaquick PCR spin columns or on the 6s manifold.
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PCR Mix
1µL 10mM dNTP
5µL 10x Buffer + MgCl2
0.75µL HiFi Polymerase
39.75µL dH2O
46.5µ total
Cycle Program:
Step Temperature (◦C) Time (minutes) Cycles
1 94 4:00 1x
2 94 0:30 10x
3 55 1:00
4 72 1:30
5 72 7:00
6 4 ∞
• Elute with 50-100µL of EB.
• Samples may be stored at -20◦C and are used as stock solutions for the next
two PCR steps.
Purpose: Setup reaction to generate final PCR product to be used in ITT.
Template source: Purified PCR products from above.
Polymerase: Expand High Fidelity Polymerase (Roche).
Primers: 5’ext1 + 3’ext2 diluted 1/200 in dH2O to a final concentration of 250nM
each primer.
Method:
• Setup a PCR reaction according to table below and cycle.
• Add 1µL of 5’final + 3’final primers diluted 1/10 in dH2O to a final concentra-
tion of 5µM each. Note: the 5’final and 3’final primer may be labeled with Cy3
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PCR Mix
1µL 10mM dNTP
5µL 10x Buffer + MgCl2
1µL primers
2µL template
0.75µL HiFi Polymerase
40.25µL dH2O
50µ total
N ote: it is possible to double all quantities and run a 100µL large reaction if larger
yields are desired. The below cycle times remain the same.
Cycle Program:
Step Temperature (◦C) Time (minutes) Cycles
1 94 4:00 1x
2 94 0:30 10x
3 53 1:00
4 72 1:30
5 72 7:00
6 4 ∞
and biotin respectively, if detection and pull-down of the template is required.
• Continue cycling with below parameters.
Cycle Program:
Step Temperature (◦C) Time (minutes) Cycles
1 94 4:00 1x
2 94 0:30 30x
3 50 1:00
4 72 1:30
5 72 7:00
6 4 ∞
• Check 0.5µL of each sample on a 1% agarose gel.
• Purify each reaction on a Qiaquick spin column or 6s manifold eluting in 50-
100µL 1% BSA dH2O solution if used for spotting or 50-100µL EB for flow
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deposition.
E.3.1.2 Genomic Source
Purpose: Generate linear expression ready templates for wheat germ or rabbit retic-
ulocyte based in vitro transcription/translation using yeast genomic DNA as the
source.
Template source: yeast genomic DNA at ∼200ng/µL (SeeGene).
Polymerase: Expand High Fidelity Polymerase (Roche).
Primers: Gene specific primers at 50µM.
Method:
• Prepare PCR mix and cycle according to tables below.
PCR Mix
1µL 10mM dNTP
5µL 10x Buffer + MgCl2
1µL primers
5µL template
0.75µL HiFi Polymerase
37.25µL dH2O
50µ total
Cycle Program:
Step Temperature (◦C) Time (minutes) Cycles
1 94 4:00 1x
2 94 0:30 30x
3 53 1:00
4 72 1:30
5 72 7:00
6 4 ∞
N ote: it is possible to drop the cycles to 10 instead of 30 in order to reduce
accumulation of PCR induced point mutations.
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• Optionally check 0.5µL of each sample on a 1% agarose gel.
• Purify each reaction on a Qiaquick PCR spin column or 6s manifold eluting in
50-100µL EB.
Purpose: Second step of the PCR generating the final expression ready linear tem-
plates.
Template source: Purified PCR products from above.
Polymerase: Expand High Fidelity Polymerase (Roche).
Primers: 5’ext1 + 3’ext2 diluted 1/200 in dH2O to a final concentration of 250nM
each.
Method:
• Setup a PCR reaction and cycle according to the tables below.
PCR Mix
1µL 10mM dNTP
5µL 10x Buffer + MgCl2
1µL primers
1µL template
0.75µL HiFi Polymerase
41.25µL dH2O
50µ total
N ote: it is possible to double all quantities and run a 100µL large reaction if larger
yields are desired. The below cycle times remain the same.
• Add 1µL (add 2µL to 100µL reactions) of 5’final + 3’final primers diluted 1/10
in dH2O to a final concentration of 5µM each. Note: the 5’final and 3’final
primer may be labeled with Cy3 and biotin respectively, if detection and pull-
down of the template is required.
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Cycle Program:
Step Temperature (◦C) Time (minutes) Cycles
1 94 4:00 1x
2 94 0:30 10x
3 56.5 1:00
4 72 1:30
5 72 7:00
6 4 ∞
• Continue cycling according to below program.
Cycle Program:
Step Temperature (◦C) Time (minutes) Cycles
1 94 4:00 1x
2 94 0:30 30x
3 50 1:00
4 72 1:30
5 72 7:00
6 4 ∞
• Check 0.5µL of each sample on a 1% agarose gel.
• Purify each reaction on a Qiaquick spin column or 6s manifold eluting in 50-
100µL 1% BSA dH2O solution if used for spotting or 50-100µL EB for flow
deposition.
E.3.2 E-box Library Generation
E.3.2.1 PCR
Purpose: Generate double stranded Ebox sequences by primer extension.
Primer sources: all primers should be suspended to 50µM in TE buffer.
Method:
• prepare a PCR mix as indicated below for each reaction.
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PCR Mix
1µL 10mM dNTP
1µL 10x Buffer + MgCl2
1µL 5’ Complement + Cy5/Cy3 primer
1.2µL unique primer
0.15µL HiFi Polymerase
5.65µL dH2O
10µ total
N ote: it is possible to increase volumes according to the final quantity of product
required.
• Cycle according to the protocol below.
Cycle Program:
Step Temperature (◦C) Time (minutes) Cycles
1 94 4:00 1x
2 94 0:30 10x
3 50 1:00
4 72 1:30
5 72 7:00
6 4 ∞
• Purify each reaction using Qiagen’s nucleotide removal kit. Purification can be
performed on a 6s vacuum manifold if necessary.
E.4 Miscellaneous
E.4.1 Coating Epoxy Slides with BSA
Purpose: Generate a BSA monolayer on epoxy slides for use as a substrate for spotted
arrays.
Method:
• Prepare 500mL of a 1%BSA PBS solution
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• Submerge slides in solution and incubate for 2-3 hours at room temperature
• Rinse each slide with 18MΩ water and dry with a stream of nitrogen or air
Storage: Slides may be stored at room temperature for several months without no-
ticeable loss of activity.
214
Bibliography
[1] M. A. Unger, H. P. Chou, T. Thorsen, A. Scherer, S. R. Quake, Science 288,
113 (2000). 0036-8075 Journal Article.
[2] J. Liu, M. Enzelberger, S. Quake, Electrophoresis 23, 1531 (2002). 0173-0835
Journal Article.
[3] J. S. Marcus, W. F. Anderson, S. R. Quake, Anal Chem 78, 3084 (2006). 0003-
2700 (Print) Journal Article Research Support, N.I.H., Extramural.
[4] C. C. Lee, et al., Science 310, 1793 (2005). 1095-9203 (Electronic) Journal Ar-
ticle Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t
Research Support, U.S. Gov’t, Non-P.H.S.
[5] T. Thorsen, S. J. Maerkl, S. R. Quake, Science 298, 580 (2002). 1095-9203
Journal Article.
[6] C. L. Hansen, M. O. Sommer, S. R. Quake, Proc Natl Acad Sci U S A 101,
14431 (2004). 0027-8424 Journal Article.
[7] S. J. Maerkl, S. R. Quake, Science 315, 233 (2007). 1095-9203 (Electronic)
Journal Article Research Support, N.I.H., Extramural Research Support, Non-
U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.
215
[8] S. Park, et al., Proc Natl Acad Sci U S A 100, 13910 (2003). 0027-8424 Journal
Article.
[9] P. J. Hung, P. J. Lee, P. Sabounchi, R. Lin, L. P. Lee, Biotechnol Bioeng 89, 1
(2005). 0006-3592 Journal Article.
[10] E. M. Lucchetta, J. H. Lee, L. A. Fu, N. H. Patel, R. F. Ismagilov, Nature 434,
1134 (2005). 1476-4687 Journal Article.
[11] J. Liu, C. Hansen, S. R. Quake, Anal Chem 75, 4718 (2003). 0003-2700 Journal
Article.
[12] E. Delamarche, A. Bernard, H. Schmid, B. Michel, H. Biebuyck, Science 276,
779 (1997). 0036-8075 Journal Article.
[13] T. Kinpara, et al., J Biochem (Tokyo) 136, 149 (2004). 0021-924x Journal
Article.
[14] L. R. Huang, et al., Nat Biotechnol 20, 1048 (2002). 1087-0156 Technical Re-
port.
[15] C. L. Hansen, E. Skordalakes, J. M. Berger, S. R. Quake, Proc Natl Acad Sci
U S A 99, 16531 (2002). 0027-8424 Journal Article.
[16] B. Zheng, J. D. Tice, L. S. Roach, R. F. Ismagilov, Angew Chem Int Ed Engl
43, 2508 (2004). 0570-0833 Journal Article.
[17] B. Zheng, R. F. Ismagilov, Angew Chem Int Ed Engl 44, 2520 (2005). 0570-0833
Journal Article.
216
[18] F. H. Arnold, Nature 409, 253 (2001). 0028-0836 Journal Article Review Re-
view, Tutorial.
[19] M. W. Nirenberg, J. H. Matthaei, Proc Natl Acad Sci U S A 47, 1588 (1961).
0027-8424 (Print) Journal Article.
[20] D. Clayton, et al., Proc Natl Acad Sci U S A 101, 4764 (2004). 0027-8424
(Print) Journal Article Research Support, U.S. Gov’t, P.H.S.
[21] P. E. Dawson, S. B. Kent, Annu Rev Biochem 69, 923 (2000). 0066-4154 (Print)
In Vitro Journal Article Review.
[22] T. L. Hendrickson, V. de Crecy-Lagard, P. Schimmel, Annual Review of Bio-
chemistry 73, 147 (2004).
[23] D. A. Dougherty, Curr Opin Chem Biol 4, 645 (2000). 1367-5931 (Print) Jour-
nal Article Research Support, U.S. Gov’t, P.H.S. Review.
[24] M. Taki, T. Hohsaka, H. Murakami, K. Taira, M. Sisido, FEBS Lett 507, 35
(2001). 0014-5793 (Print) Journal Article Research Support, Non-U.S. Gov’t.
[25] T. Hohsaka, Y. Ashizuka, H. Taira, H. Murakami, M. Sisido, Biochemistry 40,
11060 (2001). 0006-2960 (Print) Journal Article Research Support, Non-U.S.
Gov’t.
[26] S. Gite, S. Mamaev, J. Olejnik, K. Rothschild, Anal Biochem 279, 218 (2000).
0003-2697 (Print) Journal Article Research Support, U.S. Gov’t, Non-P.H.S.
Research Support, U.S. Gov’t, P.H.S.
217
[27] D. Kiga, et al., Proc Natl Acad Sci U S A 99, 9715 (2002). 0027-8424 (Print)
Journal Article.
[28] Y. Shimizu, et al., Nat Biotechnol 19, 751 (2001). 1087-0156 (Print) Journal
Article Research Support, Non-U.S. Gov’t.
[29] V. Noireaux, R. Bar-Ziv, A. Libchaber, Proceedings of the National Academy
of Sciences of the United States of America 100, 12672 (2003).
[30] N. Ramachandran, et al., Science 305, 86 (2004).
[31] P. Angenendt, et al., Anal Chem 76, 1844 (2004). 0003-2700 Journal Article.
[32] T. Sawasaki, T. Ogasawara, R. Morishita, Y. Endo, Proceedings of the National
Academy of Sciences of the United States of America 99, 14652 (2002).
[33] T. Kigawa, et al., FEBS Lett 442, 15 (1999). 0014-5793 (Print) Journal Article
Research Support, Non-U.S. Gov’t.
[34] K. Madin, T. Sawasaki, T. Ogasawara, Y. Endo, Proc Natl Acad Sci U S A
97, 559 (2000). 0027-8424 (Print) Journal Article Research Support, Non-U.S.
Gov’t.
[35] M. Zuker, Nucleic Acids Res 31, 3406 (2003). 1362-4962 (Electronic) Journal
Article Research Support, U.S. Gov’t, P.H.S.
[36] R. F. Ismagilov, J. M. Ng, P. J. Kenis, G. M. Whitesides, Anal Chem 73, 5207
(2001). 0003-2700 (Print) Journal Article.
218
[37] M. Schena, D. Shalon, R. W. Davis, P. O. Brown, Science 270, 467 (1995).
0036-8075 (Print) Journal Article Research Support, Non-U.S. Gov’t Research
Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.
[38] J. S. Kim, R. T. Raines, Protein Sci 2, 348 (1993). 0961-8368 (Print) Journal
Article Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-
P.H.S. Research Support, U.S. Gov’t, P.H.S.
[39] B. R. Kelemen, et al., Nucleic Acids Res 27, 3696 (1999). 1362-4962 (Elec-
tronic) Journal Article Research Support, Non-U.S. Gov’t Research Support,
U.S. Gov’t, P.H.S.
[40] M. E. Massari, C. Murre, Molecular & Cellular Biology 20, 429 (2000).
[41] K. A. Robinson, J. I. Koepke, M. Kharodawala, J. M. Lopes, Nucleic Acids Res
28, 4460 (2000). 1362-4962 Journal Article.
[42] C. Murre, P. S. McCaw, D. Baltimore, Cell 56, 777 (1989).
[43] T. K. Blackwell, L. Kretzner, E. M. Blackwood, R. N. Eisenman, H. Weintraub,
Science 250, 1149 (1990).
[44] E. V. Prochownik, M. E. VanAntwerp, Proceedings of the National Academy of
Sciences of the United States of America 90, 960 (1993).
[45] T. K. Blackwell, et al., Molecular & Cellular Biology 13, 5216 (1993).
[46] L. Kretzner, E. M. Blackwood, R. N. Eisenman, Nature 359, 426 (1992).
219
[47] E. M. Blackwood, B. Luscher, R. N. Eisenman, Genes & Development 6, 71
(1992).
[48] E. M. Blackwood, R. N. Eisenman, Science 251, 1211 (1991).
[49] T. D. Halazonetis, A. N. Kandil, Proc Natl Acad Sci U S A 88, 6162 (1991).
0027-8424 Journal Article.
[50] S. J. Berberich, M. D. Cole, Genes Dev 6, 166 (1992). 0890-9369 Journal Article.
[51] M. Springer, D. D. Wykoff, N. Miller, E. K. O’Shea, PLoS Biol 1, E28 (2003).
1545-7885 Journal Article.
[52] M. Byrne, N. Miller, M. Springer, E. K. O’Shea, J Mol Biol 335, 57 (2004).
0022-2836 Journal Article.
[53] A. Kaffman, N. M. Rank, E. M. O’Neill, L. S. Huang, E. K. O’Shea, Nature
396, 482 (1998). 0028-0836 (Print) Journal Article Research Support, Non-U.S.
Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t,
P.H.S.
[54] A. Komeili, E. K. O’Shea, Science 284, 977 (1999). 0036-8075 (Print) Journal
Article Research Support, Non-U.S. Gov’t.
[55] W. R. Atchley, W. M. Fitch, Proc Natl Acad Sci U S A 94, 5172 (1997). 0027-
8424 Journal Article.
[56] C. Murre, et al., Biochim Biophys Acta 1218, 129 (1994). 0006-3002 Journal
Article Review Review, Tutorial.
220
[57] A. R. Ferre-D’Amare, G. C. Prendergast, E. B. Ziff, S. K. Burley, Nature 363,
38 (1993). 0028-0836 Journal Article.
[58] T. Ellenberger, D. Fass, M. Arnaud, S. C. Harrison, Genes Dev 8, 970 (1994).
0890-9369 Journal Article.
[59] T. Shimizu, et al., Embo J 16, 4689 (1997). 0261-4189 Journal Article.
[60] S. K. Nair, S. K. Burley, Cell 112, 193 (2003). 0092-8674 Journal Article.
[61] S. Sauve, L. Tremblay, P. Lavigne, J Mol Biol 342, 813 (2004). 0022-2836
Journal Article.
[62] A. Orian, et al., Genes Dev 17, 1101 (2003). 0890-9369 Journal Article.
[63] S. Cawley, et al., Cell 116, 499 (2004). 0092-8674 Journal Article.
[64] A. S. Carroll, A. C. Bishop, J. L. DeRisi, K. M. Shokat, E. K. O’Shea, Proc Natl
Acad Sci U S A 98, 12578 (2001). 0027-8424 (Print) Journal Article Research
Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.
[65] N. Ogawa, J. DeRisi, P. O. Brown, Mol Biol Cell 11, 4309 (2000). 1059-1524
(Print) Journal Article Research Support, Non-U.S. Gov’t Research Support,
U.S. Gov’t, P.H.S.
[66] N. A. Kent, S. M. Eibert, J. Mellor, J Biol Chem 279, 27116 (2004). 0021-9258
(Print) Journal Article Research Support, Non-U.S. Gov’t.
221
[67] M. Cai, R. W. Davis, Cell 61, 437 (1990). 0092-8674 (Print) Comparative
Study Journal Article Research Support, Non-U.S. Gov’t Research Support,
U.S. Gov’t, P.H.S.
[68] R. E. Baker, D. C. Masison, Mol Cell Biol 10, 2458 (1990). 0270-7306 (Print)
Journal Article Research Support, U.S. Gov’t, P.H.S.
[69] S. Ghaemmaghami, et al., Nature 425, 737 (2003). 1476-4687 Journal Article.
[70] G. C. Yuan, et al., Science 309, 626 (2005). 1095-9203 (Electronic) Journal Ar-
ticle Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t
Research Support, U.S. Gov’t, P.H.S.
[71] C. T. Harbison, et al., Nature 431, 99 (2004). 1476-4687 (Electronic) Journal
Article Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.
[72] Y. Takeda, A. Sarai, V. M. Rivera, Proc Natl Acad Sci U S A 86, 439 (1989).
0027-8424 (Print) Journal Article Research Support, U.S. Gov’t, P.H.S.
[73] A. Sarai, Y. Takeda, Proc Natl Acad Sci U S A 86, 6513 (1989). 0027-8424
(Print) Journal Article Research Support, U.S. Gov’t, P.H.S.
[74] K. D. MacIsaac, E. Fraenkel, PLoS Comput Biol 2, e36 (2006). 1553-7358 (Elec-
tronic) Journal Article Research Support, Non-U.S. Gov’t.
[75] G. D. Stormo, J Theor Biol 195, 135 (1998). 0022-5193 (Print) Letter.
[76] G. D. Stormo, D. S. Fields, Trends Biochem Sci 23, 109 (1998). 0968-0004
(Print) Journal Article Review.
222
[77] M. L. Bulyk, Genome Biol 5, 201 (2003). 1465-6914 (Electronic) Journal Article
Research Support, Non-U.S. Gov’t Review.
[78] T. D. Schneider, R. M. Stephens, Nucleic Acids Res 18, 6097 (1990). 0305-1048
(Print) Journal Article Research Support, Non-U.S. Gov’t Research Support,
U.S. Gov’t, P.H.S.
[79] G. E. Crooks, G. Hon, J. M. Chandonia, S. E. Brenner, Genome Res 14, 1188
(2004). 1088-9051 (Print) Journal Article Research Support, Non-U.S. Gov’t
Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.
[80] T. K. Man, G. D. Stormo, Nucleic Acids Res 29, 2471 (2001). 1362-4962 (Elec-
tronic) Journal Article Research Support, U.S. Gov’t, P.H.S.
[81] P. V. Benos, M. L. Bulyk, G. D. Stormo, Nucleic Acids Res 30, 4442 (2002).
1362-4962 (Electronic) Comparative Study Journal Article Research Support,
Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.
[82] M. L. Bulyk, P. L. Johnson, G. M. Church, Nucleic Acids Res 30, 1255 (2002).
1362-4962 (Electronic) Journal Article Research Support, U.S. Gov’t, Non-
P.H.S.
[83] D. S. Spinner, S. Liu, S. W. Wang, J. Schmidt, Journal of Molecular Biology
317, 431 (2002).
[84] A. V. Grinberg, T. Kerppola, J Biol Chem 278, 11227 (2003). 0021-9258 (Print)
Journal Article.
223
[85] S. Park, et al., Biochim Biophys Acta 1670, 217 (2004). 0006-3002 Journal
Article.
[86] Y. Fujii, T. Shimizu, T. Toda, M. Yanagida, T. Hakoshima, Nat Struct Biol
7, 889 (2000). 1072-8368 (Print) Journal Article Research Support, Non-U.S.
Gov’t.
[87] M. A. Schumacher, R. H. Goodman, R. G. Brennan, J Biol Chem 275, 35242
(2000). 0021-9258 (Print) Journal Article Research Support, U.S. Gov’t, Non-
P.H.S. Research Support, U.S. Gov’t, P.H.S.
[88] S. Impey, et al., Cell 119, 1041 (2004). 0092-8674 (Print) Journal Article Re-
search Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Re-
search Support, U.S. Gov’t, P.H.S.
[89] O. Hallikas, et al., Cell 124, 47 (2006). 0092-8674 (Print) Journal Article Re-
search Support, Non-U.S. Gov’t.
[90] J. E. Hooper, M. P. Scott, Nat Rev Mol Cell Biol 6, 306 (2005). 1471-0072
(Print) Journal Article Research Support, Non-U.S. Gov’t Research Support,
U.S. Gov’t, P.H.S. Review.
[91] K. Ferrell, C. R. Wilkinson, W. Dubiel, C. Gordon, Trends in Biochemical
Sciences 25, 83 (2000).
[92] J. Walz, et al., J Struct Biol 121, 19 (1998). 1047-8477 Journal Article.
[93] M. Groll, et al., Nature 386, 463 (1997). 0028-0836 Journal Article.
224
[94] E. A. Winzeler, et al., Science 285, 901 (1999). 0036-8075 (Print) Journal
Article Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.
[95] D. M. Gelperin, et al., Genes Dev 19, 2816 (2005). 0890-9369 (Print) Journal
Article Research Support, N.I.H., Extramural.
[96] W. K. Huh, et al., Nature 425, 686 (2003). 1476-4687 Journal Article.
[97] J. R. Newman, et al., Nature 441, 840 (2006). 1476-4687 (Electronic) Jour-
nal Article Research Support, N.I.H., Extramural Research Support, Non-U.S.
Gov’t Research Support, U.S. Gov’t, Non-P.H.S.
[98] S. Paliwal, et al., Nature 446, 46 (2007). 1476-4687 (Electronic) Journal Arti-
cle Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, Non-
P.H.S.
[99] A. P. Gasch, et al., Mol Biol Cell 12, 2987 (2001). 1059-1524 (Print) Com-
parative Study Journal Article Research Support, Non-U.S. Gov’t Research
Support, U.S. Gov’t, P.H.S.
[100] J. J. Wyrick, et al., Nature 402, 418 (1999). 0028-0836 (Print) Journal Article
Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.
Research Support, U.S. Gov’t, P.H.S.
